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INTRODUCTION 
             The siddha medicine is one of the oldest traditional  system in the world.   
The word “Siddha”comes from the word “Siddhi” which means an object to be 
attained perfection or .Siddha focused to “Astamahasiddhi” that is the eight 
supranatural power. Those who attained or achieved the above said powers are known 
as siddhars .It is the first system to emphaise that health is the perfect state of 
physical, psychological, social and spiritual component of human being. 
            According to Therayar in his Thaila vargachurukkam, have been explained a 
physician should have a detailed knowledge about geographical and seasonal 
variation ,physical and mental state  of the patients and deep knowledge to about the 
diseases. 
             Faith in the medicine is necessary before taking them .Mental health is 
necessary for physical well being. Thiruvalluvar says, 
                               “Neha;ehb Neha; Kjy; ehb mJ jzpf;Fk; 
              tha;ehb tha;g;gr; nray;” 
             The system strongly advocates proper food habits.The improper food habits 
producing  disease. The universe and the body are formed by the same elements in 
different proportions. 
                              “mz;lj;jpYs;sNj gpz;lk; 
              gpz;lj;jpYs;sNj mz;lk; 
              mz;lKk; gpz;lKk; xd;Nw 
              mwpe;J jhd; ghHf;Fk; NghNj” 
                                               rl;l Kdp Qhdk; 
                  The first phase in human life is attributed to Vatha, the middle to Pitha, 
and the late phase to Kapha, 
              “thjkha; gilj;J 
               gpj;j td;dpaha; fhj;J 
               Nrj;Jk rPjkha;Jilj;J” 
                                           Njud; kUj;Jt ghujk; 
                 The basic theory of siddha system of medicine is “Food is medicine 
,medicine is food”. The human body is a compose of three humours such as Vatham, 
Pitham, kapham. Seven Physical mechanisms Uyir thathukal such as Saaram 
(plasma), Seneer (blood), Oon (muscle), Kollzuppu (fatty tissue), Enbu (bone), 
Moolai (brain), Sukkilam (semen).   
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             Siddhars defined 96 principles as the constituents of the human being. They 
are nothing   but the mineralizations of the“Five basic Elements”such Man, Neer, 
Theyu, Vayu, Agayam 
             When the normal equilibrium of three humours  (Vatham ,Pitham ,kapham) is 
disturbed, disease is caused. The factors which assumed to affect this equilibrium are 
environment, seasonal variations, diet, physical activities and stress. Under normal 
conditions the ratio between these three humours  Vatham, Pitham,kapham is 4:2:1. 
          In diagnosis, examination of eight items is required which is commonly known 
as “Envagai thervugal” 
 Nadi - Pulse 
 Sparisam - Touch 
 Na - Tongue 
 Niram - Colour 
 Mozhi - Voice 
 Vizhi – Eyes 
 Maalam - Stool 
 Moothiram - Urine  
 
             The drugs used by the siddhars could be classified into 3 groups. 
Thavara(herbal products),Thathu(organic and inorganic substances)and 
Sangamam(Animal products).The drugs also classified on the basis of five properties. 
             Suvai (taste), Gunam (character), Veeriyam (potency), Pirivu (class), 
Mahimai (action). 
            The five physical elements combine in various formula to create various types 
of objects. For example the human body as a whole in general is said to be constituted 
with Five parts of physical earth, Four parts of physical water, Three parts of physical 
heat, Two parts of physical air, and One part of physical space. The above said 
formula is only for the total human organism, and not applicable for the various 
structures in which it is constituted, such as organs, bone, flesh, nerves, skin.  
 
Tri dosha thathuvam 
Vatha   :  Vathanadi or Chandra nadi with abana vayu recides of the seat of         
                           rectum and intestines- situated in Agni mandalam  
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Pitha    : Surya nadi with prana vayu is found in the seat of water embracing  
                           the liver in Surya mandalam. 
Kapham  : Agni pulse with samana vayu is located in the seat of semen in the  
                          cold lunar region –below the top of the head embracing the pineal  
                          gland.  
            Siddhars classified the  disease into 4448 types. One among them is 
KALLADAIPPU NOI, which is assorted under visarkauruppugal noigal 
KALLADAIPPU NOI is compared to UROLITHIASIS in modern medicine.  
            According to siddha Noinadal text part I &II Neer noigal classified only 
quantity of passing urination. 
           The disease of urinary system is classified into  
1. Neerinai arukkal noigal –Acquired or Oliguria state 
2. Neerinai perukkal noigal – Polyuria state 
 
       In yugi vaidhya chinthamani-800, 2nd part, kalladaippu noi comes under 
neerinai arukkal noigal. Kidney stones are small, solid masses formed when salts or 
minerals normally found in urine become solid crystals inside the kidney. Urinary 
stones consititutes one of the most common diseases in our country and pain due to 
kidney stone is known worse than that of labour pain.  
           Kidney stones do not have a single, well defined cause, but are the result of a 
combination of factors. A stone is created when the urine does not have the correct 
balance of fluid and a combination of minerals and acids. when the urine contains 
more crystal-forming substances than the fluid can be dilute, crystals can form. The 
diagnosis of a kidney stone can be confirmed by radiological studies or ultrasound 
examination; urine tests and blood tests are also commonly performed. Preventive 
strategies may include dietary modifications and medication with the goal of reducing 
excretory load on the kidneys.  
            Several drugs are available for treating kalladaippu noi in siddha medicine 
system. It is evident from the siddha literature that therapeutic values of several drugs 
have been proved. However, clinical trials on the treatment of kalladaippu noi have 
not yet been undertaken for the medicines like, NilakumilaVer Kudineer (internal) 
mentioned in Agasthiyar Vaithiya Kaviyam 1500 respectively. Hence, these siddha 
medicines have been choosen for my dissertation work to evaluate their therapeutic 
values in the treating kalladaippu noi.  
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                                           AIM AND OBJECTIVES  
Urolithiasis  
           Urolithiasis (from greek ouron, “urine” + lithos “stone” + iasis) is the 
formation of urinary calculi (urinary stones), which are calculi formed or located 
anywhere in the urinary system. It comprises nephrolithiasis (the formation of kidney 
stones cystolithiasis (The formation of bladder stones)  
            Urinary stone formation is a common disease with an increasing incidence 
and prevalence worldwide that appears even more pronounced in industrialized 
countries such observations seen to underscore the impact of lifestyle and dietary 
choices as well as access to better medical care for urinary stone formation .  
        A total of 40 patients of both sex (20 op and 20 ip) were selected and 
administered with the following trial drug at PG department of pothumaruthuvam, 
government siddha medical college and hospital, palayamkottai 
 
PRIMARY OBJECTIVE  
             The aim of my dissertation work is to evaluate the clinical efficacy of the trial 
drug, NILAKUMILAVER KUDINEER .  
 
SPECIFIC OBJECTIVES  
             1. To recruit patients with KALLADAIPPU NOI for clinical trial, on the 
basis of etiology and clinical features mentioned in various siddha literatures and 
modern Text books.  
             2. To investigate siddha fundamental and modern parameters during and after 
treatment in all recruited patients.  
             3. To perform urine analysis, haematological studies and ultrasonography for 
all patients before and after treatment.  
             4. To perform stone analysis in selected cases.  
             5. To undertake biochemical analysis of the clinical trial drug.  
             6. To evaluate pharmacological activity such as lithotriptic, diuretic and 
analgesic activities of the trial medicine.(Nilakumilaver Kudineer.)  
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                                                      ABSTRACT  
             Kalladaippu is the most common any one disease in our country. The disease 
kalladaippu can  correlated  in modern science is urolithiasis.. One such drug, 
“Nilakumilaver Kudineer” mentioned in the book AGATHIYAR VAITHYA 
KAVIYAM -1500 ,PAGE NO.651 &652) .Hence I have chosen this medicine as my 
dissertation work to evaluate its therapeutic efficacy in treating kalladaippu noi.  
          The disease was diagnosed by following various siddha diagnostic 
investigation methods. A total of 40 patients of both sex (20 op and 20 ip) were 
selected and administered with the following trial drug at PG department of 
pothumaruthuvam, government siddha medical college and hospital, palayamkottai.  
       Nilakumilaver Kudineer – 50ml , BD morning and evening with . The trial 
medicine was subjected to biochemical, pharmacological and acute toxicity studies. 
At the end of the study trial drug is safe and effective in the treatment of 
KALLADAIPPU NOI.  
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                                        REVIEW OF LITERATURES 
SIDDHA ASPECTS 
            The siddha system of medicine is believed to be more than 10,000 years old 
and to be considered to be one of the most traditional systems. Among the various 
diseases, “Kalladaippu noi” is one of the most common diseases in India. Several 
preventive and curative treatments are found in various siddha literatures for 
kalladaipu noi. 
             The ancient siddha literature yugi vaidhya chinthamani 800 is clearly 
mentioned Kalladaippu noi is under the topic of  Neerinai Arukkal Noi. 
                                           “ePupU tpidf; Fzj;ij 
                    ePawp tpupj;Jr; nrhy;Nthk; 
                    ePupid ngUf;fnyhd;Nw 
                    ePupid aUf;f nyhd;Nw 
                    ePupopTlNd nfhy;Yk; 
                    ePHf;fl;L tpidfnshd;W” 
                                                   Njud; fupry; 
                   Neha;ehly; Neha; Kjy; ehly; - 2k; ghfk;> gf;fk; 420 
1. NtWngau;fs; (Synonym) 
          Ashmari Rogam 
 
2.   ,ay;( Definition) 
          The kalladaippu noi has been defined differently by various authors. 
i. In “Agathiyar Gunavagadam” , kalladaippu noi is defined as below: 
                                  “jhndd;w %j;jpuj;jpy; ew ewntd;W 
                jq;fpaNjhH nghbnaDk; kzy;jhdg;gh 
                thndd;w rpwpanjhU fy;yhtjg;gh 
                tskhf te;JtpOk; Neha;f;F jhNd 
                Vndd;w m];kup Nuhfnkd;w Nguhk; 
                vspjhff; fy;Yfs;jhd; tpOFk;NghJ 
                Nfhndd;w Fz;bf;fha; %j;jpuf;Foyg;gh 
                Fzkhd %j;jpug;ig ePh;j;jhiuf; NfNs” 
                Nfslh Kd; Fwpapy; vupr;ry; fz;L 
                nfbahf Ntjidfs; fhl;Lkg;gh 
                thslh rpwpanjhU fw;fs;jhNd 
                tskhd %j;jpug;ig Foy; topg;gbaha;j;  
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               Njslh tUk;NghJ jpNufe;jd;dpy; 
               njhpg;gJ Nghy apUNtjid nra;Ak;ghU 
               ehslh fw;fs;jh dpwq;fptpl;lhy; 
               eykhd Ntjidfs;jhd; jPUk;ghNu”  
                                            mfj;jpaH Fzthflk;  
The above poem written by Agathiyar, defines kalladaippu noi as “Deposition 
of sand like grains in urine, which results in formation of small, followed by 
expulsion of stones along with urine”. Further, he explained that the stones obstruct in 
the kidney, ureter, urinary bladder and urethra. When the stones reaching the urethral 
orifice, intense burning sensation in glans penis occurs. Then the stones get expelled 
and pain is relieved. 
1. In “T.V. Sambasivam pillai Agarathi”, kalladaippu noi is defined as: 
Large concentration of stones in the bladder or kidney produces calculus or 
gravel. It causes difficulty in passing urine. 
2.  In Siddha maruthuvam, kalladaippu noi is defined as: 
Sudden obstruction of flow of urine during micturition, pain in the tip of the 
penis  male and clitoris in female, burning sensation in urethral orifice, pain 
radiating from loin to groin, presence of sand-like stones in the urine are the 
cardinal symptoms of this disease. 
3.  Roga Nirnaya saaram under Roga nithaanam, kalladaippu noi is defined as:  
Pain in and around the umbilicus, dysuria, urine odours like goat‟ s urine, fever, 
chills and anorexia are common features of this disease. 
 
Noi varum vazhi (aetiology) 
The causes of the disease mentioned in various siddha literature are as follows 
01.              “miwfpNwd; tpe;jope;jhy; Nkfkhr;R 
         mKJ tope;J #Lnfhz;lhy; thA NrUk; 
         giwfpNwd; #iyf; Fl;lk; fpue;jp Gw;W 
         gTj;jpuk; fs; gpsit Nghl;L fz;lkhiy 
         miwfpNwd; miuahg;G xl;ba G[ 
         mUq;fug;ghd; rpuq;F Fd;kk; khePHf;fl;L 
         FiwaNt ePH nfhz;l me;Neha; fhrk; 
         Fbykhk; NgjpNahL fpuhzp ghz;Nl 
                                   mfj;jpaH itj;jpa ty;yhjp 600  
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02.                 “njspe;jNjhH fy;yilg;G cw;gj;jp Nfsha; 
           rpwpJehl; nlhlq;fpNa Nkfe; jd;dpy; 
           jspe;jNjhH ryg;igap Yjpuj; Njha;e;J 
           re;jrj; jhfNt gUj;Jf; nfhs;Sk; 
           tspe;jNjhH thjgpj;jq; Nfhgpj; jf;fhy; 
           te;JngUq; fy;yha; ePH topa ilj;J 
           espe;NjhH ehYtpjf; fy;y ilj;J 
           ez;ghd tuyhW ehl;lf; NfNs” 
                                            ghly; 725> gf;fk; 283 
03.                 “fyq;fpdNjhH jz;zPHjhd; Fbj;j NgHf;Fq;  
           fy;nyYk;G kaph;kz;jhd; fye;jd; dj;jpy; 
           myq;fpdNjh ud;dq;f sUe;j yhYk; 
           mOfNyhL %j;jgz;l kUe;j yhYk; 
           kyq;fpdNjhH khg;gz;l kUe;j yhYk; 
           ke;jj;jpy; tha;thd gjhHj;je; jd;id 
           Jyq;fpdNjhH Urpjd;dpw; Ritj;j yhYk; 
           RUf;fha;f;fy; yilg;Gte;J Njhd;We; jhNd”  
                   A+fp itj;jpa rpe;jhkzp - 800 ghly; 727> gf;fk; 284 
            The above mentioned poems reveal that in the patients suffering from chronic 
mega noi, the semen stagnates in the urinary tract for a long time, leading to the 
obstruction of the tract. This condition results in the deposition of urine constituents 
and formation of stones in the urinary tract. In meanwhile, due to the increased 
vatham and pitham, the small stones become large in size and obstruct the urinary 
passage. The formation of urinary stones is also attributed to the drinking 
contaminated, hard water, consuming food adultered with sand and small stones, 
contaminated food, starchy food and unhealthy food habits etc. 
               “ePupidj; jLj;jy; nra;apd; 
                    ePHf;fl;Lj; Jthuk; Gz;zhk; 
               ghhpLQ; re;J re;jpy; 
                    gz;GW Neht jhFk; 
               Neupyq; faUq; fhkpak; 
                    epr;ra Nehjy; nra;Ak; 
               ghupdp yghd thA 
                    gz;Gwr; NrU kd;Nw” 
                              rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 212  
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           It is inferred from the above that when urine is ceased deliberately, obstruction 
of urine flow, ulcer in the urethral orifice, pain in the glans penis, increased abaana 
vayu in the abdomen will result in. 
                                “Rf;fpye;jida lf;fpd; 
               RuKldPHf;fl; lhFk; 
               gf;fkhq;iffhy; re;J 
               ghu Neha; topapwq;Fk; 
               kpf;fkhH NehAz;lhFk; 
               kpFj;jpLk; gpuNk fe;jhd; 
               jf;f NjhH NghJkhfpd; 
               jupj;jpLk; thAf; $Nw” 
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; - 212 
         As per nature of the body of human beings, semen needs to be discharged 
regularly. In this regard, the above said poem emphasizes that deliberate cessation of 
seminal discharge results in fever, lumbar pain, oliguria, chest pain and white 
discharge. 
Pothu kuri kunangal  (Common symtoms) 
 Frequent urination, 
 Sudden obstruction of urine flow, 
 Excruciating pain in the glans penis and anus, 
 Sometimes, when the stone attempts to expel by rolling down, it , may 
not too able to expel due to obstruction either in urethra or in the urethral 
orifice. This condition will result in agonizing pain and swelling in the 
genito-urinary tract. 
 When the stones are rough and irregular with sharp projections burning 
sensation and pain will occur in the lower abdomen and urethral orifice, 
sometimes it may lead to hematuria. 
                                                             Noi naadal noi mudal naadal,Text  vol-II,427 
 
Some disease are associated with kalladaippu noi in Siddha text 
                       “Fj;J Kj;fhu#iy apd;F ze;jhd; 
                NfhHitaha; tpyhTjdpy; KJfpy; neQ;rpy; 
           mj;jp apdpy; ehgpapy ghdkhq;F jj;jpy; 
                mjpf Jd;khq;fpre;jhd; tsHe;J Nktpg;  
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           gj;Jkzw; gLf;ifNghw; ryj;J thug; 
                gjpneUf;fp %j;jpukhq; fpupr;rp Az;lha;j; 
          jj;Jrlq; fLg;ngLj;J kjpf yq;fpj; 
                jsHr;rp nahLkaf;fkha;j; js;Se; jhNd” 
                      A+fp itj;jpa rpe;jhkzp – 800> gh 233> gf;fk; 88 
            This poem reveal that the symptoms of kalladaippu noi include followed 
stricture of urethral orifice by sand-like crystals, block in the urethral passage. In 
addition, dysuria,   Hematuria, Fever, tiredness and guiddiness also occur. 
Classification 
     There are several types of kidney stones (urolithiasis). In the siddha books, it 
is evident from various siddha literatures . Some of them  given below. 
A. As per Maan Murugiyam 
   fy; Njhd;wy; 
               “ePufk; ePupak; miyak; 
                %d;wpDe; fw;fs; Njhd;wp 
                cg;GKj Ylk;gpd; fopTg; nghUs;fSk; 
                mdYk; IaKk; mbg;gL khRk; 
                jpuz;L ry;nydr; nrwptJ fy;Ny” 
              (ePufk; - rpWePufk;> ePupak; - rpWePHg;ig> miyfk; - fUg;ig) 
   ePuff; fy;yilg;G 
               “Rz;zk; cg;G Kjw;gy nghUs;fs; 
                rpWeP ufj;jd fye;J nrwpe;J 
                fw;Nghy; jpuz;L ePUftha;fspy; 
                epWePHf; Foha;fs; milj;J epw;gJ 
                ePuff; fy;nyd efo;e;JtH rhd;NwhH 
   ePupaf; fy;yilg;G 
               “gpire;njd ePupatypNjhd; wpLjy; 
                rpWeP uialy; vDkpit gpwTk; 
                ePupaf; fy;yil tpisj;jpL nkd;g” 
mdyf; fy;yilg;G 
               “mdypd; $Wfs;jpuz;L nrwpe;J 
               fw;Nghy; tbtha; miyf thia  
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                milg;g jiyff; fy;yilg; ghFk; 
                fha;jy; ntspwy; JaHjy; typj;jy; 
                vjpnuLg; ghjy; Njhspy; typAwy; 
                vDkpit gpwTk; kt;topj; Njhd;Wk; 
                fy;yJ Flypw; GFe;jpL khapd; 
                $wpa Fwpfs; khwpL nkd;g 
                miyfj; jf;fy; GFe;J nrwpapd; 
                fha;jy; Nehjy; Mf;if ntspwy; 
                fhkye; Njhd;wy; nkypjy; gpwTk; 
                jiytU nkd;g epiyawp E}NyhH 
                fy;yJ kUe;jpy; fiuah jhapd; 
                mWitah dPf;fy; kunad; nkhopg”; 
  jPuhjd 
                “ePuf Kfk;Giu gLjy; rPwp 
                mdy; kpFjy; cDkpit Njhd;wpd; 
                rpWePHg; gpzpfs; jPuh thFk;” 
  tif 
               “tspKjy; %d;wpDe; Njhd;w yhYk; 
                fUePH jd;dpw; Nwhd;w yhYk; 
                fy;yil ehy;tifg; gLnkd nkhopg” 
  nghJf;FwpFzq;fs; 
               “te;jp jd;dpy; mjd;fPo; kUq;fpDk; 
                tpiueuk; gplj;Jk; NehT Njhd;wy; 
                rpWePH newpapy; fy;YWj; jLg;gpd; 
                Kupe;J Kupe;J ePHtPo;e; jpLk; 
                fy;yJ tpyfp epd;wpbd; rpWePH 
                njspe;jpd kQ;rs; epWj;jp nyhopjy; 
                vDkpit fy;yilg; nghJf;Fwp nad;g 
                ePupak; ,af;Fk; cog;G kpf;fpl;by; 
                ePuJ FUjp fye;J ntspg; glYk; 
                NehT Njhd;wY kpay;ngd nkhopg”  
 Renal colic 
 Dysuria 
 Testicular pain 
 Haematuria 
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  tspf;fy;ilf; Fwpfs; 
               “fWj;Jk; rptj;Jk; Kisfs; gue;Jk; 
                tspapd; fy;yJ tbTW nkd;g” 
  mdyf; fy;yilf; Fwpfs; 
               “Rl;nld ePupak; kpfntg; gpLj;jYk; 
                NehjYk; mdyf; fy;yilf; FwpNa 
                rpte;Jk; fWj;J kQ;r shfpAk; 
                Nrq;FU tbtpy; fy;yJ Njhd;Wk;” 
  Iaf;fy;yyilf;Fwpfs; 
               “ePupaq; Fj;jy; jpzpj;jy; Fspj;jy; 
                vDkpit Iaf; fy;yilf;FwpNa 
                ntSj;Jk; Njdpw khfpA nkhspHe;Jk; 
                ngUtb Tilj;jhk; Iaf; fy;yil” 
  fUePHf;fy;yilf;Fwpfs; 
               “ePupak; Nehjy; rpWePH jilg;gly; 
                tpiutpy; fpLjy; vDkpit gpwTk; 
                fUePHf; fy;yilf; Fwpnadnkhopg” 
   Vali, Azhal, Iyya Kalladaippu commonly stone sited only at Kidney and Ureter, 
but Veener kalladaippu stone is sited in the Prostate gland(Vesicular stone). 
        
 B. In yugi vaidhya chinthamani-800 
                                “Njhd;wplNjhH ehypdpl ehkq;Nf sha; 
               RWf;fhd thjj;jpd; fy;y ilg;G 
               G+d;wpaNjhH gpj;jj;jpd; fy;y ilg;G 
               Guz;lNjhH rpNyl;Lkj;jpd; fy;y ilg;G 
               jPd;wpaNjhH njhe;jkhq; fy;y ilg;G 
               Njfj;ijg; gw;wpNa rpwpJ fhyk; 
               jhd;wpNa ryg;igapy; te;jp ope;J 
               rUtpNa ypq;fj;jpw; wupf;Fe; jhNd” 
                                              gh 728> gf;fk; 284 
                             The above poem mentioned in the yugi vaidhya chinthamani-800, 
classifies   kalladaippu noi in to four types. They are, 
      1. Vali kalladaippu 
      2. Azhal kalladaippu 
      3. Iyya kalladaippu 
      4. Mukkutra kalladaippu 
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Vali kalladaippu 
                                  “jupj;J ehgpf;F RUf;fkha; Fw;wpr; 
                rykye;jhd; tPohkw; wk;g khfp 
                tupj;JNk ypq;fj;jpy; typA khfp 
                kUtpaNjhH nghj;jpnayhQ; Rue;J fl;b 
                jphpj;jpNa fpilf;nfhlhg; gpul;lyhfpj; 
                Njk;gpNa %r;Rkha; tapW Kg;Gk; 
                cupj;jNjhH rijNghy ctHg;G khFk; 
                Xq;fpaNjhH thjf;fy;y ilg;G jhNd” 
                                              gh 729> gf;fk; 284 
            This poem clearly states that in vali kalladaippu, patients suffer from acute 
pricking pain in the lower abdomen, scanty micturition, obstruction of urine flow, 
pain in the glans penis making them unable to sit. The other symptoms include pain in 
abdomen, albuminuria, and mucous discharge. Finally stone gets expelled with urine. 
Azhal kalladaippu 
                                  “milg;ghfpr; rye;jhD kUt yhfp 
               maq;fhr;rpr; nrhUfpdhw; NghNy fhZk; 
               Gilg;ghfg; nghw;wpnaq; Fk;G Of;fkhfpg; 
               G+l;Lg;Nghy; gpFthfpg; gpul;l yhFk; 
               kilg;ghfp cjpuepw khaf;fy; yhfp 
               te;jope;J ypq;fj;jpy; khl;bf nfhs;Sk; 
               Filg;ghfpf; Fw;wyha;f; $r;ryhfpf; 
               Fjl;LNk gpj;jf;fy; yilg;G jhNd”   gh 730> gf;fk; 285 
               It is evident from the above poem that the cardinal features of azhal 
kalladaippu include obstruction of urine flow, burning sensation in external urinary 
meatus, acute pain in the urethra and excretion of small blood stained stones. 
Iyya kalldaippu 
                                    “jhdh njhg;GspNy tpy;Y Nghyr; 
                      rypahkw; Rue;JNk rw;Nw Fw;Wk; 
                 Vdhd fhNyhL iffs; re;J 
                       ,Lg;Gjhd; Filr;ryh aprpT fhZk;  
                 Ntdhd ypq;fj;jpd; ntz;ik jd;dpy; 
                       tpwtpnwd; NwfLg;ghfp tpaHitahFk; 
                 Njdhd ntSg;Gf;fy; rpWfy; yhfpr; 
                      rpf;fyha; te;jpwq;FQ; Nrl;ge; jhNd” 
                                              gh 731> gf;fk; 285 
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               This poem clearly mentions that the symptoms of iyya kalldaippu are acute 
pain around the umbilicus, pain radiating towards thigh, joint pain, Burning 
micturition, profuse sweating and expulsion of small white stones. 
Mukkutra kalladaippu 
                                 “te;jpwq;Fk; ePHj;jhiu abapw; whDk; 
               khtUj;j Kz;lhfp typA khfp 
               nehe;jpwq;fp ePHjhD kUtp ghAk; 
               nehajhd rpWkzy; Nghy; nehWq;fp fy;yhd; 
               re;jpuq;fp ePHtopapy; te;J tPOk; 
               jhf;fhd rpwq;iff;fy; jpdnkhd; Wf;F 
               Je;jpwq;fpj; jpde;jpdK kpoe;J nfhy;Yk; 
               njhe;jkhq;f yilg;Gr; #l;bl; lhNa 
                                            gh 732> gf;fk; 286 
B. In siddhar aruvai maruthuvam 
Kalladaippu noi is classified into four types 
             1. Vali kalladaippu 
             2. Azhal kalladaippu 
             3. Iyya kalladaippu 
             4. Veneer or manal kalladaippu            Page No - 112 
C. In thanvanthiri vaithyam {IInd part, page no. (9,10)} 
                                 “jpUj;jpa thj gpj;j rpNyw;gdk; gpuNfhgpj;jhy; 
               tFj;jR kupj;jh ehd;F tifg;gLk; fy;yupg;ghd; 
               gpupj;jpLQ; rpNyw;gdhR kupgpj;jh Rkup gpd;D 
               kpUj;jpL Rf;fpyhR kupehd;F nka;Jnkd;Nw” 
       The alteration of three dhoshas results in occurrence of the following four types 
of Ashmari 
          1. Kallarippan 
          2. Pitha ashmari 
          3. Silathma ashmari 
          4. Sukkila ashmari  
Kallarippan 
                                 “Rj;JePH ehse;jd;dPw; Rf;fpye;jd;dPw; rpNyw;gdk; 
               gpj;jkP JyHj;jy; fy;yha; gPrfpeP ilj;Jf; nfhs;Sq; 
               nfhj;JeP upw;WtPOq; nfhg;Gs;Neh Flk;G fhAQ; 
               rpj;jh aUrp Az;lhQ; NrHe;jfy; nyupg;ghdhNk”  
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             It is learnt from this poem that when kabam and pitham increase, urine and 
semen dry up, resulting in the formation of stone which in turn lead to obstruction of 
urinary tract, dysuria, pricking pain in umbilicus, fever and anorexia. 
 
Slathma ashmari 
                                “ePH tU jhsj; jd;dpy; epd;WePH rpWj;Jf;nfhz;L 
      NrhHe;jUk; rptg;G ntz;ik Rf;fpyk; Nghy tPOk; 
      NgHngw ehyhnkl;Lk; gpd;dkha; fy;Y tPOk; 
      VHngW rpNyw;gdj;jpy; mr;kup vd;dyhNk” 
             This poem states that when the calculus arrive the urethral orifice, the volume 
of urine gets reduced gradually, leading to oliguria. Ultimately, the stone is broken 
into four to eight pieces and pass through the urine. 
Pitha ashmari 
                                “nga;Ak;ePH ehsj; jd;dpy; gpj;jj;jh nyhpg; ngOe;J 
               nra;AT\; zj;jhy;nte;J Nrq;nfhl;il Nghw;fy; Yz;lhk; 
               ea;aNt jidfs; nra;Ak; etpy; Fzk; gpj;je;jd;dpy; 
               va;jR kupnad;nwKd; dpak;gpd uwptpd; kpf;nfhH” 
            It is evident from this poem that when pitham accumulates in the urethral 
orifice, severe pain will result in along with burning sensation.  
Sukkila ashmari 
                             “Rf;fpyk; tUq;fhyj;jpy; jk;gpj;jhw; Rf;fpye;jhd; 
             kpf;ffy; yhfpntk;gp tpjdkha; ePHtplhkw; 
             rpf;fpePH tpoh kyq;Nf kzy; tpOk; ntSf;Fe;Njfk; 
             kpf;FzQ; Rf;fpyhR kuparhj; jpankd;NwhNj” 18 
          If semen discharge is ceased it gets concentrated and dried up in the uretero-
vesical junction, preventing the flow of urine which results in anuria. Under this 
condition sand grains like stones pass through the urine and anemia occur. 
 
D. In roga nirnaya saaram under roga nithanam (page.79&80) 
Ashmari rogam is classified into five types as given below. 
                           1. Vatha ashmari 
                           2. Pitha ashmari 
                           3. Kapha ashmari  
                           4. Sukkila ashmari 
                           5. Swargara ashmari or kalladaippu rogam 
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1. Vatha ashmari 
            Urine turns to black in colour, dribbling, grunting teeth and rubbing of penis. 
2. Pitha ashmari 
            Tip of penis turns to black in colour and urine turning to red, white and yellow 
in colour 
3. Kapha ashmari 
            Urine becomes white in colour and highly viscous and flows down like honey. 
4. Sukkila ashmari 
            Cessation of seminal fluid discharge during sexual intercourse leads to 
retention of semen in vas deferens or spermatic cord, which get dripped up by 
vatham. This condition eventually results in inflammation of testis and lower 
abdominal pain. 
5. Swarkara ashmari or kalladaippu rogam 
           Semen is retained in the spermatic region and gets dried up. The dried semen 
turns to stones in the size of sand, green gram, ground nut and get mixed up with 
urine and pass through the urethral orifice. 
In anubhava deva ragasiyam 1 part ( page no.131), 
 
Ashmari rogam is classified into five types. 
 Vatha ashmari 
  Pitha ashmari 
 Kapha ashmari 
 Sukkila ashmari 
 Swarkara ashmari or kalladaipu rogam 
Vatha aasmari     
            Due to increased vatham, rigor, grunting teeth, rubbing of penis and 
umbilicus, crying, vomiting, forced excretion of faeces, dysuria and dribbling of 
black colour urine occur. 
Pitha ashmari 
            The symptoms include increased temperature in the lower abdomen, 
flatulence, Red or high concentrate urine. 
Kapha ashmari 
            The cardinal features are acute pain in the lower abdomen and urine turning to 
white in colour and highly viscous and flowing down like honey.  
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Sukkila ashmari 
            The symptoms are pain and inflammation in the testis, lower abdominal pain, 
urine taking a long time to get expelled during urination and pain during micturition. 
Swarkara ashmari or kalladaippu rogam 
            The dried semen is crushed by vatham into small stone of various sizes 
ranging from fine particles of sand or mustard to as large as green gram, or Bengal 
gram and even dates which block the passage of urine. If vatham is in normal level, 
stones will be expelled during micturition. 
      In sikitcha rathna deepam-vaidhya chinthamani-2nd part ( page no.140, 141) 
Kalladaippu rogam is classified into following four types. 
              i. Vatha kalladaippu 
             ii. Pitha kalladaippu 
            iii. Kapha kalladaippu                
            iv. Mukkutra kalladaippu 
Vatha kalladaippu 
           The symptoms include acute pricking pain in the lower abdomen, obstruction 
of the flow of urine, scanty micturition, pain in the penis, making the patient unable to 
sit, crying, flatulence, presence of albumin in the urine and mucous discharge with 
urine.  
Pitha kalladaippu 
           The symptoms are obstruction of the flow of urine, burning sensation in the 
urethral orifice (the burning sensation refers to melting point of iron put on the 
external meatus), acute pain in the urethra and expulsion the small blood stained 
stones. 
Silothuma kalladaippu 
            In this kalladaippu, patient suffers from severe pain in the lower abdomen, 
pain radiating towards the thigh, joint pain associated with rigor and pain in the tip of 
glans penis. Finally, small white coloured stones are expelled along with urine. 
Mukkutra kalladaippu 
           Pain in the urethral orifice, pain during micturition, presence of small sand 
grain like stones in urine are the cardinal features of mukkutra kalladaippu. 
 
Mukkutra verupadugal (pathology) 
           The three uyir thathukal are formed by combination of 
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S.NO    Dasanadikal      Dasavayukkal   Humours 
01.      Idakalai       Abanan    Vatham 
02.      Pinkalai       Praanan     Pitham 
03.      Sulumunai       Samaanan     Kapham 
   
Under normal condition, the three factors tend to be in their states of equilibrium 
(1:1/2:1/4)  
                                    
                                    “cw;wNjhH clypd; $W  
                cWg;Gld; tputp epd;W  
                Kw;WNk Neha;fnsy;yh  
                KjpHngwj; Njhd;Wk; NghJ  
                gw;WNk thjgpj;j  
                rpNyw;gde; jd;dpy;nyhd;iw  
                gw;wpNa Njhd;Wnkd;W  
                gfHe;jdH KdptH jhNd”  
                                     mfj;jpaH FUehb gf;fk; - 65 
As per the siddha principles, the manifestation of any disease is the result of disturbed 
kutrams (ie, vatham, pitham, kapham).  
Mukuttra vaerupaadugal  
                                  “thAtpdhy; kyryq;fl;bLk;  
                gphpj;jpLk; gpj;jk; NguhQ; ryj;jpdhNy  
                              rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 154  
          The above poem mentioned in siddha maruthuvanga surukkam emphasizes that 
alteration in diet, salt and water intake will lead to alteration, mainly increase in vatha 
and pitha kutram in the body, which in turn result in sedimentation of urine in the 
kidney. Under this condition, if abaanan is favorable, these deposits do not get 
expelled with urine. Instead, they get deposited in the urinary tract, which pave way 
for the occurrence of this disease.  
 
Functions of mukkutram  
Vatham 
Pain in the body, twitching pricking pain, inflammation, reddish 
complexion, dryness of skin, hardness of limbs, astringent sense of 
taste in the mouth, unpalatable taste, sweating during sleep, traumatic 
pain, constipation, oliguria, blackish discoloration of skin, stool 
and urine and muddy conjunctiva. 
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Pitham 
 
Hyperacidity, burning sensation in the stomach, yellowish 
discoloration of skin, eye, urine, sense of defecation, profuse 
sweating, dizziness.  
Kapham 
Fair complexion, itching, dullness, cold, heaviness, loss of sensation, 
sweetness in mouth, indigestion. 
  
Roles of mukkutram  
   Abnormal change in these three mukkutram lead to abnormal changes in 
structure, function and behavior of various body organs. These changes are listed 
below.  
 Increase Decrease 
 
 
Vatham 
Tremors, distended, abdomen, 
constipation, weakness, 
insomnia, 
Body pain, feeble voice, 
diminished competence of 
intellectual functions, 
syncope etc... 
 
 
Pitham 
Yellowish  discoloration of 
eyes, skin, urine and motion 
polyphagia, polydipsia, burning 
sensation all over the  body, 
sleeplessness. 
Decreased appetite, cold, pallor, 
symptoms associated with 
defective growth of kapham. 
  
 
 
Kapham 
Loss of appetite, excessive 
salivation, Heaviness, 
excessive musculature, 
Dyspnoea, excessive  
sleepiness. 
Prominence of bony edges, dry 
cough, lightness, profuse 
sweating, 
Palpitation. 
  
Vatham 
The term vatham denotes vayu, dryness, pain and flatulence. Based on 
functions and locations, It is classified into the following ten types. They are
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S No  Vatham General features 
Changes in 
kalladaippu 
1. 
 Piranan 
(uyirkaal) 
Responsible for respiration and it is 
necessary for proper digestion 
Normal 
2. 
 
Abanan 
(keezh nokku 
kaal) 
Responsible for all downward forces 
such as voiding of urine, stools, semen, 
menstrual flow 
Affected (scanty 
micturition, 
haematuria (due to 
sharp edged stones) 
and dusuria. 
3. 
 
Viyanan 
(paravukaal) 
Dwells in the skin and is concerned with 
the sense of touch extension and flexion 
of the parts of the body and distribution, 
of the nutrients to various parts of the 
body. 
Normal 
4. 
 
Udhanan 
(melnokkuka
al) 
Responsible for all kinds of upward 
motion such as nausea, vomiting . 
Affected( nausea, 
vomiting) 
5. 
 
Samanan 
(nadukkaaal ) 
Considered essential for proper 
digestion, assimilation and carries the 
digested nutrients to each and every 
organ. 
Normal 
6.  Naagan Helps in opening & closing of eyelids. Normal 
7. 
 
Koormam 
Responsible for vision , lacrimation and 
yawning 
Normal 
8. 
 
Kirugaran 
Induces appetite, salivation , all 
secretions in the body including nasal 
secretion and sneezing. 
Normal 
9.  
Thevathathan 
Induces and stimulates a person to Normal 
 
 
become alert, get anger, to quarrel, to 
sleep  
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Pitham 
It is the terminal life force of the body. It is subdivided into five types. 
They are, 
S.No Pitham Normal features 
Changes in 
Kalladaippu 
1. Analapitham Promotes appetite and digestion. Normal 
2. 
Ranjagapitham Responsible for the colour and Normal 
 contents of blood.  
3. 
Saathagapitham Controls the whole body and is 
held responsible for fulfilling a 
purpose. 
Affected  
(dysuria, 
oliguria) 
4. 
Pirasagapitham Dwells in the skin and Normal 
 concerned with the shine, glow,  
 texture and its complexions.  
5. 
Alosagapitham Responsible for the perception Normal 
 of vision.  
 
Kapham 
It is responsible for the streamlined functions of the body and maintains 
body’s defence mechanism intact. It is classified into five types as below 
S.no Kabham General features 
Changes in 
Kalladaippu 
1. Avalambagam Lies in the respiratory organs, exercise 
authority over other kapas and controls 
the heart and circulatory system. 
Normal 
2. Kilethagam Found in stomach as its seat, Normal 
  moistens the food, softens and  
  helps to be digested.   
10. 
 
Dhananjeyan 
Resides in the cranium and produces 
bloating of the body after death. This 
leaves from the body after 3days of 
death, forming a way through the skul 
Normal 
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3. Pothagam Hold responsible for the sensory Normal 
  perception of taste.  
4. Tharpagam Presents in the head and is 
Normal 
  responsible for the coolness of 
  the eyes, sometimes may be 
  referred to as cerebrospinal 
  fluid. 
5. Santhigam Necessary for the lubrication Patient will not 
able to walk and 
move the joints 
(hip and knee 
joints) freely. 
  and the free movements of 
  joints. 
   
   
 
Udal thathukkal 
When the functional elements ( vatham, pitham, kapham) are upset 
repercussions are felt immediately over the components due to alteration in the 
nature of somatic components. 
Saaram ( digestive enzyme) 
It is responsible for the growth and development. It keeps the individual in 
good temperament and enriches the blood. 
In kalladippu noi, saaram is affected by change in our food habits, which 
results in increase in level of vitamin D and become hypervitaminosis. Increased 
vitamin D is a main cause for kalladaippu noi (renal calculi). 
1. Senneer ( blood )  
It is responsible for the colour of blood and for the intellect, nourishment,  
strength, vigour and valour of the body. 
2. Oon ( muscle )  
  It gives suitable contour to the body, required for the physical activity. It 
feed the fat next day and gives a sort of plumpness to the body. 
        In kalladaippu noi, oon is affected. When there is a change in the level of 
vitamins due to change in our food habits. The decrease in vitamin A level may 
lead to destruction and shrinkage of the mucous membrane in the urinary tract. 
Sometimes, damaged mucous membrane get mixedup with urine and expelled.  
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3. Kozhuppu ( fat )  
It lubricates the organs to facilitate frictionless function.  
 
4. Enbu ( bones )  
  It supports and protects the vital organs, structure to the body and is 
responsible for the posture and movement of the body. 
 
5. Moolai ( bone marrow, brain )  
  It nourishes the bone (marrow) and the brain which is the centre that 
controls all systems of the body. 
 
6. Sukkilam or suronitham ( sperm & ovum)  
  It is responsible for reproduction.  
  In kalladaippu noi, sukkilam is affected by the increased body heat and 
hence semen in the spermatic region get dried up and shrunken and become small 
vesicle stones. 
Udal thathukkal Increased features Decreased features 
i. Saaram Leads to a disease identical to Loss of weight, lassitude, 
  increase in kabam like loss of dryness of the skin and 
  appetite, saliva secretion, dimished activity of the 
  depression . sense organs. 
ii. Senneer Increased blood pressure, reddish Tiredness, lassitude and 
  eye and skin,  jaundice, anaemia. 
  haematuria.  
iii. Oon Excessive muscle growth around Muscle wasting 
  the neck, cheek, abdomen, thigh,  
  external genitalia .  
iv. Kozhuppu Identical features of increased Hip pain, liver 
  oon associated with dyspnoea on enlargement and 
  exertion emaciation. 
v. Enbu Excessive ossification and Joint pain, teeth falling, 
  dentition crack in nails and hair 
   falling.  
24 
vi. Moolai Weariness of the body and eye, Osteoporosis and sunken 
  swollen interphalangeal joints, eyes. 
  oliguria and rarely healing  
  wound.  
vii. Sukkilam 
or 
suronitham 
Increased sexual activity, urinary 
calculi . 
Pricking pain in genitalia 
and Impotence or 
infertility. 
 
 
 
Udal Vanmai(Immunity)  
1. Iyarkai vanmai(Natural immunity)  
           The natural immunity of the body is present even at the time of the birth 
.This is a nonspecific immunity due to the passing of maternal antibodies to the 
foetus.  
2. Seyarkai vanmai(Acquired immunity)  
        Improving the health by nutritious food,medicines,karpams,vaccines all fall 
into this category of increasing the immunity by human measures.There are both 
specific special and non specific special karpams comes under the category 
specific immunity or seyarkai vanmai since such karpams are used against 
acquired diseases both as  
prevention and treatment for them.   
3.Kala vanmai  
      Developing the immunity and stamina according to the age of the person, 
seasons and environmental factors.  
 
Noi kanippu murai ( diagnosis and prognosis ) 
In piniyari muraimai , the following principles are followed in siddha 
system. they are, 
1. Poriyaal arithal  - Physical examination ,Perception 
2. Pulanaal arithal  - Clinical examination 
3. Vinaathal            - Medical history 
The maruthuvar (physician) should observe the patient, palpate and 
interrogate the patient thoroughly.  
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Poriyaal arithal and pulannal arithal 
Poriyaal arithal means understanding by the five organs of perception, 
whereas pulannal arithal is the understanding by sensing the objects. They are, 
 Mei  - ooru (somatic ense) 
 Vai  - suvai ( taste) 
 Kan  - Oli ( vision ) 
 Mookku  - natram ( smell     
 Sevi  - osai ( sound) 
Pulanal arithal 
 Kai   - All manoeuvres  
 Kal   - Walking  
 Vai   - Speaking  
 Eruvai  - Defecation  
 Karuvai  - Reproduction  
 
Vinaathal ( interrogation ) 
The first and foremost step in diagnosing a disease is to get to know the 
personal history of the patient through interrogation. By vinaathal, the physician 
should ask the patients about their native place, socio economic status, food habits, 
personal habits, complaints, and duration of illness poriyal arithal, pulanaal arithal 
and vinaathal are appliled through eight tools of investigation that are “envagai 
thervugal”. 
 
Mukkutra kaalam ( age distribution ) 
The period of human life of 100 years is divided into three stages. 
Stage Year Dominant humor 
First stage 01 -33 years Vatha period 
Second stage 34- 66 years Pitha period 
Third stage 67 -100 years Kaba period 
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Thinai ( land or place ) 
The study of dwelling places of patients is essential as the prevalence 
of endemic disease is very common in certain areas. 
Generally, the nilam is classified into five. They are 
Kurinji nilam mountain and its surrounding 
Mullai nilam   forest and its surroundings 
Marutha nilam fertile plains and their surroundings  
Neithal nilam seashore and their surroundings  
Palai nilam deserts and their surroundings 
Marutha nilam people are more prone to disease than other land people, 
as fertile lands of Maruthanilam is used for industrial purpose which have way 
for urbanization and settlement of huge population in smaller area. 
Paruvakaalam (season) 
In siddha system of medicine, siddhars classified a year into five seasons, 
each having two months. 
 
S.No Kaalam Kutram State of kutram 
1. Kar kaalam ( Avani & Purattasi) Vaatham Vetrunilai valarchi 
 (Aug. 16-Oct .15) Pitham Thannilai valarchi 
      2. Koothir kaalam ( iypasi & Vaatham Thannilai valarchi 
 karthigai) (Oct.16-Dec.15) Pitham Vetrunilai valarchi 
3. Munpani kaalam ( Margazhi & Pitham Thannilai adithal 
 thai) (Dec.16-Feb.15)   
4. Pinpani kaalam (masi & Kapam Thannilai valarchi 
 panguni) (Feb.16-Apr. 15)   
5. Elavenir kaalam (chithirai & Kapam Vetrunilai valrchi 
 vaigasi ) (Apr.16-june 15)   
6. Mudhuvenir kaalam ( Aani & Vaatham Thannilai valarchi 
 Aadi) (June. 16- Aug.15)    
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Envagai thervugal 
                                  “md;ghd rhj;jpuq;fs; mwpa Ntz;Lk;  
                md;ghd ehbjid gpbf;fNtz;Lk;  
                Fd;whd kiyNghd;w ehbnay;yhk;  
                Fwpg;Gld; mrhj;jpaKQ; rhj;jpaKq;fz;L  
                jd;whd ml;ltpj guPl;ir fz;L  
                jf;fhd Fzq;Fwpfs; ahTe; NjHe;J  
                td;whd thflj;jpd; EZf;fk; ghHj;J  
                tskhf gpzpajidj; jPHg;NghH jhNk  
                                        A+fp itj;jpa rpe;jhkzp  
                                  “ehb ];ghprk; ehepwk; nkhoptpop  
                kyk; %j;jpukpit kUj;JtuhAjk;  
                                               mfj;jpaH ehb  
                                  “nkaf;Fwp epwe;njhdp tpopehtpUkyk; iff;Fwp”  
                                                      
NjiuaH  
The above mentioned poems list out the Envagai thervugal as below,  
                  1. Naadi (Pulse)  
                  2. Sparisam (Palpation)  
                 3. Naa (Tongue examination)  
                 4. Niram (Colour of the body)  
                 5. Mozhi (Speech)  
                 6. Vizhi (Eye examination)  
                 7. Malam (Motion examination)  
                 8. Moothiram(Urine examination)  
Gunavagada naadi emphasises about the Envagai thervugal as the following  
                                  “juzpAs;s tpahjp jd;id al;lhq;fj;jhy;  
                    jhdpawpa Ntz;LtJ NaNjh ntd;dpy;  
                jpzpaNjhH ehbfz;fs; rj;jj;NjhL  
                    Njfj;jpdJ guprk; tUzk; ehf;F  
                apuzky %j;jukhtpitf nsl;Lk;  
                    apjk;glNtjhd; ghHj;J Fwpg;Gq;fz;L  
                guzUshy; ngupNahHfs; ghjk; Nghw;wp  
                    gz;G jtwhky; gz;bjQ; nra;tPNu”  
                                               Fzthfl ehb  
      Neha; ehly; Neha; Kjy; ehly; jpul;L – Kjy; ghfk;> gf;fk; - 129  
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     The above poem that it is imperative to apply the Envagai thervugal for 
diagnosis of the diseases.  
                                   “njhFf;fYw;w ml;ltpj guPl;ir jd;id  
               Jyf;fKWk; gz;bjNu njsptjhfg;  
               gLf;fhpa ehbia eP gpbj;Jg;ghU  
               gfHfpd;w thHj;ijiag; ghH ehit ghU  
               tFf;fupa Njfnkd njhl;Lg; ghU  
               tskhd ruPuj;jpd; epwj;ijg; ghU  
               rfpf;fupa kyj;ijg; ghU ryj;;ijg; ghU  
               rhHe;j tpopjidg; ghHj;J njsptha; fhNz  
              ePba tpopapdhYk; epd;w ehf;Fwpg;gpdhYk;  
               thba NkdpapdhYk; kynkhL ePupdhYk;  
               #ba tpahjp jd;idr; Rfk;ngw mwpe;J nrhy;Ny”  
                                    mfj;jpaH itj;jpa ty;yhjp  
Naadi nadai in kalladaippu  
                                  “tpOFk; rpyNeuk; tpLgl;L ePNuhLk;  
              xOfpa thATk; xJq;fpdhy; NehfhJ  
              tOfpa ke;jj;jhy; thAte;Nj Gfpy;  
              fOkp KjpHe;jpLk; fy;nyupg;G MFNk”  
                               jpU%yH fUf;fpil itj;jpak; 600  
 
When the vatham and mantham combined together, kalladaippu noi may occur.  
                                   “miwe;Njhk;thj NuhfpAly;  
                  mowf;z;KfKk; gy;kyKk;  
             epiwe;j tpopapy; ePH tbAk;  
                  ePz;l ehT fWj;jplTk;  
            jpiwe;jKs;sha; jhdpUf;FQ;  
                 rpW ePH nghUkp fLj;J tUk;  
            ciwe;j ePUq;fUfUj;J  
                 Kiwaha; NuhfK Kz;lhNk”                      
              mfj;jpaH ehb  
       Neha; ehly; Neha; Kjy; ehly; jpul;L – Kjy; ghfk;> gf;fk; - 165  
                                  
   “NktpathjQ; nra;Ak;  
                    Fze;jid tpUk;gpf;NfS  
                jhtpa tapW ke;jQ;  
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                    re;Jfhy; nghUj;J Nehthk;  
                Nrtpa jhJ ehrQ;  
                    rpWj;Jld; rpW ePHtPOk;  
                fhtpaq; fz;zpdhNs  
                    kykJ fUfpf; fhZk;”  
                                           ,uj;jpd RUf;f ehb 
Agaththiyar Naadi and Raththina churukka naadi describes that 
aggravation of vaatham produces symptoms of kalladaippu noi.  
                                   “nghUshd thjj;jhy; gpj;jQ; NrHe;J  
                nghUj;J Fzq;fsh K\z thArj;jp  
                nrupahik Gspj;Njg;gk; nghUky; ePupw;  
                rptg;G kyk; gpbj;jYUe;jhJ el;lk;  
                fUthd NjfkjpYisr;ry; Nrhk;gy;  
                if fhy; jwpg;G ehf;frf;F kd;dk;  
                gupthd T+z; Fiwjy; Urp Nflhjy;  
                gy NehAk; tUj;jpitf;Fk; ghq;F jhNd”  
                                                   rjf ehb  
       Neha; ehly; Neha; Kjy; ehly; jpul;L – Kjy; ghfk;> gf;fk; - 171 
  
                                   “vz;zpa thjnkhd;Wk; gpj;jkpuz; nlOe;jhfpy;  
               Gz;nzd Alk;G Nehthk; Gifnao naupAk; neQ;R  
               jpz;zkha; ehtuz;L rpWj;JePHf; fLj;J tpOk;  
               mz;zthH ciue;jTz;ik ahAU Njtd;jhNd”  
                 jd;te;jpup itj;jpak; - Kjy; ghfk;> gf;fk; 11  
         Sathaganaadi and Dhanvanthiri vaidhyam describes, when vatham and 
pitham combined together which may result  kalladaippu noi.  
 
];guprk; (touch) 
           By sparisam, the temperature of skin ( Thatpam-Cold or Veppam-Heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal 
growth of organs and tenderness can be felt.  
         On examination in kalladaippu patients, tenderness over the lower 
abdomen, renal angle and lumbar region can be felt in kalladaippu noi. In vali 
kalladaippu, swelling can be felt (may be due to hydronephrosis).  
        In pitha kalladaippu, body temperature increase in lower abdomen. In iyya 
kalladaippu, sweating occurs all over the body at the time of colic.  
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eh (Tongue)  
        The physician is expected to observe the features of the tongue and its 
associated structures that include colour, size, shape, coating, moisture, movement, 
ulcer, fissure, crust and condition of teeth and gums. In kalladaippu noi, if the 
patient suffers from constipation (valikalladaippu), the tongue would seem to be 
coated.  
 
epwk; (Colour)   
    The physician is required to observe the colour of skin, conjunctiva, tongue, nail 
bed hair etc and make a note of any abnormal colour changes. Normally,  
 Vali udal  - Black colour  
 Azhal udal - Yellow or red colour 
 Iyya udal - white or yellow colour  
 
             In kalladaippu noi, body complexion depends upon the body constitution. 
Pallor of the body is observed in sukkila ashmari.  
                  “rpf;fpePH tpoh kyq;Nf kzy;tpOk; ntSf;Fe;Njfk;  
         kpf;FzQ; Rf;fpyhR kuparhj; jpankd;NwhNjh”  
                          jd;te;jpup itj;jpak; - 2 ghfk;> gf;fk; 10  
nkhop (Speech)  
           By examining mozhi (speech), characters, hoarseness, slurring speech, 
various disorders of speech such as dysarthria can be noted. In kalladaippu noi, 
there is low pitch voice due to agonizing pain in lower abdomen and burning 
micturition.  
 
tpop (Eye)  
          The colour of conjunctiva is observed in kalladaippu noi, patients, the 
conjunctiva is pallor due to haematuria. Because haematuria may cause secondary 
anaemia.  
 
kyk; (Stools)  
              It is necessary to examine the nature, colour and quantity of stool and 
presence of blood or pus. In vali kalladaippu, proctalgia and oliguria occur due to 
renal colic.  
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                                  “jupj;J ehgpf;Fq;fPo; RUf;fha; Fw;wpr;  
                rykye;jhd; tPohkw; wk;gkhfp”  
                          A+fp itj;jpa rpe;jhkzp 800> gf;fk; - 284  
                  Urinary examination is a good diagnostic method compare to naadi and 
other Envagai thervugal. Theraiyar mentioned about urine examination as below.  
  
ePHf;Fwp rpwg;G  
                                  “jHf;frhj;jp jpupf shNdhH  
                jq;fspw; NwHe;J ehb  
                tHf;fkhk; ehb jd;dpy;  
                tUtJ kaf;fk; nkd;Nw  
                cw;wePHg; guPi\ gha;e;Nj  
                Aiuj;jd hpjw;F Neuha;   
                kw;nwhU tpjpE} ypy;iy  
                kUj;Jt fiyty;NYhHf;Nf”  
                             rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 568 
 
Siruneer pothugunam 
                                   “te;jePUf; fhpnail kzk; Eiu vQ;rNyd;  
                iwe;jpa YSit aiwFJ KiwNa  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 510  
 
The above poems states that the five parameters should be examined in each urine 
sample.  
1. Niram (Colour)  
2. Edai (Specific gravity)  
3. Nurai (Froth) 
4. Natram (Smell)  
5. Enjal (Deposits)  
  
NIRAM ( colour)  
Nira thogai  
                                   “gPjk; nrk;ikigq; fUik ntz;iknad;  
                Nwhjq; nfhOikia nahj;JF ePNu  
                            rpj;j kUj;Jthq;fr; RUf;fk; gf;fk; 510  
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The above poem reveals that urine colour may be any one of the followings,  
1. Yellow  
2. Red  
3. Green  
4. Black  
5. White  
fy;yilg;G ePupd; Fzk; (colour indicating urinary stones)  
                                  “jPg;Gyhy; fOePHr; nranydpw; Fz;bf;  
                fha;j;JHg; gyj;jhy; fjpj;j ePuhkj;  
                JHg;gyf; fgKk; NrhhpAk; nfhjpg;Gwg;  
                gw;gf yhfg; igiag; gjpe;Nj”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 520  
           The urine colour resembling the colour of flesh washed water, indicate the 
occurrence of kidney diseases. (crystaluria)  
Edai (specific gravity)  
                                   “kpfj;jbg; Gkkpfj; NjwYk; ,d;nwdpy;  
                Rfj;ijj; jUk;nka;r; RghtePH ed;Nw”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 528  
urine which is not thick, is considered healthy  
Nurai(Froth)  
                                   “ge;jnka;g; giraps fg;gLk; gUtj;  
              je;jHg; G+jkha epyKj; jpuj;jpy;  
              rk;ge;jg; gLk; jjp Eiug; GdNy”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 528  
          Urine is frothy in nature under normal condition. When there is a change in 
vali, Iyyam there will be a change in the frothiness of urine too.  
Naatram (Smell)  
kztpyf;fzk;  
                                   “fhzpjpy; rPOk; fye;jpop kzKwpd;  
               fUg;geh gpfSSq; fhkehsj;JSk;  
               tpuzKd; bd;Nwd; va;Jk]; kupay  
               jpUj;jNy jpz;z nkdkdj; Jd;Nd”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 519               
The above states that foul odour with pyuria is observed in patients with 
urolithiasis associated with secondary urinary tract infection and urethral ulcer.  
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Enjal (Deposits)  
                                   “ehHj;jp ePHghy; Nghy  
                     eitAw;wq; fpopA khdhy;  
                khuw;g Kw;w ePup  
                     ybkz;bf; fple;e jhdhy;  
                ghupe;j nkOF khq;fha;  
                     gw;wpa fy;ypdhNy  
                rPUw;w nra;if nad;W  
                     njupTw nrg;g yhNk  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 575  
                In siddha maruthuvanga surukkam the following clinical features have 
been mentioned with regard to kalladaippu noi. They are,  
             Pyuria   - Curd like micturition (cloudy)  
             Crystaluria  - Sand like deposits  
 
Neikuri  
                                   “mUe;Jkh wpujKk; mtpNuh jkjha;  
                  m/fy; myHjy; mfhyt+z; jtpHe;jow;  
               Fw;ws tUe;jp cwq;fp itfiw  
                   Mbf; fyrj; jhtpna fhJnga;  
               njhUK$Hj; jf;fiyf; Fl;gL ePupd;  
                   epwf;Fwp nea;Fwp epUkpj;jy; flNd”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 509  
 
Preparation of Patient  
            Prior to the day of urine examination for Neikuri, the patient should be 
advised to take balanced diet and the quantity of food must be proportionate to his 
appetite, In addition, he/she should have a good sleep.  
 
Method  
            After waking up in the early morning, urine should be collected in a glass 
container and must be examined within 11/2 hours. Then a drop of gingelly oil 
should be added through the side of the container without any disturbance. The 
nature of neikuri should be noted under direct sunlight.   
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Observation  
Vaatha neer  
                                 “muntd ePz;bd; m/Nj thjk;”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 532  
    If the drop of oil lengthening like a snake, it indicate vatha neer.  
 
Pitha neer  
                                “MopNghw; gutpd; m/Njgpj;jk;+”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 533  
  If the drop of oil spreading like a ring, it indicates pitha neer.  
 
Kapha neer  
                           “Kj;njhj;J epw;fpd; nkhop tnjd; fgNk”  
                            rpj;j kUj;Jthq;fr; RUf;fk;> gf;fk; 534  
  If the drop of oil remaining as that of pearl, it indicates kapha neer.  
 
Thontha neer  
                                   “mutpyhypAk; Mopapy; muTk;  
            mutpd;Kj;Jk; Mopapy; Kj;Jk;  
            Njhw;wpy; njhe;j Njhlq;fshNk”  
 The thontha neer appears as a combination of the above patterns.  
 
Mukkutra neer  
     The drop of oil immersing in to the urine, indicates mukutra neer.   
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NOI KANIPPU VIVAADHAM 
                                     (Differential diagnosis of Kalladaippu)  
Neeradaippu  
              It is characterized by decreased urinary output along with burning 
sensation of urinary bladder (Neerpai) and urethra (Neerpuzhai) with  distend 
abdomen.  
             Eventually it causes unbearable pain in voiding of urine with fresh blood 
after/before micturiation. It results in difficulty in breathing, swelling of face, back 
pain, inflammation of urethra and abdominal pain.  
 
Neer churukku  
                                   “ePupid aUf;f nyd;Dk; ePHf;fl;bd; Fzj;ijf; Nfl;L  
                ePjkpy; yhkw;Nfhr ePhG;Gio neUg;G Nghyhk;  
                ePgdh Ajj;jhw; gl;l ePytk; guhkhq; Ff;fp”  
            Theraiyar karisal, theraiyar stated that the disease is charecterized by 
reduction in the formation of urine, micturition burning sensation, pain in the neer 
puzhai and facial odema may result.  
           It also symptoms like dribbing of urine. During micturation urinary out put 
is less in amount, volume, red in colour, abnoxious/fish smell in urine, long time 
micturation , burning sensation, dribbing of urine and painful urethra.  
            The disease may also cause with out above signs and symptoms. While 
passing urine sudden blockage of urine outflow, pain in urethra, burning sensation, 
pain in flanks and back side of the hip may results sand like stone may be 
observed in urine.  
rhj;jpak;> mrhj;jpak; (Prognosis)  
                                  “#l;bl;l rhj;jpaj;ij nrhy;yf; Nfsha;  
                    RSf;fhFk; thhj;jpd; fy;yilg;G  
                G+l;bl;l gpj;jj;jpd; fy;y ilg;Gg;  
                    Gfohd Nrl;Lkj;jpd; fy;y ilg;G  
                %l;bl;l ,J%d;W krhj;a khfp  
                    Kidahd kUe;Jfspw; nrk;ik ahFk;  
                Njhl;bl;l njhe;jkhq; fy;y ilg;Gj;  
                    njhLRwNt nfhy;YkpJ #l;re; jhNd”  
                                    A+fp itj;jpa rpe;jhkzp 800  
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         According to Yugi vaidhya chintaamani and siktcharathna deepam, vatha, 
pitha and kapha kalladaippu noi are curable and preventable. Mukkuta kalladaippu 
is not curable. 
    According to Roga nirnaya saaram under Roga Nithanam, symptoms of 
Kalladaippu noi like scrotal swelling and anuria are not curable.  
kUj;Jtk; (Line of Treatment)  
                                  “itj;jpaH nray; itj;jpaNk”  
                                                 jpU%yH 800  
            The main objective of treatment is to bring down the deranged mukkutrams 
to natural eqilibrium by giving purgatives, which cure derangement of vatham, 
which is one of the causes for kalladaippu noi.  
                                  “Ngjpahy; thjk; jhOk;  
               the;jpahy; gpj;jk; jhOk;  
               erpa mQ;rdj;jhy; fgk; jhOk;”  
           As per the above mentioned poem purgation should be given to all patients 
as per their body condition. In this present study,  
          NILAKUMILAVER KUDINEER - 50 ml BD Morning and Evening  
were given to the selected patients which showed good response and in all  
kalladaippu noi patients.  
          In siddha system, treatment is not only for curing the disease but also for 
prevention and improving the body condition after curing the disease. This is said 
as kappu, neekkam and thiraippu.  
         The mode of preparation and properties and constituents of ingredient of 
the drug are given in Annexure – I.  
 
Diet  
Diet for kalladaippu patient  
      FUit my;yJ kzf;fj;ij muprpahyhf;fpa NrhW Ks;sq;fp 
(Raphanus sativus) fPiuj;jz;L> rpWfPiu (Amaranthus gangeticus) 
thioj;jz;L Plantain stem), mtiu (Dolichos lablab), ntz;il (Hibiscus 
esculentas), triy (Portulacca oleracea) griyf;fPiu (Portulacea pudrifida) 
fhrpdpf;fPiu (Hibiscus kannabinus) ghHyp muprpf; fQ;rp (Parley water) 
nfhLf;fTk;.  
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Diet restriction for kalladaippu  
      jf;fhsp (Tomato), Kl;ilf;Nfh]; ( cabbage), fhyp/g;stH 
(Cauliflower) ePf;fTk;. cg;G epiwe;j ePh; Fbf;ff;$lhJ.  
Advice  
            1. Patients should drink large quantity of water (4 lit/day)  
            2. Patient should not suppress the excretion of urine and seminal fluid.  
         3. Regarding prevention Anubhava vaidhya deva ragasiyam states the 
one should not suppress the excretion of Moothiram (Urine) and sukkilam 
(seminal fluid) is most predisposing cause for kalladaippu noi.  
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MODERN ASPECTS 
KIDNEY  
The kidney: structure and functions  
            Kidneys are a pair of excreatory organs situated obliquely in the retro 
peritoneum on either side of the vertebral column.  
           The kidneys are well protected, tucked in on either side of the spine. In 
front of the liver, behind there is the lung, constantly moving up and down.  
          In anatomical terms the posterior relations of the kidney are the 12th rib, 
diaphragm, pleura and lung and below them the quadratus lumborum and psoas 
muscles. The iliolinguinal and hypogastric nerves cross the quadratus lumborum 
muscle. Since the kidney moves up and down in respiration, at any on time it may 
be anywhere between the level of the 2nd and 3rd transverse processes of the 
lumbar vertebrae.  
         They remove waste products of metabolism and excess of water and salts 
from the blood and maintain its PH.  
 
Location  
         The kidney is occupying the epigastric ,hypochondrium, lumbar and 
umblical region. Vertically they extends from the upper border of T12 to the 
centre of the body of L3 vertebra.  
 
Size , Shape ,Measurement  
         Each kidney is Bean shaped  
         It is 11cm length  
                  6cm breadth  
                 3cm thickness  
                 Weight of the kidney - 150gm in Males  
                 135gm in Females  
        The left kidney is little longer and narrower than the right kidney because 
the long axis of kidney is directed towards and laterally .So that the upper poles 
are nearer to the median plane.  
 
External Features  
Kidneys are reddish brown in colour .It has following features.  
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Two poles  
         The upper pole – broad  
         The lower pole – pointed  
Two surfaces  
         Anterior surface - Irregular  
         Posterior surface- flat  
Two borders  
         The lateral border –Convex (close contact with the corresponding suprarenal 
gland)  
 
The Medial border – concave  
Hilum  
         The following structures are seen in the hilum from anterior to posterior side.  
1. The renal vein. 
         2. The renal artery  
         3. The renal pelvis  
          One of the branches of the renal artery enters the hilus behind the renal 
pelvis, and a tributary of the renal vein may be found in the same plane.  
        In the foetus the kidney is lobulated and is made up of about 12 lobules. 
After birth the lobules gradually fuse. So that in adults the kidney is uniformly 
smooth. However, the evidence of foetal lobulation may persist. 
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Renal system includes: 
1. Pair of kidneys  
2. Ureters  
3. Urinary bladder  
4. Urethra  
 
Capsules or coverings of kidney 
      The fibrous capsule 
            Perirenal or perinephric fat 
      Renal fascia   
       It cosists of an anterior layer of fascia of toldt and a posterior layer of 
fascia of zuckerkandl.  
Histologically, each kidney is composed of one to three million urineferous 
tubles. Each tubule consists of two parts which are embryologically distinct from 
each other. 
Left kidney 
 The tail of the pancreas and the spleen lie in front of the left kidney; 
 Anteriorly the left kidney is related to stomach, jejenum, pancreas, spleen 
and descending colon. 
 The left kidneys rises to as high as the 11th thoracic ribs posteriarly, 
extending from T11-L3 resting on diaphragm. 
Right kidney 
 The right kidney is 2-8cm lower than the left kidney, because of the large 
liver which sits superior to it. 
 Anteriorly the right kidney is related to the liver, duodenum and hepatic 
flexure of ascending colon. 
 Right kidney is related to the 12th rib posteriorly resting on diapharagm. 
 
Renal pyramid 
The basic unit of the mammalian kidney is the pyramid.  Each pyramid is 
like a bunch of flowers in a vase, the blooms are glomeruli, the stems the 
collecting duct and the whole bunch, the papilla, sits in vase, the calyx.  
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Nephron 
Nephron is defined as the structural and functional unit of kidney. Each 
kidney consists of 1 – 1. 3 millions of nephrons. The number of nephrons starts 
decreasing after about 45 to years of age at the rate of 0. 8 to 1% every year. 
Each nephron is formed by two parts 
1. A blind end called renal or Malpighian corpuscle  
2. A tubular partion called renal tubule.  
Renal corpuscles 
The renal carpuscle is otherwise known as malpighian carpulse. It is a 
spheroidal and slightly flattened structure with a diameter of about 200 µ . 
 The function of renal corpuscle is the filtration of blood which forms the 
first phase of urine formation.      
Situation of Renal corpuscles – types of nephron 
Cortical nephrons or superficial nephrons (outer cortex)  
Juxtamedullary nephrons (Inner medulla).  
 
URINE FORMATION 
 
 
42 
The urine formation includes the following three processes. 
 Glomerular filtration  
 Tubular reabsorption and  
 Tubular secretion  
Kidneys excrete the unwanted substances including metabolic and products 
and those substances, which are present in excessive quantities in the body, 
through urine. Normally, about 1 to 1. 5 liters of urine is formed every day. 
Filtration is the function of the glomerulus or renal corpuscle or nephron and, 
reabsorption and secretion are the functions of tubular portion of the nephron. 
Glomerular Filtration 
When the blood passes through the glomerular capillaries and the plasma is 
filtered into the bowman’s cpsule. All the substances of plasma are filtered except 
the plasma proteins. The filtrate is called glomerular filtrate. The glomerular 
filtration is called ultrafiltration because, even the minute particles are filtered. 
But, the plasma proteins are not filtered due to their large molecular size. The 
normal glomerular filtration rate is 125 ml/minute or about 180 liters  
            The glomerular filterate depends upon glomerualar capillary pressure 
colloidal osmotic pressure in the glomeruli and the hydrostatic pressure in the 
Bowman’s capsule. Among these pressure, the glomerular capillary pressure 
favours filtration and the colloidal osmatic pressure and hydrostatic pressure 
oppose the filtration. 
 
Tubular reabsorption 
When the glomerular filtrate passes through the tubular portion of nephron, 
both quantitative and qualitative changes occur. Large quantity of water (more 
than 99%), electrolytes and other substances are reabsorbed by the tubular 
epithelial cells. The substances which are reabsorbed pass into the interstitial fluid 
of renal medulla. And, from here, the substances move into the blood in 
peritubular capillaries. As the substances are taken back into the blood, the entire 
process is called tubular reabsorption. 
Selective reabsorption 
The tubular cells of kidney selectively reabsorb the substances present in 
the glomerular filtrate. According to the needs of the body, degree of reabsorption 
is classified into three categories.  
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                          I.    HIGH THRESHOLD SUBSTANCES 
                          II.   LOW THESHOLD SUBSTANCES  
                          III. NON-THRESHOLD SUBSTANCES 
Mechanism of reabsorption 
The mechanisms involved in tubular reabsorption are of two types: 
(i) Active reabsorption 
The substances reabsorbed actively from the renal tubule are sodium, 
calcium, pottasium, phoshates, sulphates, bicarbonates, glucose, amino acids, 
ascorbic acid, uric acid and ketone bodies. 
(ii) Passive reabsorption 
The  substances  reabsorbed  by  passive  transport  are  chloride,  urea  and 
water. 
Site of reabsorption 
 Proximal convoluted tubule 
 Loop of henle 
 Distal tubule                                 
 Collecting tubule 
Blood supply of the kidney 
The upper part receives branches from renal artery, whereas middle part 
receives from aorta, the gonadal and iliac vessels. The pelvic part is supplied by 
the internal iliac vessel. The middle rectal or uterine vessels. 
Renal veins 
 The left renal vein is about 5cm long, close to inferior vena cava, another 
reason why the left kidney is prefered live-donor transplantation. 
Venous drainage 
            The interlobular veins drain into arcuate veins, which in their turn open 
into the interlobar veins.  
The venous end of the capillary plexus along the vasa recta gives rise to 
veins which drain into the arcuate veins. 
Lymphatic drainage 
The lymphatic of the kidney drain into the lateral aortic nodes located at 
the level of origin of the renal arteries.  
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Nerve supply 
The kidney is supplied by the renal plexus, an offshoot of the coeliac 
plexus. It contains sympathetic (T10 – L1) fibres which are chiefly vasometer. The 
afferent nerves of the kidney belong to segments T10 – T12. 
 
Function of kidneys 
Kidney perform vital functions. By excreting urine, kidneys play principal 
role in the maintenance of internal environment. In addition, kidneys perform 
many other functions as described below 
1. Role in homeostasis 
Kidneys are not only the excretary organs, but are also the regulatory 
organs because their major role is in homeostasis. 
 Excretion of waste products 
Removal of wastes helps in homeostasis. Kidney excrete the 
unwanted waste products which are formed during metabolic 
activitis. 
                     Urea  - end product of amino acid metabolism.  
       Uric acid  - end product of nucleic acid metabolism  
       Creatinine  - end product of metabolism in muscles.  
       Bilirubin  - end product of hemoglobin degradation. 
                Products of metabolism of other substances.  
Kidneys also excrete harmful foreign chemical substances like 
 Toxins 
 Drugs 
 Heavy metals  
 Pesticides  
 Maintenance of water balance  
 Maintenance of electrolyte balance 
 Maintenance of acid base balance 
2. Hemopoietic function 
Kidneys stimulate the production of erythroocytes by secretery 
erythropoietin. Erythropoietin is the important stimulating factor for 
erythropoiesis. Kidney also secretes another factor called thrombopoietin, which 
stimulates the production of thrombocytes.  
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3. Endocrine function  
             The hormones secreted by kidneys are 
 Erythropoietin  
 Thrombopoietin,  
 Renin            
 1,25-di-hydroxycholecalciferol  
 Prostaglandins  
 
4. Regulation of blood pressure  
Kidneys regulate arterial blood pressure by two ways 
 By regulating the volume of extracellular fluid  
 Through rennin-angiotensin mechanism.  
 Regulation of blood calcium level  
Kidneys play a role in the regulation of blood calcium level by activating 
1,25-di-hydroxycholecalciferol into Vitamin –D. Vitamin –D is necessory for the 
absorbtion of calcium from intestine. 
The ureter 
The ureters are a pair of narrow, thick walled muscular tubes which convey 
urine from kidneys to the urinary bladder. They lie deep to the peritoneum, closely 
applied to the posteior abdominal wall in the upper part and to the lateral pelvic 
wall in the lower part. 
Dimentions 
Each ureter is about 25cm (10 inches) long of which the upper half (5 inch) 
lies in the abdomen and the lower half (5 inch) in the pelvis. It measures about 
3mm in diameter, but it is slightly constricted at three places . 
Course 
The ureter begins within the renal sinus as a funnel – shaped dilation called 
the renal pelvis. The pelvis issues from the hilus of the kidney, descends along its 
medial margin, or partly behind it. 
Normal constrictions 
The ureter is slightly constricted at three places 
 At the pelvic ureteric juction  
 At the brim of the lesser pelvis  
 At the passage through the bladder wall.  
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The ureters are muscular tubes that transport urine from the kidney to the 
bladder. They are continuous superiorly with the renal pelvis, which is a funnel 
shaped structure in the renal sinus. The renal pelvis is formed from a condensation 
of two or three major calices. 
At the three following points along their  course, the ureters are constricted. 
 At the ureteropelvic junction, just inferior to the kidney.  
 The  ureters cross the common iliae vessels at the pelvic brim.  
 The ureters enter the wall of the bladder.  
Urinary bladder 
The urinary bladder is a muscular sac in the pelvis, just above and behind 
the pubic bone. When empty, the bladder is about the size and shap of a pear. 
Urine is made in the kidneys and travels down two tubes called ureters to 
the bladder. The bladder stones urine allowing urination to be infrequent and 
voluntary. The ladder is lined by layers of muscle tisue that stretch to 
accommodate urine. The normal capacity of the bladder is 400-600ml. 
During urination, the bladder muscles contract and two sphincters (valves) 
open to allow urine to flow out. Urine exits the bladder into the urethra which 
carries urine out of the body. Because it passes through the penis, the urethra is 
longer in men (8 inches) than in women (1.5 inches) 
Urethra 
In both genders, the urethra works as a tube connecting the urinary bladder 
to the genitals. The bladder collects and stores urine until it is ready to be 
discharged through the urethra. 
          While the function remains the same for both genders, slight differences 
exist due to differences between male and female genitals.The female urethra is 
quite a bit shorter than its male counterpart and its opening is situated between a 
women’s clitoris and vagina.For males, this tube travels the length of the penis and 
serves a dual purpose; it is a conduit for both urine and semen ejaculation. 
           Infection is more common in the female urethra. The most common 
condition is called urethritis, which involves inflammation and painful urinatio 
causes vary and can include viral or bacterial infections. symptoms may include 
frequent, urgent urination and purulent or pus-like excretions and discharges. 
          Treatments depend on the exact causes and symptoms, but most involve 
differing types of prescription medications.  
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UROLITHIASIS 
The process of forming stones in the kidney, bladder, and/or urethra. 
Kindey stones are a common cause of blood in the urine and pain in the abdomen, 
flank, or groin. Kidney stones occur in 1-20 people at some time in their life. The 
development of the stone is related to decreased urine volume or increased 
excretion of stone – forming components such as calcium, oxalate, urate, cysteine, 
xanthine, and phosphate. The stones form in the urine collecting area (the pelvis) 
of the kidney and may range in size from tiny to staghorn stones the size of the 
renal pelvis itself. 
Epidemiological factors like age, sex, hereditary, occupation, seasonal 
variations, socioeconomic status and dietary habits may determine the 
geographical preponderance. 
           In India approximately 5-7 million patients suffer from kalladaippu and 
least 1/1000 of Indian population needs hospitalization due to this disease. About 
80%of those with kidney stones are men. Men most commonly experience their 
first episode between 20-30 years of age, while for women it is comparatively 
later. 
12% of men were suffered with kalladaippu by the age 40-50 years 5% of 
women suffer from this disease by the age 50-60 years. The ratio is 3:1. 50% have 
recurrence within 5-10 years. 
About 15% contain magnesium ammonium phosphate (struvite stone) and 
small numbers of cysteine or uric acid stones are found. The most common type of 
stones is formed from uric acid. About 10-15% of kalladaippu consists of struvite 
stones. 
          In developing countries, bladder stones are common, particularly in 
children. In developed countries the incidence of childhood bladder stone is slow 
and renal stones in adult are common, and this urolithiasis is worse than that of 
labour pain. The pathogenesis of calcium oxalate , which accounts for >80% of all 
urinary stones. Between 120 and 140 per 1000,000 will develop urinary stones 
each year with a male/female ratio of 3:1. (update march 2011) , for more than 
40years the urolithiasis laboratory has perfected and perform done test, calculus 
analysis. We analyze approximately 50,000 stones annually, servicing more than 
10,000 clients throughout the United States and internationally. The annual 
incidence of urolithiasis in 2008 was 1.7%. The male and female ratio was 1:1 in 
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participants with urolithiasis. A family history of urolithiasis found In 28.5% of 
the first-degree relatives of the stone- free participants (p=0.01). (urological 
research- august 2011, volume 39, issue4, pp 309-314) 
AGE : Urinary stones disease is commonly seen in the age 
  group of 20-40 years. 
SEX : Ninety percent of the stone patients are males in India. 
This differs in European countries, where the incidence 
in females is much higher. 
        
HEREDITY : 
Heredity plays a significant role in the etiopathogenesis. 15% of patients 
give a family history of stone disease. 
OCCUPATION : 
The disease is more common among sedentary workers . 
GEOGRAPHICAL INFLUENCE : 
There is wide variation in the pattern of the disease in different parts of the 
world, thus projecting the significance of the stone belt areas. 
 
SEASONAL FACTORS : 
Higher incidence of the disease and aggravation of symptoms are noted in 
summer. 
SOCIOECONOMIC STATUS : 
It is more a disease of the middle and upper classes of people. 
DIET : 
High oxalate, high calcium and high uric acid diets may promote stones 
disease but the role of these alone as causative factors is debatable. Vitamin A, 
pyridoxine and magnesium are thought to inhibit stone disease. 
 
PREDISPOSING FACTORS FOR URINARY STONES 
ENVIRONMENTAL AND DIETARY 
Low urine volumes: 
 High body temperatures, low fluid intake 
Diet: 
 High protein,  sodium, low calcium diet.  
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High sodium excretion 
 High oxalate excretion  
 Low citrate excretion  
 
ACQUIRED CAUSES 
 Hypercalcemia of any cause  
 Heal disease or resection(increases oxalate absorption and 
urinary excretion)  
 Renal tubular acidosis type I  
 
CONGENITAL AND INHERITED CAUSES 
 Familial hypercalciuria  
 Medullary sponge kidney  
 Cystinuria             
 Renal tubular acidosis type I  
 Primary hyperoxaluria 
 
TYPES OF URINARY STONES 
There are 4 types of urinary calculi-calcium containing, mixed (struvite), 
uric acid and cystine stones, and a few rare types. 
 
l.CALCIUM STONES: 
Most kidney stones are made up of calcium compounds , especially 
calcium oxalate. 
Calcium stones are the most common comprising about 75% of all urinary 
calculi. They may be pure stones of calcium oxalate (50%) or calcium phosphate 
(5%) or a mixture of calcium oxalate and calcium phosphate (45%). 
Calcium stones are usually small (4-5mm), ovoid, hard, with granular 
rough surface. They are dark brown due to old blood pigment deposited in them 
and as a result of repeated trauma caused to the urinary tract by these sharp-edged 
stones. Conditions that cause high calcium levels in the body, such as 
hyperparathyroidism, increase the risk of calcium stones. High levels of oxalate 
also increase in the risk for calcium stones. 
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2. MIXED (STRUVITE) STONES: 
About 15% of urinary calculi are made of magnesium-ammonium-calcium 
phosphate, often called struvite, hence mixed stones are also called as struvite 
stones' or' triple phosphate stones. 
Struvite stones are yellow-white or grey. They tend to be soft and friable 
and irregular in shape. 'Staghorn stone' which is large, solitary stone that takes the 
shape of the renal pelvis where it is often formed is an example of struvite stone. 
They can also be called infection stones if they occur with kidney or 
urinary tract infections. These types of kidney stones sometimes are also called 
staghorn calculi if they grow large enough. 
 
3. URIC ACID STONES: 
Approximately 6% of urinary calculi are made of uric acid. Uric acid 
stones are adiolucent unlike radio-opaque calcium stones. Uric acid stones are 
smooth, yellowish-brown, hard and often multiple. On cut section, they show 
laminated structure. 
You are more likely to have uric acid stones if u have: 
 Low urine output.  
 A diet high in animal protein, such as red meat.  
 An increase in how much alcohol you drink .  
 Gout  
 Inflamattory bowel disease.  
 
4.CYSTINE STONES:  
Cystine stones comprise less than 2% of urinary calculi. Cystine stones are 
small, rounded, smooth and often multiple. They are yellowish and waxy. They 
occur in both men and women who have the genetic disorder cystinuria. 
 
5. OTHER CALCULI: 
Less than 2% of urinary calculi consist of other rare types such as xanthine 
stones. 
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AETIOLOGY 
l.CALCIUM STONES: 
Aetiology of calcium stones is variable. 
1. About 50% of patients with calcium stones have idiopathic hypercalciuria 
without hyper calcaemia.  
2. Approximately 10% cases are associated with hyper calcaemia and 
hypercalciuria, most commonly due to hyperparathyroidism, or a defect in 
the bowel ( i.e.,absorptive hypercalciuria), or in the kidney (i.e., renal 
hypercalciuria)  
3. About 15% of the patients with calcium stones have hyperuricosuria with  
a  normal blood uric acid level and without any abnormality of calcium 
metabolism. 
4. In about 25% of patients with calcium stones, the cause is unknown as 
there is no abnormality in urinary excretion of calcium, uric acid or oxalate 
and is referred to as 'idiopathic calcium stone disease'.  
 
2. MIXED (STRUVITE) STONES:  
Stuvite stones arre formed as a result of infection of the urinary tract with 
urea-splitting organisms that produce urease such as by species of Proteus, and 
occasionally Klebsiella,Pseudomonas and Enterobacter. These are, therefore, also 
known as infection-induced stones.However, E.coli does not form urease. 
3. URIC ACID STONES: 
Uric acid stones are frequently formed in cases with hyperuricaemia and 
hyperuricosuria such as due to primary gout or secondary gout due to 
myeloproliferative disorders (e.g. in leukaemias), especially those on 
chemotherapy, and administration of uricosuric drugs (e.g. salicylates, 
probenacid). Other factors contributing to their formation are acidic urine pH 
(below 6) and low urinary volume. 
4.  CYSTINE STONES: 
Cystine stones are associated with cystinuria due to a genitically-
determined defect in the transport of cystine and other amino acids across the cell 
membrane of renal tubules and the small intestinal mucosa. 
5. OTHER  CALCULI 
                 Are  caused  due  to  inherited  abnormality  of  enzyme metabolism. 
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This  tabular column represented with prevalence of various stones and its colours 
Kidney 
stone  
type 
Popul 
ation 
Circumsta
nces 
Color 
sensitiv
ity 
Details 
Calcium 
oxalate 
80% When urine 
is acidic 
(decreases 
PH) 
Black / 
dark 
brown 
Radio- 
opaque 
Some of the oxalate in 
urine is produced by the 
body. Calcium and 
oxalate in the diet play a 
part but are not the only 
factors that affect 
theformation of calcium 
Calcium 
phosphate 
5-10% When urine 
is alkaline 
(high PH) 
Dirty 
white 
Radio- 
opaque 
Tends to grow in 
alkaline urine especially 
whenproteus are 
present. 
Uric acid 5-10% When urine 
is 
persistently 
acidic. 
Yellow 
reddish 
brown 
Radioul 
cent 
Diets rich in animal 
proteins and purines: 
substances found 
naturally in all food but 
especially in organ 
meats, fish, and 
shellfish. 
Struvite 10-15% 
Infections 
in the 
kidney 
Dirty 
white 
Radio- 
opaque 
Preventing struvite 
stones depends on 
staying infection-free. 
Diet has not been 
shown to affect struvite 
stone formation.` 
Cystine 1-2% 
rare genetic 
disorder 
Pink/ 
yellow 
Radio- 
opaque 
Cysteine, an amino 
acid (one of the 
building blocks of 
protein), leaks through 
the kidneys and into 
the urine to form 
crystals. 
Xanthine  
Extremely 
rare 
Brick 
red 
Radio- 
opaque 
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PATHOGENESIS OF STONES 
Urinary stones usually arise because of the breakdown of a delicate balance 
between solubility and precipitation of salts. The kidneys must conserve water, but 
they must excrete materials that have a low solubility. These two opposing 
requirements must be balanced during adaptation to diet, climate, and activity. The 
problem is mitigated to some extent by the fact that urine contains substances that 
inhibit crystallization. These protective mechanisms are less than perfect. When the 
urine becomes supersaturated with insoluble materials, because excretion rates are 
excessive and/or because water conservation is extreme, crystals form and may grow 
and aggregate to form a stone. 
Supersaturation 
A solution in equilibrium with crystals of calcium oxalate is said to be 
saturated with respect to calcium oxalate. If crystals are removed, and if either 
calcium or oxalate ions are added to the solution, the chemical activities increase, but 
no new crystals form. Such a solution is metastably supersaturated. If calcium 
oxalate crystals are now added, they will grow in size. Ultimately, as calcium or 
oxalate is added to the solution, supersaturation reaches a critical value at which a 
solid phase begins to develop spontaneously. This value is called the upper limit of 
metastability. Kidney stone growth requires a urine that, on average, is 
supersaturated. Excessive supersaturation is common in stone formation. 
Calcium, oxalate, and phosphate form many soluble complexes among 
themselves and with other substances in urine, such as citrate. As a result, their free 
ion activities are below their chemical concentrations. Reduction in ligands such as 
citrate can increase ion activity and, therefore, supersaturation. Urine supersaturation 
can be increased by dehydration or by overexcretion of calcium, oxalate, phosphate, 
cystine, or uric acid. Urine pH is also important; phosphate and uric acid are acids 
that dissociate readily over the physiologic range of urine pH. Alkaline urine contains 
more dibasic phosphate, favoring deposits of brushite and apatite. Below a urine pH 
of 5.5, uric acid crystals (pK 5.47) predominate, whereas phosphate crystals are rare. 
The solubility of calcium oxalate is not influenced by changes in urine pH. 
Measurements of supersaturation in a 24-h urine sample probably underestimate the 
risk of precipitation. Transient, dehydration, variation of urine pH, and postprandial 
bursts of overexcretion may cause values considerably above average. 
 
54 
Crystallization 
When urine supersaturation exceeds the upper limit of metastability, crystals 
begin to nucleate. Cell debris and other crystals present in the urinary tract can serve 
as templates for crystal formation, a process known as heterogeneous nucleation. 
Heterogeneous nucleation lowers the level of supersaturation required for crystal 
formation. Once formed, crystal nuclei will grow in size if urine is supersaturated 
with respect to that crystal phase. Multiple crystals can then aggregate to form a 
kidney stone. 
In order for a kidney stone to form, crystals must be retained in the renal 
pelvis long enough to grow and aggregate to a clinically significant size. The 
mechanism of crystal retention has been a matter of much debate. Recent studies have 
shown that common calcium oxalate kidney stones form as overgrowths on apatite 
plaques in the renal papillae. These plaques, called Randall's plaques, provide an 
excellent surface for heterogeneous nucleation of calcium oxalate salts. The Randall's 
plaques begin in the deep medulla in the basement membrane of the thin limb of the 
loop of Henle and then spread through the interstitium to the basement membrane of 
the papillary urothelium. If the urothelium becomes damaged, the plaque is exposed 
to the urine, and calcium oxalate crystallization and stone formation begins. 
Inhibitors of Crystal Formation 
Urine contains potent inhibitors of nucleation, growth, and aggregation for 
calcium salts. Inorganic pyrophosphate is a potent inhibitor that appears to affect 
formation of calcium phosphate more than calcium oxalate crystals. Citrate inhibits 
crystal growth and nucleation, although most of the stone inhibitory activity of citrate 
is due to lowering urine supersaturation via complexation of calcium. Other urine 
components such as glycoproteins inhibit calcium oxalate crystallization. 
1. CALCIUM STONES: 
The mechanism of calcium stone formation is explained on the basis of 
imbalance between the degree of super saturation of the ions forming the stone and 
the concentration of inhibitors in the urine. Most likely site where the crystals of 
calcium oxalate and/or calcium phosphate are precipitated is the tubular lining or 
around some fragment of debris in the tubule acting as nidus of the stone. The stone 
grows, as more and more crystals are deposited around the nidus. A number of other 
predisposing factors contributing to formation of calcium stones are alkaline urinary 
pH, decreased urinary volume and increased excretion of oxalate and uric acid. 
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2. MIXED (STRUVITE) STONES: 
Struvite stones are formed as a result of infection of the urinary tract with 
urea-splitting organisms that produce urease. 
 
3. URIC ACID STONES: 
The solubility of uric acid at pH of 7 is 200 mg/dl while at pH of 5 is 15 
mg/dl. Thus, as the urine becomes more acidic, the solubility of uric acid in urine 
decreases and precipitation of uric acid crystals increases favouring the formation of 
uric acid stones. Hyperuricosuria is the most important factor in the production of uric 
acid stones, while hyperuricaemia is found in about half the cases. 
 
4. CYSTINE STONES: 
The resultant excessive excretion of cystine which is least soluble of the 
naturally occurring amino acids leads to formation of crystals and eventually cystine 
calculi. 
 
CLINICAL SYMPTOMS 
 Acute renal or ureteral pain(Renal colic) 
 Hematuria (microscopic or gross blood in urine)  
 Recurrent Urinary tract infection  
 Vague abdominal and flank pain  
Small non obstructing stones or 'silent stones' located in the calyces of the 
kidney are sometimes found incidentally on x-rays or may be present with 
asymptomatic hematuria. Such stones often pass without causing pain or discomfort. 
 
KIDNEY STONE SYMPTOMS: 
            Stones in the kidneys can become lodged at the junction of kidney and ureter 
(uretro pelvic junction), resulting in 
 Acute  ureteral  obstruction  with  severe  colicky  flank  pain.  Pain    can  
be localized at the costo-vertebral angle. 
 Hematuria may be present intermittently or persistently and it may be 
microscopic or gross.  
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URETERAL STONE SYMPTOMS: 
Stones that can pass into the ureter may produce 
 Ureteral colic which is an acute, sharp, spasm like pain located in the 
flank.  
 Hematuria may be present.  
 Stones moving down the ureter to the pelvic brim and iliac vessels will 
produce.  
 Spasms with intermittent, sharp, colicky pain radiating to the lateral flank 
and around the umbilical region.  
 As a stone passes through the distal ureter near the bladder,  
 The pain remains sharp but with a waxing and waning quality. Relief is 
offered when the spasm subsides or the pain may intensify and radiate to 
the groin, testicles and labia.  
 Nausea  
 Vomiting  
 Diaphoresis  
 Tachycardia   
 Tachypnoea may be present and patients are typically uncomfortable.  
 
BLADDER STONE SYMPTOMS: 
Once a stone enters the bladder, 
 Dysuria and Urgency and frequency of micturition may be the only 
symptoms experienced.  
 Immediate relief of symptoms occurs once the stone passes out  of 
bladder.  
Staghorn Calculi 
Struvite, cystine, and uric acid stones often grow too large to enter the ureter. 
They gradually fill the renal pelvis and may extend outward through the infundibulum 
to the calyces themselves. Very large staghorn stones can have surprisingly few 
symptoms and may lead to the eventual loss of kidney function. 
Nephrocalcinosis 
Calcium stones grow on the papillae. Most break loose and cause colic, but 
they may remain in place so that multiple papillary calcifications are found by x-ray, 
a condition termed nephrocalcinosis. Papillary nephrocalcinosis is common in 
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hereditary distal renal tubular acidosis (RTA) and in other types of severe 
hypercalciuria. In medullary sponge kidney disease, calcification may occur in dilated 
distal collecting ducts. 
Infection 
Although urinary tract infection is not a direct consequence of stone disease, it 
can occur after instrumentation and surgery of the urinary tract, which are frequent in 
the treatment of stone disease. Stone disease and urinary tract infection can enhance 
their respective seriousness and interfere with treatment. Obstruction of an infected 
kidney by a stone may lead to sepsis and extensive damage of renal tissue, since it 
converts the urinary tract proximal to the obstruction into a closed, or partially closed, 
space that can become an abscess. Stones may harbor bacteria in the stone matrix, 
leading to recurrent urinary tract infection. On the other hand, infection due to 
bacteria that possess the enzyme urease can cause stones composed of struvite. 
 
Activity of Stone Disease     
          Active disease means that new stones are forming or that preformed stones are 
growing. Sequential radiographs are needed to document the growth or appearance of 
new stones and to ensure that passed stones are actually newly formed, not 
preexistent. 
 
DIAGNOSIS 
It has been standard practice to diagnose acute renal colic by intravenous 
pyelography; however, helical CT scan without radiocontrast enhancement is now the 
preferred procedure. The advantages of CT include detection of uric acid stones in 
addition to the traditional radiopaque stones, no exposure to the risk of radiocontrast 
agents, and possible diagnosis of other causes of abdominal pain in a patient 
suspected of having renal colic from stones. Ultrasound is not as sensitive as CT in 
detecting renal or ureteral stones. 
Standard abdominal x-rays may be used to monitor patients for formation and 
growth of kidney stones, as they are less expensive and provide less radiation 
exposure than CT scans. Calcium, cystine, and struvite stones are all radiopaque on 
standard x-rays, whereas uric acid stones are radiolucent. 
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DIFFERENTIAL DIAGNOSIS 
 Appendicitis  
 Cholecystitis and cholelithiasis  
 Chron's disease  
 Ectopic pregnancy and pelvic inflammatory diseases  
 Pancreatitis    
 Gastric and duodenal ulcers  
 Pyelonephritis  
 Dissecting aneurysm  
 Diverticulis  
Evaluation and Treatment of Patients with Urolithiasis 
Most patients with nephrolithiasis have remediable metabolic disorders that 
cause stones and can be detected by chemical analyses of serum and urine. Adults 
with recurrent kidney stones and children with even a single kidney stone should be 
evaluated. A practical outpatient evaluation consists of two 24-h urine collections, 
with a corresponding blood sample; measurements of serum and urine calcium, uric 
acid, electrolytes, and creatinine, and urine pH, volume, oxalate, and citrate should be 
made. Since stone risks vary with diet, activity, and environment, at least one urine 
collection should be made on a weekend when the patient is at home and another on a 
work day. When possible, the composition of kidney stones should be determined 
because treatment depends on stone type. No matter what disorders are found, every 
patient should be counseled to avoid dehydration and to drink copious amounts of 
water. The efficacy of high fluid intake was confirmed in a prospective study of first-
time stone formers. Increasing urine volume to 2.5 L per day resulted in a 50% 
reduction of stone recurrence compared to the control group. 
Urolithiasis: Treatment 
The management of stones already present in the kidneys or urinary tract 
requires a combined medical and surgical approach. The specific treatment depends 
on the location of the stone, the extent of obstruction, the nature of the stone, the 
function of the affected and unaffected kidney, the presence or absence of urinary 
tract infection, the progress of stone passage, and the risks of operation or anesthesia 
given the clinical state of the patient. Medical therapy can enhance passage of ureteral 
stones. In general, severe obstruction, infection, intractable pain, and serious bleeding 
are indications for removal of a stone.  
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Calcium Stones Hypercalciuria: Treatment 
For many years the standard therapy for hypercalciuria was dietary calcium 
restriction. However, recent studies have shown that low-calcium diets increase the 
risk of incident stone formation. Low-calcium diets may lead to stone formation by 
reducing the amount of calcium to bind oxalate in the intestine, thereby increasing 
urine oxalate levels. However, the mechanism by which a low-calcium diet increases 
stone risk has not been clearly defined. In addition, hypercalciuric stone formers have 
reduced bone mineral density and an increased risk of fracture compared to the non-
stone-forming population. Low calcium intake likely contributes to the low bone 
mineral density. A 5-year prospective trial compared the efficacy of a low-calcium 
diet to a low-protein, low-sodium, normal-calcium diet in preventing stone recurrence 
in male calcium stone formers. The group on the low-calcium diet had a significantly 
greater rate of stone relapse. Low-calcium diets are of unknown efficacy in 
preventing stone formation and carry a long-term risk of bone disease in the stone-
forming population. Low-sodium and low-protein diets are a superior option in stone 
formers. If diet therapy is not sufficient to prevent stones, then thiazide diuretics may 
be used. Thiazide diuretics lower urine calcium and are effective in preventing the 
formation of stones. Three 3-year randomized trials have shown a 50% decrease in 
stone formation in the thiazi de-treated groups as compared to the placebo-treated 
controls. The drug effect requires slight contraction of the extracellular fluid volume, 
and high dietary NaCl intake reduces its therapeutic effect. Thiazide-induced 
hypokalemia should be aggressively treated since hypokalemia will reduce urine 
citrate, an important inhibitor of calcium crystallization. 
Hyperuricosuria-Treatment 
About 20% of calcium oxalate stone formers are hyperuricosuric, primarily 
because of an excessive intake of purine from meat, fish, and poultry. The mechanism 
of stone formation is probably due to salting out calcium oxalate by urate. A low-
purine diet is desirable but difficult for many patients to achieve. The alternative is 
allopurinol, which has been shown to be effective in a randomized, controlled trial. A 
dose of 100 mg bid is usually sufficient. 
Primary Hyperparathyroidism 
The diagnosis of this condition is established by documenting that 
hypercalcemia that cannot be otherwise explained is accompanied by inappropriately 
elevated serum concentrations of parathyroid hormone. Hypercalciuria, usually 
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present, raises the urine supersaturation of calcium phosphate and/or calcium oxalate. 
Prompt diagnosis is important because parathyroidectomy should be carried out 
before renal damage or bone disease occurs. 
Hyperoxaluria: Treatment 
Patients with mild to moderate hyperoxaluria should be treated with a diet low 
in oxalate and with a normal intake of calcium and magnesium to reduce oxalate 
absorption. Enteric hyperoxaluria can be treated with a low-fat, low-oxalate diet and 
calcium supplements, given with meals, to bind oxalate in the gut lumen. The oxalate-
binding resin cholestyramine at a dose of 8-16 g/d, provides an additional form of 
therapy. Treatment for primary hyperoxaluria includes a high fluid intake, neutral 
phosphate, and pyridoxine (25-200 mg/d). Citrate supplementation may also have 
some benefit. Even with aggressive therapy, irreversible renal failure may occur. 
Liver transplantation, to correct the enzyme defect, combined with a kidney 
transplantation has been successfully utilized in patients with primary hyperoxaluria. 
Hypocitraturia: Treatment 
Treatment is with alkali, which increases urine citrate excretion; generally 
bicarbonate or citrate salts are used. Potassium salts are preferred as sodium loading 
increases urinary excretion of calcium, reducing the effectiveness of treatment. Two 
randomized, placebo-controlled trials have demonstrated the effectiveness of citrate 
supplements in calcium oxalate stone formers. 
Idiopathic Calcium Lithiasis 
Some patients have no metabolic cause for stones despite a thorough 
metabolic evaluation. The best treatment appears to be high fluid intake so that the 
urine specific gravity remains at 1.005 throughout the day and night. Thiazide 
diuretics, allopurinol, and citrate therapy may help reduce crystallization of calcium 
salts, but there are no prospective trials in this patient population. Oral phosphate at a 
dose of 2 g phosphorus daily may lower urine calcium and increase urine 
pyrophosphate and thereby reduce the rate of recurrence. Orthophosphate causes mild 
nausea and diarrhea, but tolerance may improve with continued intake. 
Uric Acid Lithiasis: Treatment 
The two goals of treatment are to raise urine pH and to lower excessive urine 
uric acid excretion to <1 g/d. Supplemental alkali, 1-3 mmol/kg of body weight per 
day, should be given in three or four divided doses, one of which should be given at 
bedtime. The goal of treatment should be a urine pH between 6.0 and 6.5 in a 24-h 
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urine collection. Increasing urine pH above 6.5 will not provide additional benefit in 
preventing uric acid crystallization but does increase the risk of calcium phosphate 
stone formation. The form of the alkali may be important. Potassium citrate may 
reduce the risk of calcium salts crystallizing when urine pH is increased, whereas 
sodium citrate or sodium bicarbonate may increase the risk. A low-purine diet should 
be instituted in uric acid stone formers with hyperuricosuria. Patients who continue to 
form uric acid stones despite treatment with fluids, alkali, and a low-purine diet 
should have allopurinol added to their regimen. 
 
Cystinuria and Cystine Stones: Treatment 
High fluid intake, even at night, is the cornerstone of therapy. Daily urine 
volume should exceed 3 L. Raising urine pH with alkali is helpful, provided the urine 
pH exceeds 7.5. A low-salt diet (100 mmol/d) can reduce cystine excretion up to 
40%. Because side effects are frequent, drugs such as penicillamine and tiopronin, 
which form the mixed soluble disulfide cysteine-drug complexes, should be used only 
when fluid loading, salt reduction, and alkali therapy are ineffective. Low-methionine 
diets have not proved to be practical for clinical use, but patients should avoid protein 
gluttony. 
 
Struvite Stones: Treatment 
Complete removal of the stone with subsequent sterilization of the urinary tract 
is the treatment of choice for patients who can tolerate the procedures. Percutaneous 
nephrolithotomy is the preferred surgical approach for most patients. At times, 
extracorporeal lithotripsy may be used in combination with a percutaneous approach. 
Open surgery is rarely required. Irrigation of the renal pelvis and calyces with 
hemiacidrin, a solution that dissolves struvite, can reduce recurrence after surgery. 
Stone-free rates of 50-90% have been reported after surgical intervention. 
Antimicrobial treatment is best reserved for dealing with acute infection and for 
maintenance of a sterile urine after surgery. Urine cultures and culture of stone 
fragments removed at surgery should guide the choice of antibiotic. For patients who 
are not candidates for surgical removal of stone, acetohydroxamic acid, an inhibitor 
of urease, can be used. Unfortunately, acetohydroxamic acid has many side effects, 
such as headache, tremor, and thrombophlebitis, that limit its use. 
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COMPLICATIONS 
Ocassionally, stones can injure the kidneys by causing infection, resulting in 
fever, chills, loss of appetite or urinary obstruction. If an UTI accompanies the 
urinary obstruction, pyelonephritis or urosepsis can occur. If stones are bilateral,they 
can cause renal scarring and damage, resulting in acute or chronic renal failure. 
 
DIET FOR URINARY STONES 
A diet for Calcium stones should limit substances that increase blood and 
urine levels of calcium, such as caffeine and sodium. It is better to avoid foods and 
beverages such as coffee, chocolate and fast foods. Food that reduce excretion of 
calcium into the urine such as cranberries can be included. Mineral supplements that 
are reported to reduce urinary calcium are magnesium and potassium. Vitamin B6 is 
also reported to reduce urinary calcium.Oxalate rich foods like spinach, beet, black 
tea and nuts should be avoided. Also avoid vitamin C rich food as vitamin C converts 
to oxalate in urine. 
Uric acid stone former should avoid animal sources of protein and red wine 
and increase their daily fluid intake. Even vegetable sources of protein like pulses and 
grains should be restricted. 
Struvite stone formers may modify their diet to increase the acidity of urine to 
inhibit bacterial growth. Urine acidifiers include specific tablets, animal proteins and 
citrus fruits. 
Cystine stone formers should avoid fish and grains containing protein that are 
rich in methionine.As excessively acidic urine encourages cystine stone formation 
foodwhich help to raise the pH of the urine such as vegetable juices and fruits can be 
taken. 
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MATERIALS AND METHODS 
 A clinical study on “The evaluation of efficacy of the trial drug Nilakumilaver 
Kudineer (Internal) in treating Kalladaippu noi”, was carried out at the Post 
Graduate Department of Pothu Maruthuvam, Government Siddha Medical College 
and Hospital, Palayamkottai. 
            For the study, a total of 40 patients of both sex (20 Out-Patients and 20 In-
Patients), suffering from Kalladaippu noi were selected and administered the fore-
said trial drug for the purpose of treating the disease.  
            The patients, both in-patients and out-patients were enrolled for the study after 
diagnosing the Kalladaippu noi, through clinical, pathological, biochemical and 
microscopic examination. In addition, Ultra-Sonogram was also done for all the 
patients who were enrolled for the study to confirm the occurrence of Kalladiappu 
noi.                   
            After discharging the inpatients from the IP ward, treatment with the trial 
medicine was continued in the OP Department as follow-up cases. 
 
Preparation of trial medicine  
           The  trial  medicine,  Nilakumilaver Kudineer  (Internal)  is  selected  based  
on their  medicinal  values  in  treating  Kalladaippu  noi,  mentioned  in  the  Siddha  
Literature, AGATHIYAR VAITHYA KAVIYAM – 1500  
Pg- 651,652 
           The ingredient was collected, purified and the medicine was  prepared, stored 
and given to the patients based on the reference cited above. References are enclosed 
in Annexure – I. 
 
Biochemical analysis of the trial medicine 
Biochemical analyses of the trial medicine was performed at the Biochemistry 
Unit of Government Siddha Medical College, Palayamkottai. Experiments were 
conducted by the unit by following the standard procedures to know the presence of 
minerals like Calcium, Sulphate, Chloride, Carbonate, Starch, Ferric Iron, Ferrous 
Iron, Phosphate, Albumin, Tannic Acid, Unsaturated Compound, Reducing sugar, 
Amino Acid and Zinc. The results of the biochemical analysis and inferences are 
given in  Annexure – II. 
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Acute toxicity studies of the trial medicine 
Acute toxicity studies were conducted in Pharmacology laboratory, at Periyar 
College of Pharmaceutical Sciences Trichy Experiments were conducted with albino 
rats by following the standard procedures. The procedures, results and inferences are 
given in detail in Annexure – III. 
Pharmacological analysis of the trial medicine 
Pharmacological actions of the trial medicine were studied at Periyar College 
of Pharmaceutical Sciences Trichy. Experiments were conducted with albino rats by 
following the standard procedures to determine the pharmacological actions like 
lithotriptic ,diuretic and analgesic effect of the trial medicine. The procedures, results 
and inferences are given in detail  in Annexure – IV. 
Criteria for the selection of patients 
For the present study, patients were selected based on the following criteria. 
 Ultra-Sonogram report, indicating the presence of Renal Calculi.  
 Urine analysis report, indicating the presence of crystals, albumin and  
 RBC depositions in the urine.  
 Past history of Renal Calculi.  
Clinical history of patients with the following symptoms.  
 Renal colicky pain  
 Burning micturation  
 Obstruction during micturation  
 Oliguria  
 Haematuria  
 Nausea  
 Vomiting  
 Sweating  
Collection and maintenance of Patients’ database 
A proforma was prepared to collect details about the patients personal and 
family history, present symptoms, history of recent and past illness, laboratory 
investigation (including urine and blood analysis), Ultra-Sonogram, method adopted 
for the purpose of treatment and management of the disease and follow-up 
procedures. The details collected were recorded in proforma for each individual 
patient and database was maintained for all the patients.   
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Investigation of Kalladaippu noi patients 
The patients were subjected to the following investigations to establish the 
diagnosis. The investigations were carried out regularly before and after the 
treatment. 
 
i) Urine examination 
The urine of patients was subjected to microscopic investigations with regard 
to the colour, specific gravity, sugar, albumin, RBCs, cast, pus cells, epithelial cells, 
crystals and other pathological constituents. 
 
ii) Biochemical examination of blood 
The blood of patients was tested biochemically to estimate the blood urea and 
creatinine level to know the present functional status of kidney. 
iii) Ultra-Sonogram (USG Abdomen KUB) 
All the patients were subjected to USG Abdomen KUB before and after the 
treatment. The USG reports of few patients are enclosed in Annexure - V. 
iv)Analysis of kidney stones 
Knowing the chemical composition of the stone helps the doctor identify why 
the patient is prone to stone formation. The kind of stone a person’s body makes 
determines what dietary changes may be needed.For example, limiting oxalate in the 
diet may help prevent calcium oxalate stones but will do nothing to prevent uric acid 
stones. Some dietary recommendations may apply to more than one type of stone.                
Most notably, drinking enough water helps prevent all kinds of kidney stones. 
In the present study, the urinary tract stones expelled along with urine in some of the 
patients during the course of treatment were analysed in a well reputed medical 
laboratory to determine the types of stones. The stone 
analysis reports are given in Annexure – VI. 
 
Criteria for measuring the positive outcome of the study 
The positive outcomes of the study was measured using the following 
Urolithiasis Symptom Score. The score of each case at the time of enrolment and at 
the end of treatment were compared and on its basis the patient was informed that he 
or she was symptoms free and cured.  
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Urolithiasis Symptom Score 
(Circle relevant number on each line) 
1. Pain/colic 0- No pain 1- Mild pain 
2 -Moderate 
pain 
3- Severe 
pain 
2. Haematuria 0 -No 1- Microscopic 2- Persistent 3 -Gross 
  haematuria    
3. Dysuria 0 -No dysuria 1- Mild dysuria 2- Moderate 3- Severe 
    dysuria  
4. Stone  1- Single stone 2- Multiple  
    stone  
5. Size of 0- Gravel < 1-3 mm to < 4 2-4 mm to < 3-5 mm and 
stones 03mm mm 5 mm above 
      
6. Position of 0- no stone in 1-Pelvic ureteric 2- Pelvis of 3 Calyces of 
stone in kidney junction kidney kidney 
kidney     
7. Position of 0- no stone in 1- Lower part of 2- Middle of 3- Upper 
stone in ureter ureter ureter ureter part of 
     Ureter 
8. Position of 0 -no stone in 1 -Base of 2- Intramural  
stone in bladder bladder ureter  
bladder     
 
Total scoring – 22, 1-7 mild, 8-14 moderate, 15-22 severe. Symptoms score – (Some 
of 8 circled numbers) 
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RESULTS AND OBSERVATION 
The results obtained from the presence study were recorded in the proforma 
with respect to the following parameters for eacch patient both out patients and in 
patients. They were analysed statistically inorder to arrive at the percentage 
composition. 
1. Age  
2. Sex  
3. Religion  
4. Occupation  
5. Socio-economic stattus  
6. Food habits  
7. Personal habits  
8. Aetiological factors  
9. Thinai  
10. Kaalangal 
11. Paruvakaalam 
12. Thegi (Constitution of body) 
13. Mukkutram 
      Derangement of Vatham  
a. Derangement of Pitham  
b. Derangement of kabam  
14. Udal Thathukkal  
15. Envagai Thervugal  
16. Neerkuri  
17. Neikuri  
18. Duration of illness  
19. Types of pain  
20. Types of Dysuria  
21. Numbeer of Stones  
22. Size of stones  
23. Position of stone  
24. Urolithiasis symptom score  
25. Grading outcomes of the study  
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TABLE –I 
AGE DISTRIBUTION 
S.No 
Age  
(in years) 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 21 – 30 04 20 04 20 
02 31 – 40 06 30 01 05 
03 41 – 50 05 25 05 25 
04 51 – 60 05 25 10 50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the patients study among the Outpatients, Kalladaippu Noi was found to be 
most common in the age group of 41 – 50 years. Among In Patients it was 
predominent in the age group of 51 – 60 years. 
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TABLE – 2 
SEX  DISTRIBUTION 
 
S.No Sex 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Male 14 70 10 50 
02 Female 06 30 10 50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Female 
 
 
 
 
 
From the above table male outpatients were most affected by Kalladaippu 
Noi and In patients were equally afffected. 
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TABLE –3 
RELIGION DISTRIBUTION 
S.No Religion 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Hindu 16 80 18 90 
02 Christian 02 10 01 05 
03 Muslim 02 10 01 05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is observed that hindus were most affected by kalladaippu noi and 
Muslims were minimally affected 
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TABLE –4 
OCCUPATION DISTRIBUTION 
S.No Occupation 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Coolie 05 25 06 30 
02 Farmer 04 20 03 15 
03 Business 03 15 02 10 
04 Private Jobs 05 25 01 05 
05 
Retired 
Persons 
01 05 01 05 
06 
Home 
Maker 
02 10 07 35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the above table shows that 30% of the out patients with 
kalladaippu noi were in the private jobs and majority of the inpatients were 
home maker. 
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TABLE –5 
SOCIO ECONOMIC STATUS 
S.No 
Socio 
Economic 
Status 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Rich 04 20 03 15 
02 Middle 06 30 08 40 
03 Poor 10 50 09 45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is determine from the above data that the majority of the In patients 
affected by the Kalladaippu Noi were from the poor class. In IN Patients Middle 
and Poor class were equally affected. 
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TABLE – 6 
DIET 
S.No Diet 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Vegetarian 08 40 05 25 
02 Mixed Diet 12 60 15 75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is noticed that most of the patients affected were taking mixed diet 
comparing of both vegetarian and mixed food. 
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TABLE –7 
PERSONAL HABITS 
S.No Personal Habits 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Alcohol 04 20 05 25 
02 Smoke 03 15 03 15 
03 
Alcohol & 
Smoke 
03 15 01 05 
04 
Tobaco / Betal 
Chewing 
01 05 01 05 
05 No Bad Habits 09 45 10 50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the above data it is learnt that majority did not have any bad habits 
and rest were taking alcohol. 
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TABLE – 8 
AETIOLOGICAL FACTORS 
S.No 
Aetiological 
Factors 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 
Known Previous 
History 
03 15 02 10 
02 Recurent UTI 03 15 02 10 
03 Others 14 70 16 80 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The above table shows that majority of the Out and Inpatients had 
other such causes. 
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TABLE – 9 
THINAI 
S.No Thinai 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Kurinji 00 00 00 00 
02 Mullai 01 05 04 20 
03 Marutham 15 75 12 60 
04 Neithal 04 20 04 20 
05 Palai 00 00 00 00 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is observed from the data that majority of the patients suffering from 
kalladaippu noi were marutha nilam. 
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TABLE – 10 
MUKKUTRA KALAM 
S.No Mukkutrakalam 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Vatham 
(0 – 33 Years) 
06 30 03 15 
02 Pitham 
(34 – 66 Years) 
14 70 17 85 
03 Kabam 
(67 – 100 Years) 
00 00 00 00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This table reveals that majority of both outpatients and inpatients, suffering from 
kalladaippu noi were in pitha kaalam (i.e.,) in between 34 – 66 years. 
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TABLE – 11 
PARUVA KALAM 
S.No 
Paruva 
kalam 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Kaar 00 00 00 00 
02 Koothir 00 00 02 10 
03 Munpani 03 15 12 60 
04 Pinpani 16 80 03 15 
05 Ilavenil 01 05 00 00 
06 Mudhuvenil 00 00 03 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The data reveals that kalladaippu noi most occured during pinpani and 
munpani kaalam 
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TABLE – 12 
THEGI 
S.No Thegi 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Vatha thegi 09 45 11 55 
02 Pitha thegi 06 30 06 30 
03 Kabha thegi 05 25 03 15 
 
 
 
 
Cases 
 
 OP  IP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the above table it is understood that people with vatha thegi was most 
affected by kalladaippu noi and kaba thegi were least affected 
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TABLE – 13 
MUKKUTRAM 
A) Derangement of Vatham 
S.No Vatham 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Pranan 00 00 00 00 
02 Abanan 22 110 20 100 
03 Viyanan 10 50 13 65 
04 Uthanan 10 50 12 60 
05 Samanan 20 100 20 100 
06 Nagan 04 20 03 15 
07 Koorman 00 00 00 00 
08 Kirugaran 00 00 00 00 
09 Thevathathan 04 20 02 10 
10 Thananjeyan 00 00 00 00 
 
 
 
 
 
 
 
 
 
The above date reveals that all the patients had derangement in Abanan and 
Samanan. Viyanana and Uthanan seems to be disturbed in the majority of the 
patients.  
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B) Derangement of Pitham 
S.No Pitham 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Analapitham 00 00 00 00 
02 Ranjagapitham 06 30 04 20 
03 Sathagapitham 08 40 11 55 
04 Prasagam 00 00 00 00 
05 Alosagam 00 00 00 00 
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 OP  IP 
It is revealed from the above table the sathaga pitham was affected in 
majority of the patients.
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C) Derangement of Kapham 
S.No Kabam 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Avalambagam 00 00 00 00 
02 Kilethagam 00 00 00 00 
03 Pothagam 00 00 00 00 
04 Tharpagam 00 00 00 00 
05 Santhigam 06 30 04 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
From the above data it is observed that only santhigam was affected in a 
few number of patients. 
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TABLE – 14 
UDAL THATHUKKAL 
S.No 
Udal 
thathukkal 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Saaram 20 100 20 100 
02 Seneer 06 30 05 25 
03 Oon 00 00 00 00 
04 Kozhuppu 00 00 00 00 
05 Enbu 05 25 08 40 
06 Moolai 00 00 00 00 
07 
Sukkilam / 
Suronitham 
00 00 00 00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The above table clearly shows that saaram was affected in all patients. 
Seneer and Enbu Thathu were affected in few patients. 
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TABLE – 15 
ENVAGAI THERVUGAL 
S.No Envagai Therugal 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Naa 02 10 02 10 
02 Niram 00 00 00 00 
03 Mozhi 00 00 00 00 
04 Vizhi 00 00 00 00 
05 Malam 00 00 00 00 
06 Moothiram 20 100 20 100 
   07 Naadi 00 00 00 00 
I. Vatha Pitham 10 50 12 60 
II. Vatha Kabam 04 20 04 20 
III. Pitha Vatham 03 15 02 10 
IV. Pitha Kabham 03 25 01 05 
 V. Kabha vatham 00 00 00 00 
 VI. Kabha Pitham 00 00 00 00 
08 Sparisam 00 00 00 00 
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From the above table it can be understood that moothiram was affected 
remarkably in all the patients considering naadi vatha pitha naadi was observed in 
majority of the patients. 
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TABLE  - 16 
Neerkuri 
S.No 
Type of Test 
Result 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 
Niram 
Normal 06 30 04 20 
Yellowish 12 60 14 70 
Yellowish red 02 10 02 10 
02 
Edai 
Normal 20 100 20 100 
Increased     
Decreased     
03 
Manam 
Normal 20 100 20 100 
Foul Smell     
04 
Nurai (Forth) 
Normal 20 100 20 100 
Increased     
05 
Enjal (Deposits) 
Absent 17 85 17 85 
Present  03 15 03 15 
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Yellowish coloured urine were noticed in majority of patients.  Smell, forth 
were normal in all of them. RBCS were found to pass in urine of 2 out-patients and 
1 in patient. 
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TABLE - 17 
Neikuri 
S.No Neikuri 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 
Vaatha neer 
(lengthens like 
snake) 
06 30 06 30 
02 
Pithaneer 
(Formation of 
ring) 
02 10 00 00 
03 
Kabaneer (Pearl 
like appearance) 
02 10 03 15 
04 
Kalappuneer 
(Seive like 
appearance) 
10 50 11 55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The above data reveals that seive like appearance was found in most of the 
cares and snake like appearance which indicates vathaneer. Kabaneer pearl like 
appearance were observed only in 3 outpatients and pitha neer were abserved only 
2 in out patient. 
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TABLE - 18 
Duration of illness 
S.No 
Type of 
Characters 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 
Less than 1 
Month 
06 30 05 25 
02 2 – 6 Month 06 30 04 20 
03 6 Month – 1 Year 02 10 05 25 
04 1 – 1 ½ Year 02 10 01 05 
05 1 ½ - 2 Year 01 05 02 10 
06 2 – 3 Year 03 15 03 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the above table it is understood that majority of out-patients 
expeienced the symptoms of this diseases. During time period of 0-6 months 
whereas the in patients between 6-12 months. Only a few in patients suffered from 
the symptoms for more than a year. 
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TABLE – 19 
Types of pain 
S.No 
Type of 
Pain 
Before Treatment After Treatment 
Out – 
patients 
In – 
patients 
Out – 
patients 
In – patients 
No of 
cases 
% 
No.of 
cases 
% 
No of 
cases 
% 
No.of 
cases 
% 
01 Severe Pain 07 35 09 45 - - - - 
02 
Moderate 
Pain 
07 35 08 40 03 15 01 05 
03 Mild Pain 06 30 03 15 - - - - 
04 No Pain - - - - - - - - 
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TABLE - 20 
Types of Dysuria 
S.No 
Severity 
Dysuria 
Before Treatment After Treatment 
Out – patients In – patients Out – patients In – patients 
No of 
cases 
% 
No.of 
cases 
% 
No of 
cases 
% 
No.of 
cases 
% 
01 Severe  10 50 11 55 00 00 00 00 
02 Moderate  07 35 06 30 03 15 02 10 
03 Mild  02 10 03 15 00 00 00 00 
04 No Pain 01 05 00 00 00 00 00 00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Case s 
 
 
 
 
 
 
 
 
In the present study majority of the cases presented with severe dysuria on 
their first visit. On their subsquient visists the symptoms decreased and ultimately 
at the end of if study period there were only 15% of cases with mild dysuria. 
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TABLE – 21 
Types of  Heamaturia 
S.No 
Type of 
Heama 
turia 
Before Treatment After Treatment 
Out – 
patients 
In – 
patients 
Out – 
patients 
In – 
patients 
No of 
cases 
% 
No.of 
cases 
% 
No of 
cases 
% 
No.of 
cases 
% 
01 
Gross 
heamaturia 
02 10 01 05 00 00 00 00 
02 
Persistant 
heamaturia 
00 00 00 00 00 00 00 00 
03 
Microscopic 
heamaturia 
00 00 00 00 00 00 00 00 
04 No heamaturia 18 90 19 95 20 100 20 100 
 
 
 
 
 
 
 
 
 
 
 
 
 
It was noted during the study that 10% of the out patients and 5% of the in-
patients had gross haematuria.  After treatment the urine of all the patients were 
normal. 
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TABLE – 22 
Number of Stones 
S.No 
Type of 
Stones 
Before Treatment After Treatment 
Out – 
patients 
In – 
patients 
Out – 
patients 
In – 
patients 
No of 
cases 
% 
No.of 
cases 
% 
No of 
cases 
% 
No.of 
cases 
% 
01 Single 11 55 12 60 02 10 03 15 
02 Multiple 09 45 08 40 02 10 01 05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Most of the USG reports of the cases revealed single stones and multiple 
stone. But after the study there were only few cases with stones with reduction in 
size of stones. 
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TABLE – 23 
Size of Stones 
S.No Size of Stones 
Before Treatment After Treatment 
Out – 
patients 
In – 
patients 
Out – 
patients 
In – 
patients 
No of 
cases 
% 
No.of 
cases 
% 
No of 
cases 
% 
No.of 
cases 
% 
01 5mm and above 10 50 08 40 02 10 01 05 
02 4mm to < 5mm 08 40 08 40 01 05 02 10 
03 3mm to < 4mm 01 05 02 10 00 00 00 00 
04 Gravel < 3mm 01 05 02 10 00 00 00 00 
 
 
 
 
 
 
 
 
 
Case s 
 
 
 
 
 
 
 
 
The USG reports of the cases before treatment revealed that in majority of 
the cases of size of stone 5mm and above. 4mm to <5mm was second major in the 
cases. At the end of study 10% of out patient and 5% of in patients presented with 
stone at the size of 5 and above. But the size were reduced comparing to the before 
treatment report. 
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TABLE – 24 
Position of stones 
S.No Size of Score 
Before Treatment After Treatment 
Out – 
patients 
In – 
patients 
Out – 
patients 
In – 
patients 
No of 
cases 
% 
No.of 
cases 
% 
No of 
cases 
% 
No.of 
cases 
% 
01 Kidney 12 60 14 70 03 15 01 05 
02 Ureter 06 30 03 15 01 05 00 00 
03 
Both kidney & 
Ureter 
01 05 03 15 00 00 00 00 
04 Bladder 01 05 00 00 00 00 00 00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Before treatment majority of the cases were presenting Renal calculi 
especially in the calyees of the kidney. Ureteric calculi were found in 30% of out 
patients and 5% of in patient. 
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TABLE - 25 
Urolithiasis symptoms score 
S.No Types of Score 
Before Treatment After Treatment 
Out – 
patients 
In – 
patients 
Out – 
patients 
In – 
patients 
No of 
cases 
% 
No.of 
cases 
% 
No of 
cases 
% 
No.of 
cases 
% 
01 15 – 22 (Severe) 11 55 12 65 00 00 00 00 
02 08 – 14 (Moderate) 06 30 06 35 00 00 00 00 
03 01 – 07 (Mild) 03 15 02 05 03 15 02 05 
04 No Symptom 00 00 00 00 17 85 18 90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The above tubular column reveals that the score severe high before 
treatment in majority of cause. It was noticed that the score gradually decreased 
during the course of the study and ultimately 85% of out patients and 90% of in 
patients had score (ie) no symptoms 
0
10
20
30
40
50
60
70
80
90
100
No of cases Percentage No.of cases Percentage No of cases Percentage No.of cases Percentage
Out – patients In – patients Out – patients In – patients 
Before Treatment After Treatment
15 – 22 (Severe) 
08 – 14 (Moderate) 
01 – 07 (Mild) 
No Symptem
97 
TABLE - 26 
Grading outcomes of the study 
S.No 
Type of 
Characters 
Out – patients In – patients 
No of cases Percentage No.of cases Percentage 
01 Good 16 80 15 75 
02 Moderate 04 20 05 25 
03 Poor 00 00 00 00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the above observations it is determined that good response was noted in 
75% of out-patients and 85% of in patients. Moderate response was observed in 25% 
of out patients and 15% of in patients. Hence, it can be concluded that the trial 
medicine, Nilakumilaver kudineer is very effictive in curing kalladaippu noi. 
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CASE SHEET OF 20 OUT PATIENTS TREATED FOR KALLAIDAIPPU NOI 
 
 
 
 
SNo OP.No Name Age Sex 
Starting of 
Treatment 
End of 
Treatment 
No of  
Days 
Treated 
Result 
01 6749 Gabreal Ganesan 48 M 21.01.2016 19.02.2016 30 Days Good 
02 9209 Aavudaiappan 30 M 28.01.2016 26.02.2016 30 Days Fair 
03 11609 Sangaralingam 36 M 04.02.2016 04.03.2016 30 Days Good 
04 12967 Ismail 40 M 08.02.2016 08.03.2016 30 Days Good 
05 10907 Joys Gracy 34 F 02.02.2016 02.03.2016 30 Days Good 
06 14148 Latha 43 F 11.02.2016 11.03.2016 30 Days Good 
07 13799 Kumar 47 M 10.02.2016 10.03.2016 30 Days Good 
08 21310 Raja 28 M 04.03.2016 02.04.2016 30 Days Good 
09 20374 Sudalai 58 M 01.03.2016 29.03.2016 30 Days Good 
10 9053 Samikkannu 40 M 28.01.2016 26.02.2016 30 Days Good 
11 11638 Malika 37 F 04.02.2016 04. 03.2016 30 Days Good 
12 16904 Shahul Hameed 35 M 19.02.2016 19.03.2016 30 Days Good 
13 18009 Ramachandran 60 M 23.02.2016 23.03.2016 30 Days Good 
14 16456 Sundari 30 F 18.02.2016 18.03.2016 30 Days Good 
15 23579 Nehrumani 52 M 12.03.2016 10.04.2016 30 Days Good 
16 23076 Vincent John 60 M 10.03.2016 08.04.2016 30 Days Good 
17 9660 Banupriya 30 F 29.01.2016 27.02.2016 30 Days Fair 
18 3611 Durairaj 48 M 11.01.2016 11.02.2016 32 Days Fair 
19 22817 Anandhi 48 F 09.03.2016 07.04.2016 30 Days Good 
20 14835 Sellaiyah 51 M 15.02.2016 15.03.2016 30 Days Good 
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BLOOD INVESTIGATIONS OF OUT – PATIENTS 
  
    Before Treatment    After Treatment   
 
 Op. 
No 
WBC WBC – DC% ESR   
WBC  
Total WBC – DC% ESR 
  
 
S.
No 
Total 
Cells/ 
 
Hb
% 
 
Hb% 
 
              
 
P 
 
L E 1/2 hr 
 
1hr 
Cells / 
Cub.mm 
P L E 1/2 hr 
 
1hr 
 
  
Cub.mm               
 
1 6749 7900 65  32 3 13  17 12.5 8100 62 34 4 5  7 13 
 
2 9209 8400 62  34 4 12  20 10.5 8000 59 38 3 10  22 12.0 
 
3 11609 8100 58  41 1 12  20 9 7700 64 33 3 30  3 12.4 
 
4 12967 7500 57  41 1 14  22 12 8700 55 43 2 28  32 12.3 
 
5 10907 9500 66  28 6 18  20 9.6 9500 63 30 7 20  25 13 
 
6 14148 9700 66  26 8 20  23 13 8800 55 39 6 26  32 13.8 
 
7 13799 8500 67  29 4 35  41 14.5 8000 60 35 5 12  20 12.8 
 
8 21310 7900 64  31 5 31  35 10.5 8500 60 38 2 18  25 13.5 
 
9 20374 8700 59  38 3 18  20 9 8000 61 37 2 23  28 12.5 
 
10 9053 7500 69  28 3 20  23 9.7 8500 62 35 3 26  30 11 
 
11 11638 8500 64  34 2 26  30 12.3 7500 60 38 2 24  31 11.8 
 
12 16904 8300 66  30 4 18  26 13.5 7300 56 38 6 27  32 13.5 
 
13 18009 7000 65  30 5 28  33 14 8800 66 28 6 20  29    14 
 
14 16546 8300 59  38 3 12  18 10 9300 62 35 3 16  22 11.5 
 
15 23579 7100 57  40 3 22  30 11 9000 67 38 5 19  25 14.5 
 
16 23076 7500 58  40 2 20  23 9.1 8300 65 30 5 22  28 10 
 
17 9660 7200 60  35 5 32  40 10.5 9500 67 28 5 23  31 9.6 
 
18 3611 9000 65  32 3 22  30 11.5 7800 54 43 3 19  28 12 
 
19 22817 9100 52  41 7 30  35 12.5 8100 52 41 7 26  33 10.5 
 
20 14838 9800 65  30 5 20  30 10 7200 59 38 3 23  30 11 
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BIO CHEMICAL ANALYSIS 
  
Blood (Sugar) 
mgs% Blood (Urea (mgs%) 
Total Cholesterol 
(mg%) 
 
Serum 
Creatinine 
S.No OP NO   
(mg
s%)       
  BT AT  BT AT BT AT  AT  BT 
1 6749 86 106 19  21 162 175 0.8   0.7 
2 9209 85 100 21  20 160 165 0.7   0.8 
3 11609 90 106 30  28 178 180 0.5   0.6 
4 12967 125 100 14  20 150 162 1.0   1.3 
5 10907 80 122 20  26 170 175 1.2   1.0 
6 14148 100 100 28  26 162 160 1.0   1.3 
7 13799 118 123 20  22 151 156 0.8   0.6 
8 21310 101 117 23  20 202 198 1.2   0.5 
9 20374 146 120 18  20 165 170 1.1   0.7 
10 9053 132 142 25  23 183 176 0.7   0.7 
11 11638 96 100 25  26 163 160 0.6   1.0 
12 16904 114 110 30  28 180 185 0.4   0.8 
13 18009 86 95 22  20 202 200 0.8   1.0 
14 16546 90 126 30  33 160 160 0.6   0.7 
15 23579 97 112 14  20 202 200 0.8   1.0 
16 23076 130 140 29  32 184 185 0.7   0.8 
17 9660 100 115 27  30 171 165 0.6   0.5 
18 3611 110 120 29  31 165 168 0.5   0.7 
19 22817 80 77 20  24 189 185 0.8   1.0 
20 14838 86 95 20  26 202 200 1.2   1.0 
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URINE ANALYSIS 
S.No 
OP 
No 
     
Urine 
Analysis      
  Before Treatment    After Treatment  
Alb Sug P.C E.C RBC 
Cast/ 
Crystal Alb Sug P.C E.C RBC 
Cast/ 
Crystal 
1 6749 NIL NIL NAD 2-3 NAD NAD NIL NIL NAD 1-2 NAD NAD 
2 9209 NIL NIL 1-4 4-5 2-3 NAD NIL NIL NAD NAD NAD NAD 
3 11609 Traces NIL 1-2 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
4 12967 Traces NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
5 10907 NIL NIL 2-5 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
6 14148 NIL ++ NAD 1-2 NAD NAD NIL NIL NAD NAD NAD NAD 
7 13799 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
8 21310 ++ NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
9 20374 NIL NIL 1-3 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
10 9053 NIL ++ NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
11 11638 NIL NIL NAD 2-5 5.0 NAD NIL NIL NAD NAD NAD NAD 
12 16904 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
13 18009 NIL NIL 1-3 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
14 16546 Traces NIL 1-5 NAD NAD NAD NIL Traces NAD NAD NAD NAD 
15 23579 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
16 23076 NIL ++ NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
17 9660 NIL NIL NAD 2-3 4-5 NAD NIL NIL NAD NAD NAD NAD 
18 3611 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
19 22817 NIL NIL 1-4 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
20 14838 ++ NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
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CASE SHEET OF 20 IN PATIENTS TREATED FOR KALLAIDAIPPU NOI 
 
 
 
 
S.No IP.No Name Age Sex 
Starting of 
Treatment 
End of 
Treatment 
No of 
Days 
Treated 
Results 
01 323 Pirapammal 60 F 08.02.2016 05.03.2016 26 Days Good 
02 328 Pappathi 38 F 03.02.2016 22.02.2016 20 Days Good 
03 299 Subbhuraj 55 M 04.02.2016 28.02.2016 25 Days Good 
04 276 Datchanamoorthi 53 M 02.02.2016 03.03.2016 31 Days Good 
05 275 Paulraj 60 M 02.02.2016 02.03.2016 30 Days Good 
06 973 Subbhammal 60 F 19.02.2016 01.03.2016 29 Days Good 
07 468 Lakshmanan 58 M 22.02.2016 26.03.2016 34 Days Fair 
08 499 Kamalam 50 F 25.02.2016 16.03.2016 20 Days Good 
09 550 Latha 30 F 29.02.2016 09.04.2016 39 Days Fair 
10 656 Subbulakshmi 42 F 10.03.2016 03.04.2016 20 Days Good 
11 590 Indhiran 48 M 04.02.2016 30.03.2016 25 Days Good 
12 671 Isaki 56 M 03.02.2016 25.03.2016 22 Days Good 
13 678 Durai 49 M 12.03.2016 14.04.2016 32 Days Good 
14 734 Nayinar 52 M 18.03.2016 16.04.2016 30 Days Good 
15 974 Perumal 56 M 19.03.2016 09.04.2016 20 Days Good 
16 746 Sujatha  30 F 19.03.2016 14.04.2016 25 Days Good 
17 796 Lakshmi 58 F 25.03.2016 20.04.2016 25 Days Good 
18 740 Saraswathi 60 F 25.03.2016 23.04.2016 28 Days Good 
19 793 Balammal 29 F 28.03.2016 26.04.2016 30 Days Fair 
20 950 Ponraj 42 M 03.03.2016 01.04.2016 30 Days Good 
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BIO CHEMICAL ANALYSIS 
    Before Treatment    After Treatment   
 
S.
No 
Ip. 
No 
WBC 
Total Cells/ 
Cub.mm 
WBC - 
DC% ESR 
  
WBC Total 
Cells / 
Cub.mm 
WBC – 
DC%   ESR 
  
 
 
Hb
% 
 
Hb
% 
 
              
  
P 
 
L E 1/2 hr 
 
1hr P L E 1/2 hr 
 
1hr 
 
       
 
       
 
                  
 
1 323 8600 62  31 7 38  42 10.2 9000 55 43 2 32  40 11 
 
2 328 8800 50  40 10 25  31 9.2 8200 62 35 3 16  19 9.5 
 
3 299 7800 67  30 3 6  17 12.8 8500 68 29 3 8  13 11.8 
 
4 276 7000 62  30 8 36  42 9.8 8600 58 38 14 27  32 11.2 
 
5 275 8000 55  30 15 30  38 13.8 8500 68 26 16 12  19 10.2 
 
6 973 8100 60  35 5 12  16 11.8 7100 60 33 7 22  25 10.6 
 
7 468 8300 61  27 12 30  32 10.4 7700 68 28 13 12  20 11 
 
8 499 8800 72  15 13 32  37 11.5 6800 58 40 2 20  23 9.8 
 
9 550 7000 58  40 2 25  31 12.4 7500 67 31 2 12  19 12.6 
 
10 656 7100 64  32 4 12  25 10 7800 65 33 2 6  17 10 
 
11 590 8800 66  28 6 12  20 11 8100 65 30 5 8  15 11.5 
 
12 671 8300 54  28 18 26  30 11 9100 62 35 3 32  38 12 
 
13 678 8500 60  31 9 11  18 9.5 8000 55 30 15 30  38 12.5 
 
14 734 7200 64  35 1 10  15 12 7900 58 40 2 15  28 11 
 
15 974 7000 54  31 15 28  32 11 7200 52 33 15 16  20 10.5 
 
16 746 6500 52  37 1 20  29 10.8 7800 70 22 8 16  19 12 
 
17 796 6800 70  27 3 8  19 9.5 8400 60 36 4 20  23 11.5 
 
18 740 7600 64  35 1 11  15 13.5 7700 56 42 2 8  13 10.8 
 
19 793 7100 59  36 15 18  25 10 7500 68 30 2 16  21 12 
 
20 950 8400 64  34 2 15  18 11.2 8400 62 37 1 21  24 12 
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BIO CHEMICAL ANALYSIS 
S.N0 IP No 
Blood (Sugar 
mgs%)  
Blood 
(Urea 
(mgs%) 
Total 
Cholesterol 
(mg%)  
Serum 
Creatinine 
           
(mgs
%) 
 BT    AT AT  BTBT AT BT AT  AT  BT 
1 323 104  110  19 18 115 95 0.5  0.7 
2 328 120  116  33 35 170 182 0.8  0.6 
3 299 94  120  18 22 144 140 1.2  1.0 
4 276 107  110  35 33 110 128 0.8  0.5 
5 275 125  100  15 12 215 218 0.6  0.8 
6 973 123  120  33 28 235 230 1.0  0.8 
7 468 99  102  23 28 183 170 0.6  0.5 
8 499 125  110  24 22 174 168 0.7  0.5 
9 550 150  140  35 33 200 204 1.2  0.9 
10 656 101  125  26 28 207 210 0.6  0.5 
11 590 101  120  30 28 220 200 0.8  0.6 
12 671 98  114  28 32 180 200 0.4  0.6 
13 678 130  142  26 28 167 170 0.8  0.7 
14 734 110  108  26 22 143 140 1.2  1.0 
15 974 137  130  30 34 160 146 0.7  0.5 
16 746 113  133  15 21 125 117 0.5  0.6 
17 796 100  94  25 21 164 140 0.5  0.8 
18 740 126  130  18 20 176 161 0.3  0.6 
19 793 104  110  27 32 245 220 0.7  0.8 
20 950 100  98  33 38 220 200 1.2  0.8 
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URINE ANALYSIS 
       
Urine 
Analysis      
S.No 
IP 
No   
Before 
Treatment    After Treatment  
  Alb Sug P.C E.C RBC 
Cast/ 
Crystal Alb Sug P.C E.C RBC 
Cast/ 
Crystal 
1 323 NIL NIL 1-2 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
2 328 NIL NIL 1-4 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
3 299 NIL NIL 1-2 1-2 NAD NAD NIL NIL NAD NAD NAD NAD 
4 276 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
5 275 Traces NIL 2-5 NAD NAD NAD Traces NIL NAD NAD NAD NAD 
6 973 ++ NIL NAD NAD 5-6 NAD NIL NIL NAD NAD NAD NAD 
7 468 NIL NIL NAD 2-3 NAD NAD NIL NIL NAD NAD NAD NAD 
8 499 NIL ++ NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
9 550 NIL NIL 5-7 NAD 5.0 NAD NIL NIL 1-2 NAD NAD NAD 
10 656 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
11 590 ++ NIL 2-4 2-5 NAD NAD NIL NIL NAD 0-1 NAD NAD 
12 671 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
13 678 NIL NIL 2-4 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
14 734 NIL NIL NAD NAD 5.2 NAD NIL NIL NAD NAD NAD NAD 
15 974 Traces NIL 2-3 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
16 746 NIL NIL NAD NAD NAD NAD NIL NIL NAD NAD NAD NAD 
17 796 NIL NIL 2-5 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
18 740 NIL ++ NAD 1-2 NAD NAD NIL NIL NAD 0-1 NAD NAD 
19 793 NIL NIL 2-3 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
20 950 NIL NIL 1-2 NAD NAD NAD NIL NIL NAD NAD NAD NAD 
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DISCUSSION 
         The  present  study  is  “To  evaluate  the  efficacy  of Clinical Randamized 
control trial  drug NILAKUMILAVER KUDINEER   (Internal)” in the treatment of 
kalladaippu,(Urolithiasis). Out of 20 out patients and 20 in patients were selected 
based on clinical features and modern investigations parameters and siddha diagnostic 
methods (envagai thaervugal) were  carried out  after the disease.It is confirmed by 
ultrasonagram. The trial drug  NILAKUMILAVER KUDINEER  was prepared and 
given to the patients. The reports of urine, blood and general details were collected 
from the patients before and after treatment. The urolithiasis symptom score of each 
patient before and after treatment were compared to assess the therapeutic value of 
the trail drug   “NILAKUMILAVER  KUDINEER” . 
AGE 
In this study, among the 20 out-patients, Kalladaippu noi was found to be the 
most common in the age group, 41-50 years (35%) and in case of inpatients, it was 
predominant (65%) in the age group, of 51-60 years. 
SEX 
It was observed from the study that among the 20 outpatients majority of 
them (70%) were male and (30%) were female. Whereas among inpatients majority 
of them were females (50%) and (50%) were male cases. 
RELIGION 
        In the current study the majority of both outpatients (80%) and inpatients (90%) 
were hindus. Only a minority of them were Christians (10%) and muslims (10%) 
among outpatients and inpatients. 
OCCUPATION  
From the data collected during the enrolment of patients it was learnt that 
25% of the outpatients were engaged in private jobs and 35% of the inpatients were 
home makers. The rest of them were of coolies (25% of OP and 30% of IP), farmers 
(20% of OP and 15% of IP), and retired employees (5% of OP and 5% of IP). 
 
SOCIO-ECONOMIC STATUS 
The present study revealed that of ( 50% OPD and 45%  IPD) and were 
hailing from the poor class. The second majority were from middle sector (30% of 
outpatients and 40% of inpatients). Patients from rich sector were only 20% and the 
visited OP to attain treatment.  
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FOOD HABITS 
Out of the 40 cases who were recruited for the study majority of them (60% of 
outpatients and 75% of inpatients) were taking mixed diet comprising both vegetarian 
and non-vegetarian items. 
PERSONAL HABITS 
           From the history taken from the patients it was noted that 45% of outpatients 
and  50% inpatients were not involved in any bad habits. 15% of outpatients and 20% 
inpatients had alcoholies. 
AETIOLOGICAL FACTORS 
It was learnt that 70% of outpatients and 80% of inpatients had others causes 
of Kalladaippu noi. 15% of outpatients and 10% of inpatients had known previous 
history of Kalladaippu noi. In the Recurrent UTI (15% of OP and 10% of IP), 
Kalladaippu noi might be attributed to other causes such as altered food habits, 
inadequate water intake and drinking contaminated water / hard water. 
THINAI 
Among the patients who were selected for the trial 75% of the outpatients and 
60% of the inpatients were from marutha nilam. 20% of inpatients were from mullai 
nilam and 20% of inpatients were from neithal nilam. 
MUKKUTRA KAALAM 
It is vivid from the history of the patients that majority of them (70% of 
outpatients and 85% of inpatients) were in Pitha Kaalam (34 – 66 years). The rest of 
them (30% of outpatients and 15% of inpatients) fell under Vatha kaalam (0 – 33 
years). 
PARUVAKAALAM 
In general, Kalladaippu noi occurs in all the seasons. But in the present study, 
it was found to be the commonest during pinpani kalam (80% outpatients 15% of 
inpatients) and munpani kaalam (15% of outpatients 60% of inpatients). Only 5% of 
outpatients suffered from this disease during Ilavenil and 10% koothir kaalam. 
THEGI (CONSTITUTION OF BODY) 
In this study,Vatha thegi patients were found to be the most affected by 
Kalladippu noi (50% of outpatients and 60% of inpatients), The second major were 
Pitha thegi (25% of outpatients and 20% inpatients). Only a few of them (25% of 
outpatients and 20% of inpatients) were Kabha thegi.  
 
108 
MUKKUTRAM 
A. DERANGEMENT OF VATHAM 
In the contemporary study, it was noted that all the patients under treatment 
had disturbances in Abaanan and Samaanan, which was the primary cause for 
oliguria, dysuria and formation of calculi. Viyaanan was affected in 50% of 
outpatients and 65% of inpatients which was the cause for renal colic experienced by 
the patients. Derangement in Dhevathathan (20% of outpatients and 10% of 
inpatients) caused tiredness in the patients and disturbances in Uthaanan resulted in 
nausea / vomiting in 50% of outpatients and 60% inpatients. 
B. DERANGEMENT OF PITHAM 
It was noted that Sadhagam was affected in 40% of outpatients and 55% of 
inpatients resulting in dysuria, renal colic and difficulty in their regular work in day to 
day life. Ranjagam was found to be disturbed in 30% of outpatients and 20% of 
inpatients. 
C. DERANGEMENT OF KAPAM 
Santhigam was found to be affected in 30% of outpatients and 20% of 
inpatients, causing joint pain in elderly patients. 
 
UDAL THATHUKKAL 
Among the patients selected for the study Saaram was affected in all patients 
causing sluggishness. Enbu thaathu was found to be affected in 30% of outpatients 
and 25% of inpatients and they suffered from arthralgia. Senneer was found to be 
affected in 25% of outpatients and 40% of inpatients. 
 
ENVAGAI THAERVUGAL 
In this study, Moothiram was affected in all the patients.Naa was affected in 
10% of outpatients and 10% of inpatients featuring fissures in their tongue. Vatha 
pitha naadi was felt in most of the patients (50% of outpatients and 60% of 
inpatients).The second major type of naadi was Pitha vatha naadi (15% of outpatients 
and 10% of inpatients).It was noticed that only 20% of the outpatients 20% of the 
inpatients had vatha kabha and 5% of inpatients affected by Kaba pitha and Pitha 
kabha naadi. 
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NEERKURI  
        It was noted that the urine colour was yellowish in 60% of outpatients and 70% 
inpatients and it was normal in 30% of outpatients and 20% of inpatients. Edai, 
Manam and Nurai were normal in all the patients. There were no deposits found in 
the samples of all the patients. 
NEIKURI 
When Neikuri was tested in the urine samples of the patients it was observed 
that the urine samples of majority of them (50% of outpatients and 55% of inpatients) 
revealed that kalapu neer. (30% of outpatients and 30% of inpatients) Vatha neer. 
DURATION OF ILLNESS 
          Majority of the patients experienced symptoms of Kalladaippu noi only in the 
past 2-6 months period (30% of outpatients and 20% of inpatients) and 6 months – 1 
year (10% of outpatients and 25% of inpatients). 30% of outpatients and 25% of 
inpatients suffered from the disease less than one month. 
TYPE OF PAIN 
Through investigations in patients it was observed that 35% of the inpatients 
and 45% of outpatients suffered from severe pain and 35% of outpatients and 40% of 
inpatients experienced moderate pain on their first visit. 30% of outpatients 15% 
inpatients experienced mild pain. But at the the end of treatment only 15% of 
outpatients 5% of inpatients of the total 40 patients were found with moderate pain. 
Majority of them (80%) were relieved from renal colic. 
SEVERITY OF DYSURIA 
            On their first visit majority of the cases ( 50% of outpatients and 55% of 
inpatients) experienced severe dysuria and moderate dysuria ( 35% of outpatients and 
30% of inpatients). On their subsequent visits the symptom decreased and finally at 
the end of the trial only 15% of the outpatients experienced mild dysuria and 10% of 
inpatients experienced moderate pain. 
NUMBER OF STONES 
          Most of the ultrasonogram reports of the patients (55% of outpatients and 60% 
of inpatients ) revealed single stones and 45% of outpatients and 40% of inpatients 
revealed multiple stones on the day of enrolment. At the end of the trial only a few 
cases (10% of outpatients and 15% of inpatients with single stone, 10% of outpatients 
and 5% of inpatients with multiple stones) presented with stones in their USG reports. 
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SIZE OF STONES  
           The USG reports of the cases before treatment showed that majority of the 
cases (50% of the outpatients and 40% of the inpatients) presented with stone of size 
4 to 5mm . But after treatment only 10% of outpatients and 5% of inpatients had 
stones of size  4to 5mm . 
POSITION OF STONES 
           The USG reports of the patients before treatment revealed stones which were 
mostly (60% of outpatients and 70% of inpatients) present in the calyces of 
kidney.Ureteric calculi were comparatively lesser (30% in outpatients and 15% in 
inpatients) and only 5% of outpatients and 15% of inpatients had stones both in 
kidneys and ureter. After treatment 15% of outpatients and 5% of inpatients had renal 
calculi and 5% of outpatients had ureteric calculus. 
STONE ANALYSIS 
Three stones were received from 3 different patients at the end of the 
treatment. Three stones were analysed in a well reputed laboratory to determine the 
composition of stones. The analysis of the stones indicated the presence of calcium 
oxalate. The stone analysis reports of all the three patients are enclosed as Annexure 
VI. 
PRECIPITATING FACTORS 
In the present study, the personal history of patients and laboratory 
investigations revealed that the occurrence of Kalladaippu noi might be attributed to 
altered food habits , drinking contaminated water / hard water, inadequate water 
intake, suppressing seminal discharge, and poor health awareness. 
 
TREATMENT 
The trail  medicine  selected  for  the  clinical  study  was   
NILAKUMILAVER KUDINEER  -50ml  BD morning & evening . The present 
study proved the therapeutic values of the trial medicine which is evident from the 
absence of calculi and symptoms associated with kalladaippu noi in majority of the 
patients. Good response was noticed in 50% of outpatients and 65% of inpatients and 
moderate response in 25% of outpatients and 15% of inpatients. The good and 
moderate response of trial drug in treating Kalladaippu noi is attributed to the 
lithotriptic , diuretic  and analgesic effects of the trial medicine. 
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SUMMARY 
A  study on Kalladaippu noi with the following Clinical trial medicine was 
undertaken for my dissertation work at the Post Graduate Department of Pothu 
Maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai. 
            The trial drug is NILAKUMILAVER KUDINEER - 50ml BD morning & 
evening  (internal). 
The study was conducted 
 To find therapeutic out the efficacy of the trial medicine in dissolving or 
disintegrating the calculus.  
 To know the efficiency of the medicine in spontaneous expulsion of the 
calculi.  
 To know about the recurrence (or) any adverse effects in the patients 
during the course of treatment with the trial medicine 
The patients were showed good prognosis within a short period. Renal 
colic and burning micturation reduced within 5 days of treatment. It was observed 
that all other signs and symptoms relieved at the end of course of the treatment 
with the trial medicine and strict diet restriction (pathiyam). From the clinical 
examination and enquiring the patients, it was noted that stones were broken into 
fragments and expelled out in the form of sand grains and gravels with urine. It 
was evident from the laboratory and ultra-sonographic investigations that the trial 
medicines helped in the spontaneous expulsion of calculus in some of the patients. 
Good response was noticed is in 80% of OPD and  75% of IPD and 
moderate response in 20% of outpatients and 25% of inpatients. The patients were 
advised to take the trial medicine, NILAKUMILAVER KUDINEER after food. 
As the ingredients included in the trial drug have lithotriptic , diuretic and 
analgesic effects, they should have compensated the deranged pitham in 
Kalladaippu and initiated diuretic action to expel the stone. The patients were 
advised to restrict diet to avoid recurrence.  
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The pharmacological study revealed that the trial medicine had lithotriptic, 
diuretic and analgesic effects. The acute toxicity study revealed that the trial drug 
did not produce any toxic effects. Accordingly, the patients under treatment also 
did not experience any adverse effects during the course of treatment with the trial 
medicine. 
In this study, it has been proved that the trial medicine,  
NILAKUMILAVER KUDINEER  (Internal)  is  highly  effective  and  
economically  viable   in  curing  KALLADAIPPU NOI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
The following  conclusions  have  been drawn from the Open Labelled Phase II,  
RCT  study on “The evaluation of efficacy of the trial drug, (internal) in 
NILAKUMILAVER KUDINEER  treating KALLADAIPPU NOI”, was carried out at 
the PG Department of Pothu Maruthuvam, Government Siddha Medical College and 
Hospital, Palayamkottai as my dissertation work. 
 
1. The ingredients incorporated in the trial medicine helped to cure Kalladaippu noi 
by compensating the increased pitham which is attributed to the diuretic, 
lithotriptic action, analgesic effect, as mentioned in the various siddha literatures - 
Annexure I. (Page No – 114) 
2. The biochemical analysis of trial medicine revealed that the presence of various 
minerals like Calcium, Chloride, and Ferrous Iron - Annexure II. (Page No – 
117)  
3. The acute toxicity study on the trial medicine revealed that it had no toxic effects 
– Annexure III.  
4. The pharmacological study on trial medicine revealed the lithotriptic, diuretic and 
analgesic effect of the trial medicine – Annexure IV.  
5. The Ultra sonogram reports of patients before treatment and after treatment were 
compared to evaluate the prognosis in patients – Annexure V  
6. The analysis of the stones of some of the patients revealed that the presence of 
calcium oxalate - Annexure VI.  
7. Clinically, the trial medicine is free from side effects as no patient experienced 
side effects during the course of treatment.  
8. The result showed good response in 80% of outpatients and 75% of inpatients and 
moderate response in 20% of outpatients and 25% of inpatients. 
The trial medicine was found to have lithotriptic, diuretic analgesic effect, and 
have properties to compensate the increased pitham, which is one of the important causes 
for Kalladaippu. From this study, it has been proved that the trial medicine, is highly 
effective a NILAKUMILAVER KUDINEER and economically viable in curing 
Kalladaippu noi.  
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 ANNEXURE - I 
PREPARATION OF TRIAL MEDICINE 
                          The purified drug is coarsely pounding or milling. For the preparation of    
decotion   25gms of the powder is boiled and make kashayam. 
NILAKUMILAVER KUDINEER(Internal) 
                      The following  raw drug  required for the preparation of  trial medicine 
Nilakumilaver were purchased. 
 
Name of the Drug Nilakumilaver 
Botanical Name     Gmelina asiatica 
Family Name         Verbenaceae 
Parts used               Roots , Leaves 
Quantity 350gms 
Pharmacological 
action 
Anti inflammatory, Diuretic, Alterative, Demulcent, 
Aromatic  
 
         Characters  ; 
             Rit  : rpWifg;G 
             jd;ik : jl;gk; 
             gphpT   : ,dpg;G 
    Dosage: 
                        50ml twice a day 
         Duration: 
                        30 days.  
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epyf;Fkpo; 
               “NgjpNahL fz;nrhUfy; Nguhj rPjsKk; 
             thjtyp nfhl;lhtp khe;jKk; Nghk; - Xjr; 
             ryf;Fkpiof; nahj;j jdf;fUq;fs; khNj 
             epyf;Fkpiof; ifapnyL eP” 
 
      ,jid ePhpdpy; Nrh;j;J myr ePuhdJ FoFog;Gj; jd;ikailAk;. ,jid  
nfhLj;Jtu ntl;il ePh;f;fLg;G ePh;g;igjhgpjk; ePq;Fk; 
 
NtW ngah;fs; 
         mKjr;Nrhfpjk; 
         nrbf;Fkpo; 
         rhujp 
         Fkps; 
         epyf;Fkpo; 
                          (rhk;grptk; gps;isj;jkpo;) 
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epyf;FopoNtH FbePH 
 
NrUk; ruf;F 
  
epyf;Fkpo; NtH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE - II 
BIO-CHEMICAL ANALYSIS OF NILAKUMILAVER KUDINEER 
Preparation of the extract: 
5gms of the drug was weighed accurately and placed in a 250ml clean beaker. 
Then 50ml of distilled water was added to it and dissolved well. Then it was boiled well 
for about 10 minutes. It was cooled and filtered in a 100ml volumetric flask and then it 
is make up to 100ml with distilled water this fluid was taken for analysis. 
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1. TEST FOR CALCIUM 
2ml of the above prepared extract is taken 
in a clean test tube. To this add 2ml of 
4% Ammonium oxalate solution 
A white 
precipitate is 
formed 
Indicates the 
presence of 
calcium 
2. TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
chloride solution. 
No white 
precepitate is 
formed 
Absence of 
sulphate 
3. TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution 
No white 
precipitate is 
formed 
Absence of 
chloride 
4. TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
No Brisk 
effervessence is 
formed 
Absence of 
carbonate 
5. TEST FOR STARCH 
The extract is added with weak iodine  
solution 
Blue colour is 
formed 
Indicates the 
presence of 
starch 
6. TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro cyanide. 
 No blue colour is 
formed 
Absence of 
ferric iron 
7. TEST OF FERROUS IRON  
The extract is treated with concentrated 
Nitric acid and Ammonium thiocyanate 
solution 
Blood red colour 
is formed 
Indicates the 
presence of 
ferrous iron 
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8. TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow 
precipitate is 
formed 
Absence of 
phosphate 
9. TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No Yellow 
precipitate is 
formed 
Absence of 
Albumin 
10. TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
Blue black 
precipitate is 
formed 
Indicates the 
presence of 
tannic acid 
11. TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It gets 
decolourised. 
 
Indicates the 
presence of 
unsaturated 
compound 
12. TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 
2 minutes and add 8-10 drops of the 
extract and again boil it for 2 minutes. 
Colour change 
occurs. 
Indicates the 
presence of 
Reducing 
sugar 
13. TEST FOR AMINO ACID 
One or two drops of the extract is placed 
on a filter paper and dried well. After 
drying, 1% Ninhydrin is sprayed over the 
same and dried it well. 
No Violet colour 
is formed 
Absence of 
Amino acid 
14. TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white 
precipitate is 
formed 
Absence of 
Zinc. 
 
Inference: 
The  extract  prepared  from  the  given  sample  NILAKUMILAVER 
KUDINEER contains  Calcium,  starch,  ferrous  iron,  tannic  acid,  reducing  sugar  and 
unsaturated compounds.  Biochemical Analyis report was done by Department of Bio 
Chemistry,      Government   Siddha   Medical College, Palayamkottai.  
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ANNEXURE – III 
PHARMACOLOGICAL ANALYSIS 
EVALUATION OF ANTILITHIATIC EFFECT OF NILAKUMILAVER  
KUDINEER ON 1%ETHYLENE GLYCOL INDUCED  
LITHIASIS IN ALBINO RATS 
INTRODUCTION 
Urinary stone disease has afflicted humankind since antiquity and can persist, 
with serious medical consequences, throughout a patient’s lifetime. In addition, the 
incidence of kidney stones has been increased in western societies in the last five 
decades,in association with economic development. Most calculi in the urinary system 
arise from a common component of urine, e.g.calcium oxalate (CaOx), representing up to 
80% of analyzed stones (1).Currently, open renal surgery for nephrolithiasis is unusual 
and used only rarely since the introduction of extracorporeal shockwave lithotripsy 
(ESWL), which has revolutionized urological practice and almost become the standard 
procedure for eliminating kidney stones. However, in addition to the traumatic effects of 
shock waves, persistent residual stone fragments and the possibility of infection, suggest 
that ESWL may cause acute renal injury, a decrease in renal function and an increase in 
stone recurrence (2,3). 
A number of vegetable drugs have been used in India and elsewhere which claim 
efficient cure of urinary stones (4). In the indigenous system of medicine, the 
Nilakumilaver Kudineer is reported to be useful in the treatment of urinary stones. 
However, so far no systematic study has been reported regarding the 
antiurolithiatic property of Nilakumilaver Kudineer. In the present study, an effort has 
been made to establish the scientific validity for the antiurolithiatic property of 
Nilakumilaver Kudineer using ethylene glycol induced hyperoxaluria model in rats. 
 
Materials and methods 
 Preparation of choornam  
 Pharmacological screening for antiurolithiatic activity  
 Animal selection  
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For  acute  toxicity  studies,  Wistar  albino  mice  of  either  sex  weighing 
between 25 and 30 g were selected and healthy adult male Wistar albino rats weighing 
between 150 and 200 g were selected for the antiurolithiatic activity. The animals were 
acclimatized to standard laboratory conditions (temperature:25±2 ◦C) and maintained on 
12-h light:12-h dark cycle. They were provided with regular rat chow(Lipton India Ltd., 
Mumbai,India) and drinking water ad libitum. The animal care and experimental 
protocols were in accordance with Institutional Animal 
 
Ethical Committee (IAEC). 
Acute toxicity studies 
        The acute oral toxicity study (5)was carried out as per the guidelines set by 
Organization for Economic Cooperation and Development(OECD)received from 
Committee for the Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA).One-tenth of the median lethal dose (LD50)was taken as an effective dose(6) 
Ethylene glycol induced urolithiasis model 
Ethylene glycol induced hyperoxaluria model (7) was used to assess the 
antilithiatic activity in albino rats. Animals were divided into eight groups containing 
six animals in each. 
 
ANTI LITHOLYTIC ACTIVITY 
Antilithiotic activity 
 Urolithiasis is the third most common disease of the urinary tract and it is 
affecting the human beings since the earliest days. The recognition of different types of 
urinary calculi also resulted in more varieties of medical treatment. Still recurrence rates 
continue to be high with one of every two patients having another stone within 5 years. 
So, there is a need to develop new drugs to prevent the recurrence of kidney stones. In 
most cases of the urolithiasis, the common component is either calcium oxalate (75-90%) 
or magnesium ammonium phosphate to an extent of 5-10%. Many remedies have been 
employed during ages to treat urinary stones. Most of the remedies were taken from 
plants and proved to be useful.  
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Chemicals and apparatus 
Ethylene glycol was obtained from Merck Ltd., Mumbai, India. All other 
chemicals and reagents used were analytical grade and procured from approved chemical 
suppliers. Apparatus such as the metabolic cages (Tecniplast, Italy), semiautoanalyzer 
(Metrolab, 1600-DR), cold centrifuge (Remi Instruments, C-30BL), UVspectrometer 
(Shimadzu Scientific Instruments, UV-3600) were used in the study 
Animals 
Male Wistar albino rats (120-150gm) were used for this experiment. They were 
maintained at 25 ± 2° C and relative humidity of 45 to 55% and under standard 
environmental conditions (12 hr. light 12 hr. dark cycle). The animals had free access to 
food (Sri Venkateswaraa Enterprises, Bangalore, India) and water ad libitum.  
Treatment protocol 
Method : Ethylene glycol and ammonium chloride induced hyperoxaluria model was 
used to induce calcium oxalate urolithiasis.  
Groups – 5 groups of 6 animals each 
Group – I  : Treated as normal control received 10ml/kg of normal saline through           
     orally 
Group – II  : Urolithatic control received calculi inducing treatment for 28 days, 
comprised of 0.75% v/v ethylene glycol with 1% w/v ammonium chloride 
in drinking water ad libitum for three days to accelerate lithiasis followed 
by only 0.75% v/v ethylene glycol for 25 days 
Group – III  : treated as Test - I received 100mg/kg of Nilakumilaver Kudineer with 2 
ml of sterile water through orally  for 28 days + received calculi inducing 
treatment for 28 days, comprised of 0.75% v/v ethylene glycol with 1% 
w/v ammonium chloride in drinking water ad libitum for three days to 
accelerate lithiasis followed by only 0.75% v/v ethylene glycol for next 25 
days 
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Group- IV : treated as Test - 2 received 200mg/kg of Nilakumilaver Kudineer with 2 
ml of sterile water through orally for 28 days + received calculi inducing 
treatment for 28 days, comprised of 0.75% v/v ethylene glycol with 1% 
w/v ammonium chloride in drinking water ad libitum for three days to 
accelerate lithiasis followed by only 0.75% v/v ethylene glycol for next 25 
days 
Collection and analysis of urine 
On the 28th day of calculi induction treatment, all animals were kept in individual 
metabolic cages and urine samples of 24 h were collected. The collected urine samples 
were measured for following parameters. 
Urine volume 
Animals were placed in separate metabolic cages for 24 h and total urinary 
volume was measured using the measuring cylinder and reported in ml. 
Urine pH 
Uric acid crystals were found to deposit most frequently in the concentrated acid urine. 
Thus, the acidity of the urine was tested using the pH meter. 
Urinary oxalate 
The 1 ml of urine was acidified beforehand by concentrated HNO3 to solubilize 
crystals and then adjusted to pH 7 by NaOH in the presence of color indicator, the 
bromothymol blue. About 2ml of saturated CaSO4 and 14 ml of pure ethanol were added 
to precipitate oxalate overnight. The samples were centrifuged at 450× g for 10 min and 
then filtered on filter paper. The precipitate obtained was solubilized in 10 ml of water 
acidified by 2ml of concentrated sulfuric acid. The samples were titrated by a solution of 
KMnO4. 
Urine calcium 
It was estimated by using commercially available standard kit of Biolab 
diagnostics Pvt. Ltd. Tarapur (India) as per o-cresolphthalein complexone method. 
Determination of urine calcium was done by using CHARIOT prince autoanalyser. 
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Urine magnesium 
It was estimated by using commercially available standard kit supplied by Biolab 
diagnostics Pvt. Ltd. Tarapur (India) as per Calmagite method. Determination of urine 
magnesium was done by using CHARIOT prince autoanalyser. 
Collection and Serum analysis 
After urine collection period, blood was obtained from the retro-orbital under 
anaesthetic condition and animals were sacrificed by cervical decapitation. Serum were 
separated by centrifugation and analyzed. 
Serum uric acid 
It was estimated by using commercially available standard kit of Biolab 
diagnostics Pvt. Ltd. Tarapur (India) as per Colorimetric enzymatic method and analysed 
by CHARIOT prince autoanalyser. 
Serum creatinine 
It was estimated by using commercially available standard kit as per 
Urease/salisylate method. Determination of serum creatinine was done by using 
CHARIOT prince biochemistry autoanalyser. 
Blood urea 
It was estimated by using commercially available standard diagnostic kit of 
Biolab Diagnostics-India using diacetymonoxime colorimetric end-point method. 
Determination of Blood urea was done by using CHARIOT prince biochemistry 
autoanalyzer. 
Kidney homogenate analysis 
The abdomen was cut open to remove both kidneys from each animal. Isolated 
kidneys were cleaned off extraneous tissue and rinsed in ice-cold physiological saline. 
The left kidney was finely minced and 10 % homogenate was prepared in Tris-Hcl buffer 
(0.02 mol/l, pH 7.4). The homogenate was used for measurement of various biochemical 
parameters. 
Estimation of biochemical markers 
The homogenate was used to assay the marker enzymes in serum, urine and tissue 
constituents like ACP, Alkaline phosphate (ALP), Aspartate aminotransferase (AST), 
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Alanine aminotransferase (ALT) and Lactate dehydrogenase (LDH) were estimated 
respectively using different types of enzyme marker kits. 
STATISTICAL ANALYSIS 
Data expressed as Mean ± S.E.M. The data were analyzed using one-way analysis 
of variance (ANOVA) followed by Dunnett’s test and p<0.05 considered as statistical 
significant. 
Effect of Decoction of Nilakumilaver Kudineer on urinary excretion 
Group Treatment Dose 
Urine 
Calcium 
(mg/dl) 
Oxalate 
(mg/dl) 
I 
Control 
(Distilled water) 
 
2 ml/kg, p.o. 
1.842 
± 
0.010 
0.841 
± 
0.011 
II 
Urolithiatic Control 
(Gentamycin + CPD) 
 
80mg/kg, i.p. 
10.669 
± 
0.177 
3.314 
± 
0.080 
III 
Standard 
(Cystone) 
 
750 mg/kg, p.o. 
9.110 
± 
0.047 
0.174 
± 
0.007 
IV 
Gentamycin 
+  
Nilakumilaver 
Kudineer 
80mg/kg, i.p  
+ 
100 mg/kg, p.o. 
4.462 
± 
0.103
 
1.587 
± 
0.027 
V 
Gentamycin 
+  
Nilakumilaver 
Kudineer 
80mg/kg, i.p  
+ 
200 mg/kg, p.o. 
7.520 
± 
0.071 
2.619 
± 
0.127 
 
n = 6. Values are expressed as ± S.E.M.  
***P < 0.0001 vs. Control (followed by two way ANOVA). 
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 Effect of Decoction of Nilakumilaver Kudineer on Serological Parameters 
Group Treatment Dose 
Serum 
Urea 
(mg/dl) 
Creatinine 
(mg/dl) 
I 
Control 
(Distilled water) 
 
2 ml/kg, p.o. 
43.017 
± 
0.169 
0.663 
± 
0.018 
II 
Urolithiatic Control 
(Gentamycin) 
 
80mg/kg, i.p. 
173.912 
± 
0.330 
3.173 
± 
0.081 
III 
Standard 
(Cystone) 
 
750 mg/kg, 
p.o. 
48.163 
± 
0.092
 
0.542 
± 
0.007 
IV 
Gentamycin 
+  
Nilakumilaver 
Kudineer 
80mg/kg, i.p  
+ 
100 mg/kg, 
p.o. 
32.270 
± 
0.106 
0.357 
± 
0.008 
V 
Gentamycin 
+  
Nilakumilaver 
Kudineer 
80mg/kg, i.p  
+ 
200 mg/kg, 
p.o. 
34.318 
± 
0.160 
0.448 
± 
0.010 
 
n = 6. Values are expressed as ± S.E.M. 
***P < 0.0001 Vs. Control (followed by two way ANOVA).   
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ACUTE TOXICITY STUDY 
Acute oral toxicity refers to those adverse effects occurring following oral 
administration of a single dose of a single dose of a substance or multiple doses given 
within 24 hours. Acute toxic class method (OECD guidelines 423, (2000) was followed 
to arrive at the maximum safety dose of the drug extracts. Three Wistar strain female 
albino rats (8-12 weeks old, 180-200g body weight) were used in each group. Single dose 
(2g/kg) of the Nilakumilaver Kudineer was orally administered to overnight fasted (food 
but not water withheld) animals while control animals received the vehicle (0.3%w/v 
CMC). Animals were observed individually after dosing at least once during the first 4 
hrs and daily thereafter, for a total of 14days. Body weights of the animals were recorded. 
The other observations include changes for skin, fur, eyes and mucous membranes, 
respiratory, circulatory and autonomic and central nervous system and somatomotor 
activity and behavior pattern. At the end of 14 days, all animals were subjected to gross 
necropsy. 
  Statistics 
Data are expressed as mean ± SEM; data analysed by one way ANOVA followed 
by Dunnet’s  multiple range tests to determine the significance of the difference between 
the control group and rats treated with test compounds. 
* Values were considered significant at P < 0.5. 
Results 
Acute toxicity study 
All of the rats fed with the food sample showed normal general behavior, respiratory 
pattern, cardiovascular signs, motor activities, reflexes and normal change in skin and fur. 
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TABLE - 1 
Hematological values of Nilakumilaver Kudineer in the acute toxicity study 
S. No Parameter Control Sample 2g/kg 
1 White blood cells (x10
3
/µl) 9.36±0.54 8.85±0.36 
2 Hemoglobin (g/dl) 11.50±0.26 10.75±0.84 
3 Mean corpuscular volume 60.45±2.3 62.58±1.9 
4 Mean corpuscular hemoglobin conc. (g/dl) 34.56±0.86 31.36±0.25 
5 Platelet (x10
5
/µl ) 5.60±0.52 5.70±0.60 
6 Red blood cell (x10
6
/µl ) 3.87±0.24 3.75±0.30 
Values are expresses as Mean ± S.E.M. 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
Table - 2 
Blood chemical values of food sample in the acute toxicity study 
S. No Parameter Control Sample 2g/kg 
1  Glucose (mg/dl) 148.75±3.96 145.60±3.58 
2  BUN(mg/dl) 34.26±1.23 36.58±1.42 
3  Creatinine(mg/dl)  0.46±0.06 0.50±0.12 
4  Total protein (g/dl) 5.48±0.23 5.62±0.17 
5  Albumin (g/dl) 3.49±0.62 3.68±0.24 
6  Total bilirubin (mg/dl) 0.26±0.02 0.32±0.04 
7  AST (u/l) 141.5±3.76 144.25±2.43 
8  ALT (u/l) 86.36±1.75 89.47±1.26 
9  ALP (u/l) 75.57±2.16 78.64±1.88 
 
Values are expresses as Mean ± S.E.M. 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
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Discussion and conclusion 
In acute toxicity study for 14 days, at a dose of 2g/kg of Nilakumilaver Kudineer 
sample were chosen for the experiment. In the aspect of general behaviours, the rats 
treated with food sample at a single dose had no signs of behavior changes and toxic 
signs. The treated groups revealed no significant differences in body weight gain. The 
increase in body weight may have resulted from physiological changes in rats such as 
metabolism, food and water intake. However, the result from animal health monitoring in 
the entire period of 14days showed no sign of morbidity and diseases.  
The albino Wistar rats were healthy as shown by the normal appearance of 
general behavior, respiratory pattern, cardiovascular signs, motor activities, reflexes and 
normal change in skin fur. 
With regards to hematological values, most of values in treated groups were 
normal in comparison with the control group. Significantly, some values were different 
from those of the control group such as RBC, MCV, MCHC, and platelet. However, such 
values are within the normal ranges. These variations may have resulted from variation 
among animal groups (Feldman et al., 2000) (Inala et al., 2002). Therefore, these results 
suggest that the test drug did not cause hematological or immunological defects in rats.  
Furthermore, blood chemical examination was performed in order to evaluate any 
toxic effects on liver. In this study, the levels of these blood chemical values were minor 
changes and remained within the normal range (Casley and King, 1980) (Levine, 1995) 
(Angkhasirisap et al., 2002). 
In conclusion, Nilakumilaver Kudineer sample given orally to Wistar rats did not 
produce toxicities. 
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DIURETIC ACTIVITY OF NILAKUMILAVER KUDINEER 
Introduction 
Medicinal plants can be important sources of unknown chemical substances with 
potential therapeutic effects. Besides, the World Health Organization has estimated that 
over 75% of the world’s population still relies on plant-derived medicines, usually 
obtained from traditional healers, for basic health-care needs 
 
(1). The study of plant species with diuretic effects is still a fruitful research in search of 
new diuretics. Diuretics are the drugs that increase the rate of urine flow; clinically 
useful diuretics also increase the rate of excretion of Na+ (natriuresis) and an 
accompanying anion, usually Cl-. Most clinical applications of diuretics aim to reduce 
extracellular fluid volume (edema) by decreasing total body Nacl content. Although 
continued administration of diuretic causes a sustained net deficit in total Na+, the time 
course of natriuresis is finite because renal compensatory mechanisms brings Na+ 
excretion in line with the Na+ intake, a phenomenon known as diuretic braking. 
Diuretics alter the excretion of other cations (e.g. K+, H+, Ca2+, Mg2+), anions (e.g. Cl, 
HCo3- and H2Po4) and uric acid. In addition diuretics may alter renal hemodynamics 
indirectly mediated by local prostaglandins synthesis(2). 
Despite the popular use of this Nilakumilaver Kudineer  preparation, there are no 
data about the pharmacological effect of Nilakumilaver Kudineer  on diuretic activity. 
The aim of the present study was to evaluate the potential diuretic and natriuretic 
activities Nilakumilaver Kudineer on different experimental animal. 
Material and Methods 
Experimental animals 
Healthy male albino rats weighing 180-200 g were used for the study. The 
animals were maintained in polypropylene cages of standard dimensions at a 
temperature of 37 ± 1°C and standard 12h : 12h day/night rhythm. The animals were fed 
with standard rodent pellet diet (Hindustan Lever Ltd.) and water ad libitum. Prior to the 
experiment, the animals were acclimatized to the laboratory conditions. The 
experimental protocol was approved by Institutional Animal Ethical Committee (IAEC) 
constituted under CPCSEA.  
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Drug Treatment 
The Nilakumilaver Kudineer at the dose levels of 200, 400 mg/Kg body wt., p.o. 
was administered once daily for three consecutive days. Furosemide (20 mg/Kg; p.o.) 
was used as standard for diuretic activity. Control group of animals (n=6) received 
normal saline (10 ml/Kg) 
 
Experimental design 
The animals were divided into 4 groups of 6 rats each as follows; Group I: 
received only 10ml/kg normal saline Group II: received Furosemide 20 mg/kg, 
Group III: received PS 200 mg/kg body weight p.o., Group IV: received PS 400 mg/kg 
body weight p.o 
 
Diuretic activity 
Rats were fasted overnight and treated with vehicle, Furosemide and PS stated 
above along with normal saline (50 ml/kg). The rats were placed in metabolic cages and 
the urine samples were collected for 24h, measured using a standard measuring cylinder. 
The amount of urine (in ml) collected for 24 h was compared and tabulated (3). 
 
Natriuretic activity 
Estimation of Sodium and Potassium content of the urine samples of all groups 
of animals were done by using a laboratory model flame photometer. The ratio of 
Na+/K+ is calculated for Natriuretic activity. A value greater than 2.0 indicates a 
favorable Natriuretic effect. Ratio greater than 10.0 indicates a potassium sparing effect 
(4). 
 
Statistical analysis 
The results were expressed as mean ± S.E.M. Statistical comparisons were made 
by means of newmann keuls multiple range tests.p values smaller than 0.05 was 
considered as significant. 
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Table no:1 Diuretic activity of NILAKUMILAVER KUDINEER (urine Volume) in 24 
Hours 
 
      Group Treatment Urine volume 
I Normal saline 10ml/kg 7.80±0.60 
II Frusemide 20mg/kg 12.60±0.85** 
III PC 200mg/kg 12.05±0.72** 
IV PC 400mg/kg 11.80±0.65** 
 
Values are Mean ± SEM, n=6, **p<0.01. 
 
Table 2: Natriuretic activity of Nilakumilaver Kudineer 
 
Treatment  Na+ K+ Na+/K+ 
Normal Saline 1.70±0.05 0.68±0.02 2.50 
10ml/kg     
  Frusemide 3.20±0.08** 0.85±0.04** 3.76 
20mg/kg     
PC 200mg/kg 1.95±0.06* 0.70±0.01ns 2.78 
PC 400mg/kg 2.90±0.12** 0.68±0.02ns 2.22 
 
Values are Mean ± SEM, n=6, *p<0.05, **p<0.01,  NS - not significant 
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RESULTS AND DISCUSSION 
Table -1 shows the urine volume collected in 24 hours for all the groups. It is 
evident that the Nilakumilaver Kudineer treated groups excreted more urine than the 
control groups. The PC at 200 and 400 mg/kg exhibited comparable effect with that 
of the reference drug Furosemide 20 mg / kg and the results were statistically 
significant. Table -2 shows the sodium and potassium content of the urine for all 
groups. The amount of Sodium excreted was increased for Furosemide treated group; 
statistically significant rise in Na+ excretion was also noticed for PC treated groups. 
The potassium content excreted in the urine was statistically insignificant for all the 
groups. The Natriuretic effect was calculated by employing the formula Na+ / K+. It 
was found that the Nilakumilaver Kudineer treated groups possess favorable 
Natriuretic effect. The present study showed that the PC significantly increases the 
urine output and excretion of urinary sodium and had no effect on the urinary 
potassium excretion. Diuretics have two separate connotations; increase urinary per 
se and net loss of solute (i.e. electrolyte) and water (i.e. saluretic). These two 
processes are involved in the suppression of renal tubular reabsorption of electrolytes, 
water and low molecular weight organic compounds into the blood stream and a 
consequence; promote the formation of urine (5). An attempt to extrapolate the 
diuretic action of plant extract from rats to man using the activity of Furosemide in 
the organism as a guideline has been reported. The results clearly shows that the PC 
at doses of 200 and 400 mg / kg produced significant dose dependent increase in 
urinary excretion and urinary 
sodium loss but no effect on urinary potassium loss with respect to control and 
standard drug treated groups. The data demonstrates that the PC has diuretic effect, 
Natriuretic effect but no potassium sparing effect and is as potent as Furosemide. This 
indicates the use of PC as a diuretic agent based on a sound mechanistic background. 
Also the excretion of potassium ions was similar to the untreated group, which rule 
out the possibility of hypokalemia and associated ototoxicity (6). 
 
Conclusion 
From the above results, it is concluded that Nilakumilaver Kudineer used by 
folklore traditionally showed significant diuretic activity. The experimental evidence 
obtained in the laboratory model could provide a rationale for the traditional use of 
this plant as diuretic. 
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 ANALGESIC ACTIVITY OF NILAKUMILAVER KUDINEER AGAINST 
ACETIC ACID INDUCED WRITHING REFLUX IN MICE 
Analgesic activity of Nilakumilaver Kudineer at a dose of 100 mg/kg and 200 
mg/kg was evaluated by acetic acid induced writhing reflux in mice. Painful reactions 
in animals may be produced by the chemicals such as phenylquionolone, bradykinin 
etc. like that, acetic acid pain reaction which is characterized as a writhing response. 
Construction of abdomen, turning of trunk (twist) and extension of hind legs are taken 
as reaction to chemically induced pain. Analgesics (both narcotic and non-narcotic) 
inhibit writhing response. 
Requirements 
Animal: Swiss albino mice (20 – 25g) either sex 
Drugs and chemicals: Diclofenac sodium (standard), 
             Acetic acid (1%), Nilakumilaver Kudineer 
Method 
Treatment protocol 
Group- 1: Treated as normal control received 10ml/kg of normal saline through orally 
Group- 2: treated as standard control received 10mg/kg of diclofenac sodium through  
                 orally 
Group- 3: treated as Test-I received 100mg/kg of Nilakumilaver Kudineer with 2 ml  
                 of sterile water through orally 
Group- 4: treated as Test- II received 200mg/kg of Nilakumilaver Kudineer with 2 ml  
                 of sterile water through orally 
Both dose of Nilakumilaver Kudineer were administered one hour prior to the 
acetic acid administration. Note the onset on writhing. Record the numbers of 
abdominal contractions, trunk twist and extension of hind limbs as well as the number 
of animals showing such response during a period of 10 minutes were noted. 
Statistics 
Data are expressed as mean ± SEM; data analyzed by one way ANOVA 
followed by Dunnet’s  multiple range tests to determine the significance of the 
difference between the control group and rats treated with extracts. 
* Values were considered significant at P < 0.01.  
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Table - 1 
Analgesic activity of Nilakumilaver Kudineer against acetic acid induced writhing 
reflux in mice 
 
Treatment Dose (mg/kg) No. of writhing % reduction in 
reaction time 
Group I 
Normal saline 
Inject 1%v/v acetic acid 
1ml/100g of body weight 
35.2±2.6 - 
Group II 
Standard 
10mg/kg Diclofenac 
sodium through orally 
7.5±0.7 78.69*** 
Group III 
Nilakumilaver 
Kudineer 
100mg/kg administered 
through orally 
 
13.6±1.2 61.36*** 
Group IV 
Nilakumilaver 
Kudineer  
200mg/kg administered 
through orally 
 
10.4±1.5 70.45*** 
 
Values are  expressed as mean ± SEM  
Values are analysed by one way ANOVA followed by Dunnet’s multiple range tests  
*** Values were considered significant at P < 0.001. 
 
Results 
The table values show that analgesic activity of Nilakumilaver Kudineer at a 
dose of 100mg/kg and 200mg/kg by acetic acid induced writhing reflex. The result 
reveals that both doses of Nilakumilaver Kudineer possess significant analgesic 
activity at P < 0.001.  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
KALLADAIPPU (UROLITHIASIS) WITH NILAKUMILAVER KUDINEER 
 
FORM-I 
(SCREENING AND SELECTION PROFORMA) 
1.Name :_______________ 2.Age: ____3.gender: _____  4.Phone no:  _________ 
5. OP No:                                   6. IP No:                                  7. S.No: 
 INCLUSION CRITERIA:  
 Age :30 - 60Yrs 
 Sex : Both male and female 
 Colicky pain: "loin to groin".  
 Nausea, vomiting and sweating  
 Hematuria 
 Pyuria: pus in the urine. 
 Dysuria: burning on urination when passing stones  
 Oliguria: reduced urinary volume  
 Patients who are willing for admission and stay in IPD for 20 days or 
willing to attend OPD 
 Patients who are willing to undergo radiological investigation and give 
blood for laboratory investigations. 
 Patient willing to sign the informed consent stating that he/she will 
consciously  stick to the treatment during 20 days but can opt out of the 
trial of his/her own conscious discretion.  
 
EXCLUSION CRITERIA 
 In women, gynecologic processes that include ovarian torsion, ovarian 
cyst and ectopic pregnancy.  
 In men, testicular tumor, epididymitis or prostatitis 
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 Appendicitis 
 Cholecystitis 
 Diverticulitis 
 Colitis 
 Pyelonephritis 
 Perinephric abscess 
 Cystitis and UTI 
 Sexually transmitted diseases 
 Pelvic inflammatory disease 
 Post renal azotemia: the blockage of urine flow through a ureter. 
 
 
DATE  : 
STATION :      SIGNATURE OF  HOD 
 
 SIGNATURE OF INVESTIGATOR                                 SIGNATURE OF 
LECTURER 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
KALLADAIPPU(UROLITHIASIS) WITH NILAKUMILAVER KUDINEER 
 
FORM l A     
    
HISTORY PROFORMA ON ENROLLMENT 
 
1. Serial No of the case:   _______________                           2. OP/IP No:_________ 
 
       
3. Name: ________________               4. Gender:  Male                     Female    
 
 
5. Age (years): _________   DOB            
      Date       Month            Year 
 
6.Address: -------------------------------------- 
                     -------------------------------------- 
                     -------------------------------------- 
 
7.A.Occupation:    -----------------------------                      B. Nature of work----------- 
 
 
8. Educational  Status:   A) Illiterate                  B)Literate          
 
 
9.Height:---------- cms                10.Weight:----------kg 
 
11. Complaints and Duration:   
_____________________________________________________________________ 
_____________________________________________________________________ 
 
_____________________________________________________________________ 
 
12. Past History                    
 Hypertension    ______________     
   
Diabetes mellitus ______________     
   
Asthma  ______________     
   
PT   ______________ 
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HABITS 
    
A) Smoking  : 1. Yes                 duration ________ years;    Number - _____     2. No  
 
B) Alcoholism:1. Yes                duration ________ years;    Quantity- ____ ml 2. No  
 
C) Tobacco chewing:  1. Yes                duration ________ years                          2.No 
                                     
D) Betel chewing     :  1. Yes                duration ________ years                          2.No 
 
 
13. Diet style:   A.Pure vegetarian                B.Non-vegetarian                C. Mixed diet 
 
14. Drug history: Had the patient been treated before with allopathy drug?  
 
                                A) Yes                                    2) No                                     
 
15 Marital status :   1.Married         2.Unmarried                                                  
 
16. Family history : 
 
      Whether this problem runs in family?             1. Yes                               2.No   
  
       If yes, mention the relationship of affected person(s)  - 
___________________________                                                                                                                   
 
 18. Bowel habits & micturition:      Normal  
 
            History of habitual constipation              1.Yes                      2.No                                                       
 
            History of frequent diarrhoea                  1.Yes                      2.No                                                         
 
            History of frequent dysuria                     1.Yes                      2.No                
 
 
19. Psychological state:      Normal                    Anxiety                   Depression             
 
  Date    :   
   
  Station   : 
 
  Signature of the Investigator: 
 
 
  Signature of the Lecturer :                                                           Signature of the 
HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
KALLADAIPPU(UROLITHIASIS) WITH NILAKUMILAVER KUDINEER 
 
FORM II & II-A 
 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
 
1. S.NO :  ______________________       2. OP/IP NO     : _____________                            
      3.  Name  : _______________________      4. Age         : _____________    
      5. Gender  : ______________________     6. Date of assessment : __________
  
                       
 SIDDHA SYSTEM OF EXAMINATION 
1. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
      
   0
st
Day 
 
  07
th
Day
 
  
  15
th 
Day
 
        
 21
st 
Day  
 
 28
th
 Day 
 
 30
th 
Day 
Vali       
Azhal       
Iyyam       
Vali Azhal       
Azhal vali       
Iyya vali       
Vali Iyyam       
Azhal Iyyam       
 Iyya Azhal       
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II. NAA:[TONGUE] 
III.NIRAM: [COLOUR COMPLEXION]    
0
th
 Day 07th day 14th Day 21st
 
Day 28th Day 30th day 
Dark/ 
Yellow/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted / 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
Dark/ 
Yellow/ 
tinted/ 
Pale 
  0th Day 07th Day  14th Day   21st Day 28th Day 30th Day 
Colour Dark/         
Yellow/ 
Red/       
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Taste Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Sweet/ 
Bitter/ 
Sour/ 
Pungent/ 
None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Baldness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
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IV.MOZHI: [VOICE] 
 
 
 
 
V.VIZHI: [EYES] (Lower palpabrel conjunctiva)   
    
 
 
 
 
VI. MALAM; [BOWEL HABITS / STOOLS] 
 
 
 
 
0
th
 Day  07th day 14th Day 21st
 
Day 28th Day 30th day 
Medium/ 
High/ 
Low / 
Pitched 
Medium/ 
High/ 
Low/ 
Pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ 
pitched 
Medium/ 
High/ 
Low/ 
pitched 
0
th
 Day  07th day 14th Day 21st
 
Day 28th Day 30th day 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ Pale 
 0
th
 Day 07th Day 14th Day  21stDay 28th Day 30th day 
Colour Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ Pale 
 Dark/ 
Yellow/ 
Red/ 
Pale 
Dark/ 
Yellow/ 
Red/ Pale 
Dark/ 
Yellow/ 
Red/ 
Pale 
Consistency Solid/ 
Semisol
id/ 
Watery 
Solid/ 
Semisoli
d/ 
Watery 
Solid/ 
Semisoli
d/ 
Watery 
Solid/ 
Semisoli
d/ 
Watery 
Solid/ 
Semisoli
d/ 
Watery 
Solid/ 
Semisoli
d/ 
Watery 
Stool  bulk                          Normal
/ 
Reduce
d 
 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipation   Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Present/ 
Absent 
 
Diarrhoea Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
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VII. URINE EXAMINATION: 
 
NEERKURI 0
th
 Day  07th day 14th Day 21st
 
Day 28th Day  30th Day 
Niram 
[Colour]   
White/ 
Yellowi
sh/ 
Straw 
coloured
/ 
Crystal 
clear 
White/ 
Yellowis
h/Straw 
Coloured
/ 
Crystal 
clear 
White/ 
Yellowis
h/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowis
h/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowis
h/ 
Straw  
coloured/ 
Crystal 
clear 
White/ 
Yellowish
/ 
Straw  
coloured/ 
Crystal 
clear 
Manam 
[Odour] 
Present/  
Absent 
 Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Present/  
Absent 
Nurai 
[Froth] 
Nil/ 
Reduced
/ 
Increase
d 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Edai 
[Sp.gravity]                                
Normal/ 
Increase
d/ 
Reduced  
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Enjal 
[Deposits] 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Volume   Normal/ 
Increase
d/ 
Reduced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased
/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
NEIKURI 0
th
 Day  7th day 14th Day 21st
 
Day 28th Day  30th Day 
Serpentine fashion       
Annular/Ringed 
fashion 
      
Pearl beaded fashion          
Mixed fashion       
Other fashion       
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VIII. SPARISAM: [PALPATORY  PERCEPTION] 
0
th
 Day  7th day 14th Day 21st
 
Day 28thDay 30th day 
Warmth/ 
Cold/ 
 Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
 Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
Warmth/ 
Cold/ 
Sweat 
 
5. THEGI: [ TYPE OF BODY CONSTITUTION]    
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
6.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
 Kurinji                     Mullai                   Marutham                    Neithal                  Palai 
(Hilly terrain)           (Forest range)        (Plains)                     (Coastal belt)        (Arid 
regions)  
 7. KAALAM: 
Kaarkalam -                                  Pinpanikalam  -    
Koothirkalam -                             Ilavenil - 
Munpanikalam  -                          Muthuvenil - 
8. GUNAM: 
Sathuvam   -                      Rasatham -                         Thamasam  - 
9.IMPORIGAL (SENSORY ORGANS): 
  0
th
 Day  7th day  14th Day  21st
 
Day  28th Day   30th Day 
Mei  
(Skin) 
      
Vai 
(Buccal Cavity) 
      
Kann 
(Eye) 
      
Sevi 
(Ear) 
      
Mooku 
(Nose) 
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10. KANMENDRIYAM ( MOTOR ORGANS) 
 
11.KOSANGAL(Sheath)   
 0
th
 Day  7th day 14th Day  21st
 
Day 28th Day 30th Day 
Annamaya  
Kosam 
      
Pranamaya kosam        
Manomaya 
kosam  
      
Vignanamaya 
kosam  
      
Ananthamaya 
kosam  
      
 
12. MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
A)VATHAM: 
 0
th
 Day  7th day 14th Day 21st
 
Day 28th Day 30th Day 
Praanan       
Abaanan        
 0
th
 Day  7th day 14th Day 21st
 
Day 28th Day 30th Day 
Kai (upper 
limb) 
      
Kaal (lower 
limbs ) 
      
Vai   (buccal 
cavity) 
      
Eruvaai 
(excretory 
organs) 
      
Karuvaai  
(reproductive 
organs) 
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Viyaanan       
Udhaanan       
Samanan       
Naagan       
Koorman       
Kirukaran       
Devathathan       
Dhananjeyan       
 
B) PITHAM:   
 0
th
 Day  7th day 14th Day 21st
 
Day 28th Day 30th Day 
Analapitham        
 Ranjagam       
Saathagam       
Praasagam       
Aalosagam       
 
C) KABAM: 
 0
th
 Day  7th day 14th Day 21st
 
Day 28th Day 30th Day 
Avalambagam       
Kilaethagam       
Pothagam       
Tharpagam       
Santhigam       
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1.SEVEN DHATHUS: (7 SOMATIC COMPONENTS)  
 
14. SYSTEMIC EXAMINATION: 
 0
th
 Day  7th day 14th Day 21st
 
Day   28th
 
Day 30th Day 
Locomotor system       
 
Cardiovascular 
system 
 
 
     
 
Respiratory system     
 
 
     
Gastro intestinal 
system 
     
 
 
     
Central nervous 
system  
 
 
     
Urogenital system       
Endocrine system       
 
 0
th
 Day  7th day 14th Day 21st
 
Day 28th Day 30th Day 
Saaram [Chyme]       
Senneer [Blood]        
Oon [Muscle]       
Kozhuppu [Fat]       
Enbu [Bones]       
Moolai [Bone 
marrow] 
      
Sukkilam / Suronitham / 
Sperm / Ovum  
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15. GENERAL EXAMINATION: 
 0
th
 Day 7th
 
Day  14th Day  21st
 
Day 28th
 
Day 30th
 
Day 
Height (cms)       
Weight (kg)       
Temperature (F
0
)          
Pulse rate (per min)       
Heart rate (per min)       
Respiratory rate 
(per min) 
      
Blood pressure 
(mm/Hg) 
      
Pallor       
Jaundice       
Clubbing       
Cyanosis       
Lymphadenopathy       
Pedal edema       
Jugular vein 
pulsation 
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16. CLINICAL SYMPTOMS (USS): 
Urolithiasis Symptom Score 
(Circle relevant number on each line) 
1. Pain/colic 0- No pain 1- Mild pain 
2 -Moderate 
pain 
3- Severe pain 
2. Haematuria 
0 -No 
haematuria 
1- Microscopic 2- Persistent 3 -Gross 
3. Dysuria 0 -No dysuria 1- Mild dysuria 
2- Moderate 
dysuria 
3- Severe 
4. Stone  1- Single stone 
2- Multiple 
stone 
 
5. Size of 
stones 
0- Gravel < 
03mm 
1-3 mm to < 4 
mm 
2-4 mm to < 5 
mm 
3-5 mm and 
above 
6. Position of 
stone in kidney       
0- no stone in 
kidney 
1-Pelvic 
ureteric 
junction 
2 Pelvis of 
kidney 
3 Calyces of 
kidney 
7. Position of 
stone in ureter 
0- no stone in 
ureter 
1- Lower part 
of ureter 
2- Middle of 
ureter 
3- Upper part 
of 
ureter  
8. Position of 
stone in 
bladder 
0 -no stone in 
bladder 
1 -Base of 
bladder 
2- Intramural 
ureter 
 
 
 
Total scoring – 22, 1-7 mild, 8-14 moderate,15-22 severe. Symptoms score – (Some 
of 8 circled numbers) 
Date       :       
Station   : 
 
Signature of the Investigator: 
 
Signature of the Lecturer      :                                        Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI,TIRUNELVELI DISTRICT 
 
POST-GRADUATE DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
KALLADAIPPU(UROLITHIASIS) WITH NILAKUMILAVER KUDINEER 
 
FORM III-LABORATORY INVESTIGATIONS 
1 Sl.No  2 OP/IP No  
3 Bed No  4 Name  
5 Age  6 Gender  
 
I. Haemotological Investigations 
  Before Treatment After Treatment 
1 
 
TC (cells/mm)   
2 
 
DC (%)   
 a)Neutrophils  
 
 
 b)Lymphocytes  
 
 
 cMmonocytes  
 
 
 d)Eosinophils  
 
 
3 
 
ESR(mm)   
 a)1/2 hour  
 
 
 b)1 hour  
 
 
4 
 
Haemoglobin   
5 
 
Blood sugar   
6 
 
Blood urea   
7 
 
Serum creatinine   
8 
 
Serum cholesterol   
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II.URINE EXAMINATION 
 
  
 
Before Treatment After Treatment 
1 
 
Albumin 
 
  
2 Sugar 
 
  
3 Epithelial cells 
 
  
4 Pus cells 
 
  
5 Red blood cells 
 
  
6 Casts/Crystals 
 
  
 
 
 
III.USG 
           
 IMPRESSION 
 
Before Treatment After Treatment 
1 
 
Size 
 
  
2 Grade 
 
  
3 Residual Urine Volume 
 
  
4 Others 
 
  
 
 
Date       :       
Station   : 
Signature of the Investigator: 
 
Signature of the Lecturer      :                                        Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
KALLADAIPPU(UROLITHIASIS) WITH NILAKUMILAVER KUDINEER 
 
CONSENT FORM-IV A 
Certificate by Investigator 
 I certify that I have disclosed all details about the study in the terms readily 
understood by the patient. 
Date: ……………..      Signature: …………………………. 
  Name: …………………………….. 
Consent by Patient 
              I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up including 
the laboratory investigations to be performed to monitor and safeguard my body 
functions. 
    I am aware of my right to opt out of the trial at any time during the course of 
the trial without having to give the reasons for doing so. 
      I, exercising my free power of choice, hereby give my consent to be included        
             As a subject in the clinical trial of NILAKUMILAVER KUDINEER  for 
the management of KALLADAIPPU ( UROLITHIASIS) 
. 
Date: ………………..   Signature: 
………………………………… 
Name: ……………………………………. 
Date: ……………….    Signature of Witness: ……………………. 
Name………….. …………………………   
                                                                        Relationship: ……………………………. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
KALLADAIPPU(UROLITHIASIS) WITH  NILAKUMILAVER KUDINEER 
 
FORM IV B 
WITHDRAWAL FORM 
Name: ________________________       OPD/ IPD number: __________ 
Age   : ________         Sex : _____      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal: 
 Long absence at reporting       : Yes                 No 
 Irregular treatment        : Yes                 No 
 Shift of locality                                                   : Yes                 No 
 Increase in severity of symptoms                 : Yes                 No 
 Development of severe adverse drug reactions  : Yes                 No 
 Date    :      
Station :     
 SIGNATURE  OF  INVESTIGATOR                          SIGNATURE  OF     HOD 
          
                      
 SIGNATURE  OF LECTURER 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF MARUTHUVAM 
 
 PRECLINICAL AND PHASE-II RANDOMIZED OPEN CLINICAL STUDY 
ON  KALLADAIPPU(UROLITHIASIS) WITH NILAKUMILAVER 
KUDINEER 
 
FORM IV C 
PATIENT  INFORMATION SHEET 
 
 Urolithiasis is refers to the entire clinical picture of the formation and passage 
of crystal agglomerates called renal calculi or stones in the urinary tract. 
 The main factor causing this disease in to the absence of some proteins, 
glycosaminoglycans, pyrophosphate and citrate present in urine which help to 
keep otherwise salts in solute. 
 Many herbal and mineral siddha medicines are currently practiced by the 
siddha practioners for Diabetes mellitus. 
 The trial drug is prescribed only with evidence of siddha literature. 
 The trial drug is prepared at the Gunapadam lab of government siddha 
medical college & hospital,palayamkottai, under the   direct supervision of 
teaching faculties of   Maruthuvam and Gunapadam Dept. 
 
              Details of the trial drug: 
            
               NILAKUMILAVER KUDINEER  
               DOSAGE      :  50ml twice a day  
         DURATION : 30 days  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL 
KALLADAIPPU(UROLITHIASIS) WITH NILAKUMILAVER KUDINEER 
FORM  IV  E 
ADVERSE DRUG REACTION FORM 
 
Name: ________________________       OPD/ IPD No : __________ 
Age: ________      
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Description of adverse reaction: 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
Date: 
Station:  
       
SIGNATURE  OF  INVESTIGATOR                             SIGNATURE  OF   HOD 
          
                      
 
SIGNATURE  OF LECTURER 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
 
DEPARTMENT OF POTHU MARUTHUVAM 
 PRECLINICAL AND PHASE II RANDOMIZED CLINICAL TRAIL ON  
KALLADAIPPU(UROLITHIASIS) WITH  NILAKUMILAVER KUDINEER 
 
FORM IV –E 
                                               (DRUG COMPLIANCE FORM) 
 
 Name : _____________________ Age/ Sex : ___________     S. No : _________  
OPD/ IPD No : ____________ Date       : ___________   Bed No : _________   
Name Of The Drug  : NILAKUMILAVER KUDINEER  
Drugs issued date :  
Drugs returned date : 
 
S.NO DATE 
DRUG TAKEN TIME 
MORNING TIME EVENING TIME 
Day 1    
Day 2    
Day 3    
Day 4    
Day 5    
Day 6    
Day 7    
Day 8    
Day 9    
Day 12    
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Date   : 
Station   :   
SIGNATURE  OF  INVESTIGATOR :                                                               
SIGNATURE  OF   HOD       : 
          
                      
SIGNATURE  OF LECTURER      :  
 
 
            S.NO DATE MORNING/TIME EVENING/TIME 
Day 13    
Day 14    
Day 15    
Day 16    
Day 17    
Day 18    
Day 19    
Day 20    
Day 21    
Day 22    
Day 23    
Day 24    
           Day 25    
           Day 26    
Day 27    
Day 28    
Day 29    
Day 30    
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